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Abstract 
High-throughput screening is now widely used to isolate specific or improved 
activities of various enzymes. However, most of the current screening methods are 
based on in vitro procedures. The aim of this project is the development of an in vivo 
directed evolution approach to study a novel racemase enzyme. 
Although in vivo selection in itself is not new, this project emphasises a new 
approach to the high throughput in vivo concept, selecting an enzyme activity 
apparently unintended by nature. The selection, which can screen a library of 106 108 
mutants per assay, is complementary to in vitro screening, and applies new genetic 
tools for strain construction. Since the racemase under investigation is active on 
commercially important compounds, this method may also be suitable to identify and 
improve new industrial biocatalysts. The focus of the study is an N-acylamino acid 
racemase from Amycolatopsis which displays relaxed substrate specificity upon N-
acetylated amino acids but no activity towards free amino acids. As such, this 
enzyme is potentially valuable to use with well established enantioselective acylases 
for the dynamic kinetic resolution of L- or D-amino acids. However, the racemase 
displays properties which limit its usefulness as a biocatalyst, such as a low substrate 
turnover, and inhibition of activity at substrate concentrations exceeding 50mM. The 
racemase also appears to have evolved serendipitously from a different activity of the 
enolase superfamily. 
The in vivo selection developed in this work is based on the construction of specific 
auxotrophic mutants, which require expression of this racemase activity for growth. 
This offers a way to explore this very interesting and novel N-acylamino acid 
racemase activity of an enzyme in the enolase superfamily. The screening of libraries 
of variants derived from the wild type enzyme was applied, to unveil mutations 
which improve activity, and demonstrate the value of the in vivo approach. This in 
vivo selection could therefore potentially help to understand the evolution of new 
activities in the enolase superfamily and develop a new class of biocatalyst to expand 
the utility of acylase resolutions by industry. 
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1. Introduction 
Biocatalysis has been a very important and successful method for the industrial 
production of amino acids. In 1999 the total market for proteinogenic amino acids 
was about 1.5 million tons, with estimated revenue of around €3.5 billion. In respect 
of the market volume the most important amino acid is L-glutamate (650000 tons per 
year), followed by methionine (450000 tons per year), L-phenylalanine and L-
aspartate (12000 tons per year each). In general, amino acids have this considerable 
economic importance because of their broad spectrum of industrial applications[ 1 ]. 
Biosynthetic routes have been important for the production of enantiomerically pure 
amino acids, which are valuable compounds for the agricultural, pharmaceutical [2] 
and food industries. For example, L-amino acids derived from large scale 
fermentation are widely used as food additives e.g. L-glutamate in the form of 
monosodium glutamate as a flavour enhancer, L-phenylalanine[3] in the sweetener 
AspartameTM, or L-lysine and L-threonine as animal feed supplements. 
Biotransformation using immobilised enzymes has also been successfully applied to 
produce amino acids such as L-aspartate and L-methionine[4-6]. Increasingly, 
biocatalysis is also sought to prepare unnatural amino acids such as L-tert-leucine[7] 
and S-phenyl-cysteine[8] for pharmaceutical use. In these cases the enantiomerically 
pure amino acid is produced by biotransformations such as resolution and in some 
cases asymmetric synthesis. D-amino acids prepared by biocatalytic methods[9] such 
as hydantoinase[10], are also used in semi-synthetic 3—lactam antibiotics and as 
chiral synthons for organic synthesis, or as intermediates for cosmetics, pesticides 
and pharmaceuticals. The use of biocatalysis is gaining in popularity due to increased 
concerns regarding the impact of chemistry on the natural environment, which 
affects the choice for new synthetic processes. Thus, the development of new routes 
to chiral molecules, which are more environmentally friendly, has become an 
important factor for public awareness as well as for the industrial demand[ 11 ]. Tn 
addition, biocatalytic processes are often more economically and ecologically 
attractive, because less waste are produced which needs to be disposed of or 
recycled. 
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1.1. 	Routes to enantiomerically pure amino acids 
Production of amino acids can be achieved using various general routes. Amino acids 
are isolated as components of natural protein-containing material in the extractive 
processes, while alternative chemical or biological methods allow the targeted 
synthesis of amino acids. Due to the increased and broader demand by industry, 
researchers have tried to apply biocatalysis more generally, to capitalise upon the fact 
that many enzymes possess enantiospecificity unmatched elsewhere in the synthetic 
chemist's repertoire. However it has been difficult to find a general and economic 
method, as each process has particular limitations. 
1.1.1. 	Extraction 
L-cysteine is currently the main amino acid produced using extractive processes. 
Keratin from hair, feathers and animal bristles is hydrolysed by treatment with strong 
acids. The dimeric oxidation product cystine can be filtered from the hydrolysate 
because of its poor solubility. Electrochemical reduction of the disulfide bridge in 
cystine yields cysteine[12]. Although direct access to various amino acids can be 
achieved by extractive methods, the formation of salts as by-products can lead to 
considerable environmental impact. Recent approaches, using extremophilic 
biocatalysts to overcome this disadvantage have already led to promising results[13, 
14]. 
1.1.2. Fermentation 
Traditional fermentation is particularly efficient at large scale especially (>1,000 
tons/annum), but very specific and generally limited to natural L-amino acids. 
Fermentation has relied on the ability of certain microorganisms to tolerate and/or to 
excrete certain amino acids at high concentrations. Typically, L- and D-amino acids 
are toxic to cells at the high concentrations required for economical production at 
large scale and mechanisms of resistance are poorly characterised. Additionally, 
-2- 
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overproduction of a particular amino acid generally requires multiple mutations 
related to a specific biochemical pathway which are not applicable to the production 
of other amino acids. Accordingly each system requires extensive individual research 
and development, and the method therefore is generally limited to a few 
proteinogenic L-amino acids[15] (glutamic acid, lysine, phenylalanine and 
threonine). Thus, for the production of lysine, an early fermentation process made 
use of a pair of E. coil mutants (Figure 1). Wild type E. coli can synthesise its own 
lysine from carbohydrates and ammonia, but the first mutant lacked the u,-
diaminopimelic acid decarboxylase that normally converts a,E-diaminopimelic acid 
(DAP) to lysine. 
	
E. co/i mutant 	 E. coil mutant 
lacking DAP 0 	 0 	 lacking lysine 	 0 
decarboxylase decarboxylase 
carbohydrate and ammonia 	 HO OH 	 OH 
DAP decarboxylase 
NH2 	NH2 	 NH2 	NH2 
a,c—diaminopimelic acid 	 L-Iysine 
(DAP) 
Figure 1: Production of lysine using a pair of E. coil mutants 
After the concentration of DAP had reached a maximum in the presence of the first 
mutant, the first strain was removed and another E. coil strain was added. This 
mutant produced DAP decarboxylase, but lacked lysine decarboxylase, allowing 
lysine to accumulate. 
A second method to produce lysine use a single-stage fermentation process is now 
generally used for the microbial synthesis of L-lysine. A mutant of Corynebacterium 
giucamicum is used during this process. Molasses is the most common carbon 
source, and biotin is used to suppress the excretion of glutamic acid. The final 
concentration of L-lysine is reported to be nearly 60 gIL, and the fermentation cycle 
takes between 48 and 72 hours. The yield of L-lysine from carbohydrate is nearly 
40%, according to the stoichiornetry (Figure 2). 
C12H22011+ 502 + 2NH3 
	




Figure 2: Production of lysine via a single-stage fermentation process 
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Nevertheless, thanks to a detailed understanding of amino acid biosynthesis, 
fermentation methods have benefited from both recombinant and classical methods 
of strain improvement, including genetically modified strains producing 
threonine[ 16, 17] or cysteine[ 18] and methods of in vivo selection to improve 
phenylalanine biosynthesis by removing phenylalanine-mediated feedback 
inhibition[ 19]. Though amino acid production by fermentation is limited in scope, 
these general methods and molecular tools can now be more widely applied, as 
discussed below. 
1.1.3. 	Resolution 
Resolution methods have been more broadly applied than fermentation approaches 
for amino acid production. More than 60% of all enzyme reactions conducted by 
industry are enantioselective or regioselective resolution processes, which utilise 
hydrolase enzymes such as acylases esterases, amidases or lipases[20, 21]. A 
particular example of esterase activity concerns ct-Chymotrypsin. It is a serine 
protease that catalyses the hydrolysis of amide bonds of proteins at aromatic amino 
acids such as phenylalanine, tyrosine and tryptophan. It can also catalyse the 
hydrolysis of ester bonds and has been use synthetically in the enantioselective and 
regioselective transformation of a variety of amino acids. The enzyme is highly 
selective for L-amino acids and this has been exploited in the enantioselective 
hydrolysis of various protected racemic amino acid esters such as N-acetyl-DL-
tryptophan methyl ester, N-acetyl-DL-tyrosine ethyl ester and N-acetyl-DL-
phenylalanine methyl ester[22]. In each case, hydrolysis of the L-enantiomer 
occurred giving rise to the L-amino acids and the unreacted D-enantiomers, all with 
high optical purity. 
These processes are advantageous in some aspects: they are often broadly applicable 
in industry due to the relatively relaxed substrate specificity of the enzymes used[20] 
and the enzymes are often stable and appropriate for scale-up. In the case of amino 
acid manufacture, specific examples of useful hydrolytic enzymes termed acylases 
have become known, the enzyme function is well understood and the enzymes 
InTro uoO U U 
themselves are increasingly available at low cost. The example shown in Figure 3 is 




S CO2H 	 HNy 
SCO2 	







Figure 3: Resolution of N-acetyl methionine using aminoacylase 
The racemic N-acylarnino acid substrates used are inexpensively prepared (N-
acylamino acids) and recovery of the products is straightforward. Nevertheless, in the 
L-methionine process and other resolutions employing acylase, the yield is limited to 
a maximum of 50% due to the remaining unreacted isomer. To exceed this yield, 
complex and expensive recycle processes are required, generally involving chemical 
steps that often use solvents, which introduce ecological problems. If the process 
economics cannot tolerate the recycle, the unreacted isomer is discarded, creating a 
further problem in waste disposal. Accordingly, people have investigated methods to 
increase the yield of resolution reactions, such as selective crystallisation or substrate 
racemisation. This has also prompted interest in the development of asymmetric 
approaches to the synthesis of amino acids as single enantiomers using chemistry or 
biocatalysis. 
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1.1.4. 	Asymmetric methods 
In addition to the resolution of racemic mixtures as mentioned above, there are three 
main approaches to preparing optically active amino acids: chemical synthesis using 
compounds from the chiral pool, asymmetric synthesis, resolution of a racemic 
mixture as mentioned above and biotechnological methods. 
1.1.4.1. Chemical methods 
Although chemical asymmetric syntheses of amino acids are known and frequently 
applied at small scale[23, 24], there are few examples of the large scale application 
of this approach. The Strecker synthesis or the Bucherer method[25], a modification 
of the Strecker method in which ammonium carbonate takes the place of ammonia 
(Figure 4), are generally used in the industrial manufacture of racemic amino acids, 
or alternatively using cobalt or palladium as a transition metal catalyst in 
amidocarbonylation[26]. 
	
NH3 + CO2 + H20 	(NH)HCO3 	 0 
+ CH3SH 	so 
	 S 	
NH 




+1.5H2O LNH3  
+ 0.5 K2CO3 - 1.5 CO2 
0 
- KHCO3  
K 
+ CO2  
+H2O 	 NH2 
Figure 4: Methionine synthesis by the Degussa process 
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Even though there are few commercially viable chemical processes for the 
production of enantiomerically pure amino acids, racemates can still be converted 
readily into enantiomerically pure compounds by a number of biocatalytic methods. 
In the case of methionine, its principal use does not require enantiomerically pure 
methionine, as the nonnatural D-methionine can be metabolised by adults and 
animals into the biologically active L-enantiomer through a transamination reaction, 
and therefore could be synthesised using procedures that do not provide 
enantiomerically pure products. 
Interesting and potentially economical routes to amino acids using asymmetric 
synthesis have been described. These typically employ transition metal catalysts in 
hydrogenation reactions. Asymmetric hydrogenation has its origins in the soluble 
Wilkinson catalyst modified with chiral phosphine ligands. Thus, in the early 1970s, 
















Figure 5: Monsanto process for L-DOPA 
This was a landmark in industrial asymmetric synthesis[27, 28], which opened the 
way for other commercialised catalytic asymmetric syntheses promoted by a chiral 
transition metal complex, such as the Enichem synthesis of S-phenylalanine, using a 
bis-aminophosphine PNNP[29, 30]. Some more classical chemical routes have been 
studied for a long time and the list is not exhaustive[31, 32]. Still, original 
approaches were recently reported using asymmetric Strecker reactions[33], 
Mannich-type reactions (Lewis acid mediated addition)[34, 35], organolithium 
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reagents[36] or organoboranes[37, 38]. Although in some cases successful, the 
drawback to this approach remains that the catalysts are often very selective for 
substrates and therefore the method cannot be applied broadly. In addition the 
preparation of the catalyst is often expensive and there can be problems in 
recovery[39] or disposal of the heavy metals used. As a result these methods can 
often not be scaled up economically. More recent works[40-46] studied the 
combination of metal catalysts and enzymes for the synthesis of optically active 
compounds. 
1.1.4.2. Biological asymmetric methods 
Whereas living microorganisms are used as biocatalysts in the production of amino 
acids by fermentation, the catalysts in biotransforrnations have various forms, such as 
isolated enzymes or metabolically inactive cells. As a result, transformation of 
compounds that do not occur in natural metabolic pathways may be possible. Thus, 
these processes are the methods of choice for the production of D-amino acids and 
other noimatural amino acids such as L-tert-leucine. Biocatalytic routes to the 
synthesis of amino acids as single enantiomers have been extensively studied. 
Although these methods are free of some of the problems faced by metal catalysts, 
such as the cost of expensive ligands and waste disposal, they generally suffer the 
same problem of limited breadth of application. This is a major problem for applied 
biocatalysis where the development time is often longer than a chemical route. If the 
application is narrow then the risk is greater in process development at large scale. 
For example, the reductive amination of a keto acid to the corresponding a-amino 
acid using a dehydrogenase biocatalyst[47, 48] is reported to be very efficient in 
specific cases, such as the manufacture of L-tert-leucine[49, 50] (Figure 6). 
I ritroduct on 
NH2 
leucine dehydrogenase 
(H3C)3C'J~ CO2H + 
NH3 	
(H3C)3C 	CO H + H
20 
trimethylpyruvate 	 L-tert-leucine 
PEG-NADH 	PEG-NAD 
CO2 + NH3 	 HCO, NH4 
formate dehydrogenase formate 
Figure 6: Enzymatic synthesis of L-tert-leucine 
For soluble reactants and products, enzymes are preferentially immobilized in an 
enzyme-membrane reactor. To prevent the cofactor from escaping through the 
membrane, it can be enlarged with polyethyleneglycol (PEG)[51]. With a suitable 
process of cofactor regeneration, enzymatic cofactor-dependent reductive amination 
of trimethylpyruvate is the route of choice for large-scale synthesis of 
enantiomerically pure L-tert-leucine. Degussa operates an industrial process 
producing high-quality L-tert-leucine via this route. However this biocatalyst is 
dependent upon NADH for activity and requires a second biocatalyst and complex 
engineering to retain the expensive NADH[52]. As a result its application seems 
limited to particular, high value amino acids, as it has not been reported in any other 
application. 
Similarly, aminotransferases[53] have been successfully scaled for the synthesis of 
particular amino acids, such as L-2-aminobutyric acid. This type of biocatalyst is 
attractive since it has a broad specificity but is compromised because it generates a 
keto acid by-product that has to be removed. The occurrence of this by-product 
suggests that the recovery of the desired amino acid product may also be complex 




L-aspartic acid oxaloacetic acid 
asp artc 
inotrarisfcrasc 
R 	coaH y 
RCO2H H2N H 







Figure 7: Synthesis of chiral amino acids with aminotrasferases 
A more general solution, which would take advantage of the broad understanding 
and applicability of hydrolytic enzymes in kinetic resolution, would result from 
greater availability of dynamic kinetic resolution. 
1.1.4.3. Deracemisation and dynamic kinetic resolution 
Deracemisation is the conversion of a racemic mixture into a single enantiomer 
through a stereoinversion reaction, giving theoretical yields and enantiomeric excess 
(e.e.) of 100%. However, a more recent definition was proposed in 2001[54]: 
Deracemisation constitutes any process during which a racemate is converted into a 
non-racemic product in 100% theoretical yield without intermediate separation of 
materials. According to this definition, dynamic kinetic resolution, dynamic kinetic 
asymmetric transformation, dynamic thermodynamic resolution, stereoinversion, and 
enantioconvergent transformation of a racemate would all constitute subtypes of 
deracemisation. On the other hand, desymmetrisation of prochiral and meso-
compounds and kinetic resolution of racemates (including subtypes thereof, such as 
sequential or parallel kinetic resolution and enantiodivergent transformations) are not 
considered to be deracemisation. 
Dynamic kinetic resolution is a major goal[55, 56] in applied biocatalysis, as 
classical kinetic resolutions are limited to a maximum of 50% due to the remaining 
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unreacted isomer. The dynamic kinetic resolution process (Figure 8) involves a 
classical kinetic resolution coupled with in situ substrate racemisation[57]. 
kcat(R) 




(8)-substrate 	 01 (8)-product 
slow 
Figure 8: Dynamic kinetic resolution 
Substrate racemisation in theory enables complete conversion of the starting material 
to the desired product, resulting in theoretical yield and e.e. of 100%. But for the 
dynamic kinetic resolution to be effective, the rate of racemisation (krac) must be at 
least as great as the rate of product formation (kcat(R)), to reach the theoretical yield 
of 100%. For the maximum efficiency, product formation should be irreversible, the 
enantiomeric ratio (E) should be > 20 (where E= kcat(R)/ kcat(S)) and krac should be 
approximately ten times faster than kcat(R) [58]. 
Since the harsh conditions of chemical racemisation are generally incompatible in 
situ with enzymatic hydrolysis, an appealing approach is the establishment of an 
entirely enzymatic process in which substrate specific racemisation is achieved by 
means of a second enzyme which operates under conditions compatible with an 
enantioselective hydrolase such as the acylase biocatalyst mentioned above. An 
example of one such process, which has been developed commercially for amino 
acid production, involves hydantoinase reactions[59]: This process is efficient in 
certain cases, such as D-phenylglycine manufacture, although it often requires three 
biocatalysts acting in concert (hydantoinase, carbamoylase, racemase) (Figure 9). 
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Figure 9: Hydantoinase process for production of D- (or L-) amino acids by DKR 
The most versatile biocatalysts for this process currently derive from Aspergillus, but 
are not readily expressed with high efficiency and in a co-ordinated manner in a 
more readily manipulated and scalable system e.g. E. coli. This system is also 
currently limited to D-amino acids[60] although recent discoveries[61] and 
efforts[62, 63] to expand the utility of hydantoinase to L-amino acids have effectively 
applied the process of directed evolution[64, 65]. 
Despite its limitations, the hydantoinase process remains a potentially excellent and 
high yielding route and a good example of the potential utility of racemases in 
industry. 
Analogous to the hydantoinase system, the prospect of developing a substrate 
specific racemase enzyme to use in conjunction with the well-established acylase 
process is therefore extremely interesting. In the case of acylase hydrolysis, the 
substrate racemase would require being highly active and specific for N-acylated 
compounds such as N-acylamino acids but to display little or no activity upon the 
free amino acids themselves. Ideally the enzyme should also possess a broad 
substrate tolerance within the family of N-acylamino acids (Figure 10). The 
development of general methods to obtain and improve such racemase enzymes is 
the focus of this thesis. 
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Figure 10: Reaction scheme of the acylase process 
The fact that an enzyme from Arnycolatopsis species TS-1-60, has been shown to 
possess a minor level of this activity[66-70] is therefore very encouraging to the 
overall objective. Subsequently, other enzymes with similar activity have been 
described in Streptomyces atratus[71], Amycolatopsis azurea[72] and Amycolatopsis 
orientalis[73]. 
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1.2. 	N-acylamino acid racemase (NAAAR) 
1.2.1. Amycolatopsis species TS-1-60 NAAAR 
During the 1980's, work was carried out to identify a biocatalyst with N-acylamino 
acid racemase (NAAAR) activity. A screen[68-70] specifically for N-acetyl 
methionine racemase activity, employing 49,000 different strains, identified a 
racemase in an Amycolatopsis species that displays relaxed substrate specificity 
towards N-acylated amino acids but no activity towards the free amino acid 
equivalents (might be explained by substrate preference or the chemistry of cc-proton 
acidity[74, 75]). 
Some development work was carried out upon this enzyme to explore its potential 
application in the production of enantiomerically pure amino acids. Used in 
conjunction with an enantio selective amidohydrolase or acylase, this enzyme offers 
the possibility to establish a dynamic kinetic resolution process, producing a single 
amino acid isomer from racernates of particular acylated amino acid substrates. The 
enzyme shows activity upon a broad range of N-acylated amino acid substrates, 
particularly methionine and phenylalanine. The findings that N-acetyl-L-methionine 
displayed the highest activity, and that substrates with hydrophobic side-chains were 
preferred (methionine, phenylalanine, glutamine, tryptophan, leucine), suggested that 
the side-chain-binding region has a preference for binding hydrophobic moieties. 
Upon further examination by a different research group[76] the enzyme was 
characterised, not principally as a racemase but as a dehydratase, o-succinyl benzoate 
synthase (OSBS), a member of the muconate lactonising enzyme (MLE) subgroup of 
the enolase superfamily of enzymes. Before describing this superfamily, it is 
important to define what is meant by the term superfamily. One classical definition 
simply describes enzymes families as homologous enzymes of >50% sequence 
pairwise identity, known to catalyse the same reaction on structurally similar 
substrates; and superfamilies as evolutionarily related proteins of <50% sequence 
identity[77]. But homologous proteins in superfamilies may also exhibit percent 
-14- 
Introduction 
sequence identity well below 50% and have diverged to the point that they mediate 
very different overall functions. A more recent definition is that the members of 
mechanistically diverse superfamilies catalyse different overall reactions that are 
related by a common partial reaction in which a chemically similar intermediate is 
generated and significantly stabilised by conserved functional groups and elements 
of secondary and tertiary structure. In the case of the enolase superfamily, various 
subgroups of enzymes carry out distinct reactions which all involve the initial 
abstraction of a proton. 
The low level of racernase activity of the Amycolatopsis species TS-1-60 OSBS was 
confirmed and appears to be a by-product of the reaction mechanism when supplied 
with N-acylamino acid substrates. There is no evidence as to any selective pressure 
or advantage to the organism to have evolved this racemase activity. 
The NAAAR is not a very efficient catalyst for the racemisation of its "preferred" 
substrate, N-acetyl methionine; as shown by the values Of kcat, KM, and kcat/KM which 
are respectively 6.4 s, 11 mM, and 590 M' s 1[76]. The reason for the low activity 
is that NAAAR is not the natural reaction catalysed by this protein; instead, the 
protein is an OSBS as judged by the value of its "superior" kinetic constants for this 
reaction, 120 s 1 , 0.48 mM, and 2.5x105 M 1 s, respectively, for kcat, KM, and 
kcat/KM. Thus, the protein originally characterised for its activity toward racemisation 
of N-acetyl methionine has been found to show a Ca. 1000-fold greater activity 
toward dehydration of 6-hydroxy-2-succinyl-2,4-cyclohexadiene carboxylate (Figure 














Figure 11: The elimination reaction of a substituted cyclohexadiene catalysed by the 
promiscuous OSBS/NAAAR 
Accordingly, the NAAAR reaction catalyzed by the OSBS from Amycolatopsis 
species TS-1-60 is an example of functional promiscuity, arising because the 
hydrophobic substrate for the NAAAR reaction can bind in the same cavity as the 
substrate for the OSBS reaction and be properly positioned between Lys163 and 
Lys263, located at the ends the second and sixth 3-strands, respectively, so that the 
1,1-proton transfer reaction can occur (Figure 12[78]). 
A 	 B 
OSB 	 N-Ac-Met 
Lys 163 	 Lys 163 
-: 	 Lys 263 	 "V Lys 263 
"& MgY 	 d0 "( Mg 2- 
Lys 161 	 Lys 161 	I 
Asp 189 	 Asp 189 
Asp 239 	 Asp 239 
IGIu 214 	 Glu 214 
Figure 12: The active site of the promiscuous OSBS/NAAAR from Amycolatopsis species 
TS-1-60. Position of the substrate for (A): the OSBS reaction; (B): the NAAAR reaction 
The mechanisms of both the natural OSBS reaction and the promiscuous NAAAR 
reaction are initiated by abstraction of the a-proton of the substrate to generate an 
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Figure 13: The mechanism of NAAAR reaction 
The structure and mechanistic details of NAAAR are now well documented[75, 79], 
and in the case of the NAAAR expressed by Deinococcus radiodurans, the 
framework K170-D195-E220-D245-K269 was determined to catalyse 1,1-proton 
exchange of N-acylamino acids. The enzyme is constituted by four subunits 
enclosing the substrate (Figure 14[80]): catalytic site (C), metal-binding site (M), 
side-chain-binding site (S) and a flexible lid region (L). 
Lys269 S  
0 ieu2gjM 7~ 
H2N 	 Asp246 
Tyr329 o_XHK Mg...... G1u220 M 
Ty 	
H3C 	 H2N 	Asp195 




LLI 	 c 
Figure 14: Schematic representation of the 4 subunits of the active site of the NAAAR 
from D. radiodurans enclosing the substrate 
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Although examples of the potential use of NAAAR in an applied bioprocess have 
been described at low substrate concentration (<50 mM) the enzyme does not appear 
to have been developed for commercial use. This may be partly due to the highly 
competitive arena for low cost amino acid production, e.g. fermentative production, 
standard resolution approaches and alternative resolution methods employing 
enzymes such as hydantoinase. More likely is the fact that, the enzyme has 
properties, which are significantly limiting for a useful biocatalyst, such as low 
turnover, and substrate mediated inhibition at concentrations exceeding 50 mM. 
Nevertheless, there are some aspects of this enzymatic activity, which render it 
extremely attractive as an industrial biocatalyst. Primarily, it has very broad 
specificity for amino acid side chains, it is produced from a single gene (although, it 
is a monomer in E. coli, but a homo-octamer in Amycolatopsis), it requires a divalent 
metal ion for activity but no complex prosthetic group as cofactor and therefore no 
need for retention or recycling of a cofactor. In addition, the reaction substrates can 
be prepared using inexpensive and general chemistry. These properties warrant 
additional investigation of this enzymatic activity at both academic and applied 
levels, such as the potential to identify further examples of this activity or to improve 
the Amycolatopsis species TS-1--60 racemase activity and the potential to produce 
NAAAR in recombinant cells with acylase or amidase. 
Since this activity seems to have arisen by chance, as there is no known requirement 
for this activity in microbial cells, then it seems reasonable to consider that perhaps 
additional examples of NAAAR could be found if a powerful selection or screen for 
this activity was devised. Additionally, the application of a powerful high throughput 
screen or selection could enable the artificial evolution or enhancement of this 
activity using methods of directed evolution[81], which are now becoming 
widespread and increasingly powerful, due to new methods and tools e.g. error prone 
polymerase chain reaction (PCR) and mutator strains and the increasing availability 
of data derived from microbial bioinformatics and genomics. 
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1.2.2. 	Enolase superfamily 
The enolase superfamily[82-84] is one of the best-described enzyme superfamilies to 
date. This group of enzymes is related in three main ways. The first way is the 
common aspects of enzyme mechanism: Its members can be characterised by 
mediating a common fundamental chemical step, the stabilisation of enolate anions 
generated from abstraction of a proton a to a carboxylate (Figure 15). 
H 
HO, 
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cis, cis-muconate 	 muconolactone 
Figure 15: Characteristic reaction of the 3 subgroups of the enolase superfamily 
The second way is the sequence identity/homology of its members. Indeed, even if 
the sequences of these enzymes are divergent, some closely conserved motifs in 
these sequences at specific positions are remarkable: 7 positions (Lys 164, Lys 166, 
Asp 195, Glu 221, Glu or Asp 247, His 297 or Lys 273, Glu 317) seem to have a 
very important role in the activity of this superfamily. By comparing the binding 
pockets among members of the enolase superfamily, it appeared differences in the 
side-chain-binding site and flexible lid region may contribute to their distinct 




conserved, suggesting they are essential for their common strategy in the formation 
of an enolic intermediate. 
The last way is related to the 3-D structural conservation (domains) (Figure 16). The 
activity of each enzyme is dependent upon a divalent metal ion (Mg 2+  or Mn2 ) This 
feature provides a critical link for understanding the interdependence of their 
structures and functions. 
, 
Figure 16: The highly conserved active site structure in the 3 subgroups of the enolase 
superfamily 
The enolase superfamily is constituted by more than 100 sequences to date, closely 
related (homology for a few of them is shown Table 1 - page 21), which can be 
classified amongst these three subgroups: 
Enolase related enzymes including enolases, CPEPS, cMycBP, 
Mandelate racemase (MR), 
a Muconate lactonizing enzyme group (MLE): including OSBS. 
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Since NAAAR is a member of this superfamily but dehydratase activity rather than 
racemase activity is the principal native activity of the enzyme, this suggests that 
given members of this superfamily may possess characteristics of the reactions 
carried out by different enolase superfamily. This raises the possibility that members 
may mutate under appropriate evolutionary conditions to acquire these different 
activities. A recent study which introduced single substitutions within members of 
the MLE group[85], one of the 3 subgroups of the enolase superfamily, and the 
group to which the OSBS/NAAAR belongs, appeared to support the idea that 
interconversion of enolase superfamily activities is possible. This indicates the 
functional promiscuity of these enzymes. 
This raises several questions: Could directed evolution in vitro followed by in vivo 
selection demonstrate fluidity amongst these enzymes i.e. introducing novel activity 
to members of this family? Could selection for NAAAR activity reveal new enzymes 
appropriate for industry? Could novel isolates of NAAAR activity be more 
appropriate for industrial application than the NAAAR that is known? Could this 
expand the role of dynamic kinetic resolution? Could the application of such 
enzymes be extended from amino acids to the much broader class of chiral amines? 
To address these questions, a highly specific in vivo selection for N-acylamino acid 
racemase activity was devised and developed in this work. 
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Homology: sequences producing significant alignments with A. sp. TS-1-60 NAAAR gene (Source:www.npsa-pbil.ibcp.fr using BLAST search) 
CD STRAINS TYPE OF ENZYMES E-VALUE 
Amycolatopsissp. TS-1-60 NAAAR Use as reference 
Amycolatopsis oriental/s subsp. Larida NAAAR 
Deinococcus radiodurans NAAAR 3.00E-82 
rD Aeropynm pemix 398AA LONG HYPOTHETICAL NAAAR 4.00E-82 
Deinococcus radiodurans NAAAR 6.00E-82 
The rrnoplasma acidophilum PROBABLE NAAAR 600E-61 
Thermoplasma volcanium NAAAR 1 .00E-55 
Rhodococcus opacus CHLOROMUCONATE CYCLOISOMERASE 2.00E-30 
CL 4/cal/genes eutrophus (Ralston/a eutropha) PUTATIVE MUCONATE CYCLOISOMERASE (EC 5.5.1 I) 
2. 
 1 .00E-28
Pseudomonas aeruginosa MUCONATE CYCLOISOMERASEI 1.00E-23 
Alcaligenes eutrophus (Ralatonia eutropha) CHLOROMUCONATE CYCLOISOMERASE (EC 5.5.1.7) (MUCONATE CYCLOISOMERASE II) 1 00&23 
Pseudomonas putida PUTATIVE MUCONATE CYCLOISOMERASE I 6.00E-23 
CrQ Burkholderia sp. NK8 CHLOROMUCONATE CYCLOISOMERASE (BC 5.5.1.7) 1.00E-22 
-. Acinetobacter calcoaceticus MUCONATE CYCLOISOMERASE I (BC 5.5.1.!) (CIS CIS- NILE I) 2.00E-22 
Rhodococcus opacus MUCONATE CYCLOISOMERASE I (BC 5.5,1.!) (CIS. CIS-MME I) 2.00E-22 
A/cal/genes eutrophus (Ralston/a eutropha) CHLOROMUCONATE CYCLOISOMERASE (BC 5.5.1.7) 5.00E-22 
Pseudomonas putida MILE 1.00E-21 
= Pseudomonas aeruginosa CHLOROMUCONATE CYCLOISOMERASE 1.00E-21 
Pseudomonas pat/do CHLOROMUCONATE CYCLOISOMERASE (BC 5.5.1.7) (MUCONATE CYCLOISOMERASE II) 2.00E-2 I 
TQ Pseudomonas aeruginosa CHLOROMUCONATE CYCLOISOMERASE 200E-21 
CD 
Pseudomonas sp. (strain P51) CHLOROMUCONATE CYCLOISOMERASE (BC 5.5.1.7) (MUCONATE CYCLOISOMERASE II) 4.00E-2I 
Frateuriasp. ANA-18 MUCONATE CYCLOISOMERASE (EC 5.5.1.I) 
Pseudomonas putida MUCONATE CYCLOISOMERASE I (BC 5.5.1.!) (CIS, CIS-MLE I) 6.00E-21 
Z A/cal/genes eutrophus (Ralstonia eutropha) CHLOROMUCONATE CYCLOISOMERASE 7.00E-2I 
Variovoraxparadoxus CHLOROMUCONATE CYCLOISOMERASE 3.00E-20 
Acinetobacter Iwoffli MUCONATE CYCLOISOMERASE II (BC 5.5.1.1) (CIS, CIS-NILE I!) (tulLE!) 4.00E-20 
"e Acinetobacter Iwoffli MUCONATE CYCLOISOMERASE 12 (BC 5.5.1.1) (CIS, CIS-NILE 12) (MLE2) 5.00E-20 
Streptomyces cod/color PUTATIVE ISOMERASE 8.00E-20 
Rhizobium loti (Mesorhizobium loti) M1.E 2.00E-I 8 
Deinococcus radiodurans CHLOROMUCONATE CYCLOISOMERASE, PUTATIVE 2.00E-17 
Ha/aba cterium sp. (strain NRC-I) CHLOROMUCONATE CYCLOISOMERASE I .00E- 15 
Pseudomonasputida MR (BC 5.1.2.2) (MR) 3.00E-I 4 
Bacillus halodurans MUCONATE CYCLOISOMERASE 5.00E-14 
Comamonas acidovorans (Pseudomonas acidovorans) CHLOROMUCONATE CYCLOISOMERASE (FRAGMENT) PPJd4 
Rhodoj'erax sp. P230 CHLOROMUCONATE CYCLOISOMERASE (FRAGMENT) 1.00E-13 
Streptomyces coelicolor PUTATIVE RACEMASE 6.00E-1 2 
S'2 Rhizobium lot! (Mesorhizobium loll) MR 6.00E-12 
Sulfolobus solfataricus MR /NILE RELATED PROTEIN 6.00E- 12 
Streptomycescoelicolor PUTATIVE ISOMERASE 6,00E-12 
Staphylococcus aureus svbsp. aureus Mu50 OSBS 6.00E-12 
Escherichia co/i 01 57:H7 PUTATIVE MUCONATE CYCLOISOMERASE I 8.00E12 
?" Staphylococcus aureus OSES I.00E-11 
*The  E-value is related 10 homology; the closer to zero, the more important is the homology between the gene from TS-1-60 and the others genes 
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1.3. 	Approach of this project 
The work described in this thesis describes the conception and testing of such a 
method to explore the potential to discover and to evolve more active and industrially 
suitable variants of this type of racemase biocatalyst. This project is valuable for 
different reasons: Firstly, it will help in the understanding of the 
fluidity/interchangeablility of genes and enzymes in the enolase superfamily. 
Secondly it could give rise to a valuable new family of industrial biocatalysts. 
Thirdly, it could illustrate the continuing value of in vivo selective methods to 
augment in vitro methods of directed evolution and provide new methods for 
biocatalyst discovery and development. It offers an in vivo method that benefits from 
earlier understanding of the value of this type of approach in fermentation routes to 
amino acids but takes advantage of tools recently made available. 
1.3.1. 	Directed evolution 
By observing evolution in nature, scientists have learned how to apply and benefit 
from natural processes and have discovered various types of enzymes that have been 
used, as they existed in the nature. However, the problem with the use of native 
enzymes is that nature did not design enzymes to operate under the arduous and 
demanding conditions required by industry. Now new methods and new data are 
changing the way that we discover enzymes. Nowadays, screening methods are much 
improved and can benefit from increased use of robotics, miniaturisation, high 
throughput analysis and better analytical methods such as mass spectra and NIVIR. 
Accordingly, the analysis of enzymatic activities and reactions are easier and more 
efficient. Powerful tools in chemistry (combinatorial chemistry) and in biology (such 
as PCR, directed evolution and strains construction) as well as bioinformatics 
tools[86, 87] (genomic databases) have opened a very large field of investigation in 
research. 
The improvement of molecular biology tools as PCR, mutator strains, biological 
mutation and then, in the 1990s, error prone PCR[88-90] and Stemmer gene 
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shuffling[9 1] have increased the number of opportunities and rate of development of 
new enzymes. Thanks to genomics, it may be possible to explore a tiny fraction of 
the possibilities that nature, even in 4 billion years, has not. 
Bioinformatics permit quicker and easier use of databases than a few years ago such 
that it is now possible to identify homology between genes (proteins), which could 
potentially be interesting to screen and thereby to identify novel enzymes for 
particular applications. Thus, it is becoming possible to explore the ability to convert 
one enzyme activity to another perhaps within a superfamily of enzymes related by 
mechanism and structure to further advance new enzyme discovery. Often the key is 
to devise a powerful screening method or a powerful in vivo selective approach. By 
choosing an appropriate selective method, it could become possible to screen, 
identify, and even evolve novel enzymes. This work will address this issue with 
particular emphasis on as the discovery of novel N-acylamino acid racemases. 
Enzymes can be tailored for optimal performance in industrial applications by 
evolutionary molecular engineering[92], also called directed evolution or in vitro 
molecular evolution (Figure 17). 
R2ticn*t protein dmgn 	 FN1 
Figure 17: The main steps of the discovery and evolution of novel proteins 
The evolutionary strategy is a simple adaptive process: the accumulation over 
multiple generations of beneficial mutations produced randomly and fixed by 
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selective pressures. The major steps in a typical directed enzyme evolution 
experiment are outlined in Figure 18. 








repeat process 	\\\ 
: 
O ' c9. b°00 0 
Insert library into Q 	expression vector 
/ Insert gene library into host cells which produce enzyme variants 
(one cell, one sequence) 
Screen cells for the 
property of interest 
Figure 18: Experimental strategy for directed evolution using error prone PCR 
The genetic diversity for evolution is created by mutagenesis and/or recombination 
of one or more parent sequences. These altered genes are cloned back into a plasmid 
for expression in a suitable host organism (bacteria or yeast). Clones expressing 
improved enzymes are identified in a high-throughput screen, or in some cases, by 
selection, and the genes encoding those improved enzymes are isolated and recycled 
to the next round of directed evolution. The random mutant library is typically 
generated using a method of random DNA mutation such as a chemical mutagen, a 
DNA repair deficient "mutator" organism or error prone PCR in which the point 
mutation frequency is controlled by varying the pH, the concentration of divalent 
cations, or other parameters. 
As shown in Figure 19, the number of variants that could be made if every possible 
amino acid substitution were accessible (for example, by codon-synthesis methods) 
increases exponentially along the simultaneous substitution of amino acids. If point 
mutations are introduced randomly at the DNA level, the accessible sequence 
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diversity is limited. On average, only 5.7 different amino acids are accessible by 
single base pair changes in a codon. 
The number of possible variants of a protein that can be created by introducing 
M substitutions simultaneously over N amino acids is 19m [N!.! (N-AD! 111 
5.7m [NU (N-M)!M!] 
The number of 
possible variants 
Sequence length 	320, Number of amino acids changed= 1 6 080 
1 824 
Sequence length = 320, Number of amino acids changed= 2 18425 440 
1 658 290 
Sequence length = 320, Number of amino acids changed= 3 37 108 836 160 
1 001 938 576 
Sequence length = 320, Number of amino acids changed= 4 55 876 630 047 920 
452 600703 388 
Figure 19: Variation of the possible variants of a protein in function of the number of amino 
acids changed 
Furthermore, the number of clones[93] that must be screened to see a given number 
of unique amino acid level variants must increase to account for remaining wild-type 
protein sequences arising from the degeneracy of the genetic code. To have 95% 
confidence that a given number of amino acid level variants has been sampled in a 
screen or selection, the number of unique clones must be multiplied by a factor of 
approximately ten. 
Thus the 'sequence space' of possible proteins is huge beyond the imagination (20N) 
Even in 4 billion years, nature has had a chance to explore but a tiny fraction of these 
possibilities. A laboratory exploration of this vast space of sequences and their 
corresponding functions must obviously be severely limited and carefully 
guided[94]. Because much of sequence space will be devoid of the desired function 
and probably even folded proteins, it is best to direct the evolution of one (or more) 
existing enzymes rather than look for function in random peptide libraries. 
For studying wild-type protein function, the Vartanian group[95] suggested creating 
a single amino acid substitution per protein, which corresponds to approximately 1.5 
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mutations per gene. This level of mutagenesis allows to independently characterise 
the effects of each amino acid substitution on protein function[85, 96]. For directed 
protein evolution, mutagenesis rates that average 2 to 6 mutations per gene are 
regarded as most effective for creating mutant libraries to find proteins with 
enhanced activity[97, 98] or interconvert functionalities of homologous enzymes[85, 
99-101]. Mutational levels beyond 6 mutations per gene usually result in the 
complete loss of protein activity[ 102]. However, there have been exceptional cases 
where proteins tolerate extremely high levels of mutation[95, 103]. 
1.3.1.1. Random mutagenesis using error prone PCR 
PCR-based random mutagenesis has gained popularity over chemical methods (e.g., 
nitrous acid, hydroxylamine, etc.) since it can produce a higher level and a larger 
variety of mutation[104, 105]. The procedure involves performing a PCR reaction 
under conditions that reduce the fidelity of nucleotide incorporation, cloning the 
resulting PCR fragments, and then screening the resulting library for novel mutations 
which affect protein activity[ 106, 107]. To do so, the standard procedure is altered by 
increasing the concentration of MgCl2, adding MnC12, or changing the concentration 
of the 4 dNTPs[88, 90]. Using the right conditions it is possible to introduce 
mutations at a rate up to 7 base pairs per 1000 during a 30 cycles PCR. Kits for PCR 
random mutagenesis are commercially available, and optimised to offer a variety of 
buffer conditions for performing random mutagenesis, allowing to adjust the reaction 
for a desired error rate. For example, with the kit available from Clontech, the 
mutagenesis rate is first raised by increasing the amount of manganese in the 
reaction. Further increases in mutation rate are obtained by increasing the level of 
dGTP in the reaction, while keeping the concentration of manganese constant. 
Mutation rates from two to eight mutations per l000bp can therefore be achieved. 
Nevertheless, the method requires numerous manipulations (PCR reaction, digestion, 
ligation) and introduces some difficulties: ligation of the PCR products is critical and 
the mutational bias should be optimised. 
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1.3.1.2. Random mutagenesis using mutator strain Epicurian Coli ® XL1 -Red 
Stratagene constructed the XL1 -Red mutator strain to generate random mutations 
quickly and easily. This strain[ 108] is deficient in three of the primary DNA repair 
pathways in E. coli: mutS[109], mutD[1 10] and mut7]1 11]. The mutS mutation 
causes error-prone mismatch repair, while the mutD mutation causes the deficiency 
in 3'- to 5'- exonuclease of DNA polymerase III (subunit of DNA polymerase III 
involved in proofreading and self-editing function, which normally removes 
incorrectly paired nucleotides during DNA replication). The muff mutation disables 
the hydrolysis of 8-oxodGTP generated by highly reactive oxygen species 
(superoxide, hydrogen peroxide, hydroxyl radical) during normal aerobic 
metabolism. It can then be misincorporated during replication to opposite template 
adenines. The random mutation rate is approximately 5,000-fold higher than that of 
wild-type (mutation rate compares well to error prone PCR). The XL1-Red 
procedure is a straightforward method: it requires simply using the construct to 
transform the XL1-Red strain and propagating the transformants. After propagation 
in the XL1-Red strain, the mutated plasmid DNA is retrieved and used to retransform 
the provided XL1-Blue competent cells for analysis. Nevertheless it has some 
disadvantages: the rapid mutation rate affects the chromosome[112], and after 
prolonged growth, the subsequent colonies are probably not genetically identical to 
the original strain, leading the host strain to be unstable, and some mutations can 
cause plasmid loss that may eliminate useful enzyme variants. 
I nerod.uc tion 
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Figure 20: Proposed in vivo selection 
The selection for NAAAR activity (Figure 20) applies specific amino acid 
auxotrophs so that an N-acetyl-D-amino acid can be supplied as the only available 
precursor of a deficient L-amino acid. If the cell needs a specific L-amino acid for 
growth and is capable of hydrolysing the corresponding N-acetyl-L-amino acid then 
maybe it can be supplemented with the corresponding N-acetyl-D-amino acid to 
select for racemisation to the corresponding N-acetyl-L-amino acid. 
This method, if successful, could offer the possibility to readily screen a library of 
106 108  mutants for N-acylamino acid racemase activity in 3-4 days. Using 
auxotrophs of E. coli available from public strain repositories (e.g. the E. coli 
Genetic Stock Center), specific racemase activities can be sought. In this case, L-
phenylalanine and L-methionine auxotrophs were chosen as the test systems. The 
main reasons for the choice of these 2 systems reside in the fact that N-acetyl 
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known NAAAR from strain TS-1-60. These two L-amino acids are also relevant 
industrially, and are easy to access and to prepare as N-acetyl derivatives. 
The first stage in this work is to confirm the phenotype of E. coil amino acid 
auxotrophic mutants. This is very important as it establishes the supplemental growth 
medium requirements of an L-amino acid auxotroph (for example pheA mutant 
requiring L-phenylalanine). This test should show the inability of the auxotroph to 
grow on the D-amino acid. The next step is to test for hydrolysis of an N-acyl-L-
amino acid precursor when provided in the growth medium as the only supply of the 
deficient amino acid. This is to determine any necessity to supply acylase enzyme 
exogenously because no certainty exists concerning the ability of the strain to 
hydrolyse the N-acyl-L-amino acids. As the N-acyl-L-amino acid hydrolysis must not 
be rate limiting, one way is to introduce a high level of L-aminoacylase known in the 
literature[113]. In principle, this should render the cells able to efficiently use N-
acyl-L-amino acids as a source of required free amino acids (Figure 21). 
Figure 21: Test on pheA mutant for N-acyl-L-phenylalanine hydrolysis 
The selection is then carried out by plating the cells on a M9/glucose minimal 
medium, which is supplemented with only the N-acetyl-D-amino acid. The 
theoretical basis of the selection is therefore that bacteria carrying and expressing an 
N-acetylamino acid racemase gene with the desired specificity are able to grow 
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Figure 22: Theoretical screen for N-acylamino acid racemase 
The plasmid carrying any gene whose product enables growth of the auxotrophic 
host is then isolated from these bacteria; and tested for NAAAR activity. Such 
isolates upon characterisation may then serve as templates for further mutation and 
selection in a process of directed evolution of NAAAR activity (Figure 23). 
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Figure 23: Methods for directed evolution of NAAAR activity 
-31 - 
ntrodui;i 
1.4. 	Conclusions and aims 
The potential to identify novel enzymatic methods to conduct dynamic kinetic 
resolution processes is an exciting field. The NAAAR activity, which was shown to 
be a secondary function of an enzyme which is primarily a dehydratase of the 
enolase enzyme superfamily, is an appropriate target for studies of directed 
evolution. A significant number of members of this enzyme superfamily have been 
identified and the gene sequences published. The potential exists to identify 
additional NAAAR activities through sequence alignment and screening using the 
data in microbial gene and genome banks. The fact that one member of this family 
displays racemase activity indicates that others may also do so or that the activity 
could be selected. Because this enzyme activity produces amino acids as the product, 
it may be possible to devise efficient and versatile selective methods using microbial 
mutants deficient in specific amino acids (auxotrophs) in order to select for enzymes 
with N-acylamino acid racemase activity and to evolve altered substrate specificity or 
other properties in the known Amycolatopsis species TS- 1-60 enzyme and any others 
identified. 
Using similar approaches the potential may exist to subsequently select evolution of 
N-acylamino acid racemase activity in mutant libraries derived from this enzyme and 
homologues. Although chemically a more challenging reaction, this approach would 
also provide a graphic illustration of the fluidity of enzyme function and would have 
major implications for applied biocatalysis. Finally, although the earlier studies 
showed that the NAAAR activity of the strain TS-1-60 is not ideal for biocatalysis 
due to slow turnover and substrate inhibition, in common with other racemases it has 
fundamental features appropriate for applied biocatalysis. 
In this project, in vivo selections will be devised and constructed which will 
hopefully identify variants of enolase superfamily enzymes that show novel NAAAR 
activity. These selection methods will be based upon the construction of mutants of 
E. coli, which eliminate an essential enzyme, thereby preventing growth on an 
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appropriate selective medium. Complementation of this deficiency will form the 
basis of the identification of novel activity in variants generated by random 
mutagenesis of enolase superfamily members. Genes encoding enzymes of the 
enolase superfamily will be identified, isolated and subjected to novel selective 
methods to determine if new activity can be introduced. 
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2. Results and discussion 
Since NAAAR activity appears to have arisen by chance the basis of this work is to 
determine if this activity can be identified and/or enhanced using directed evolution. 
Such an approach raises the possibility that enolase superfamily members may be 
mutated to acquire these different activities. 
2.1. 	Cloning various OSBS genes into pTTQ18 system 
The plasmid pTTQ18[114] is a high-copy number plasmid containing 100 copies 
per cell. Gene expression is driven using the tac promoter derived from the E. coli lac 
operon and controlled by induction using IPTG. The replication of the plasmid is 
controlled by ColE 1 (pBR322) as origin of replication. The plasmid can be selected 
in growing cells by addition of ampicillin to the culture, as it carries an ampicillin 
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2.1.1. Amplification of NAAAR gene from TS-1-60 
The NAAAR gene was amplified from Amycolatopsis TS-1-60 (ff0 15079) using 
primers containing EcoRI and Sphl restriction sites. The PCR was carried out using 
the entire chromosomal DNA of TS-1-60, purified using Qiagen Genomic DNA Kit 
and stored at 4°C, to avoid subsequent difficulties concerning precipitation due to 
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freezing. This gene was particularly difficult to clone due to a high level of G and C 
(70%). Many PCR experiments were carried out, varying the following specific 
parameters: 
. 	Use of 2 different polymerases (Taq DNA polymerase and High 
Fidelity polymerase, 
Temperature of annealing and denaturation, 
Use of DMSO (2%, 5% and 10%), 
Primers and extended primers, 
Gradient of temperature, 
The final conditions that reproducibly yielded a PCR product are listed in the 
Materials section. 
The PCR product was digested with EcoRI/$pij restriction endonucleases and then 
ligated into EcoRI/pj digested pTTQ18. The final construct was then used to 
transform Top 10 E. coli cells. The Top 10 E. coli strain is a very versatile host[115], 
improving the quality of plasmid DNA by elimination of non-specific endonuclease 
by endonuclease I (endAl) and reducing the occurrence of recombination of the gene 
of interest (recAl). Also, unmethylated DNA propagated from non-E. coli sources 
such as PCR is transformed with higher efficiency (hsdRMS[1 16]). The 
transformation efficiency of this strain is i09 cfu/tg. Positive transformants were 
identified by restriction analysis and tested for expression in JM109. This plasmid 
was named pRS7-1 and sequenced to verify no changes were introduced from the 
original sequence. 
2.1.2. Amplification of NAAAR gene from Amycolatopsis orientalis NRRL 2452 
The NAAAR gene was amplified from Amycolatopsis orientalis (NRRL 2452) with 
primers containing EcoRI and Sphl restriction sites. The PCR was carried out using 
the isolated chromosomal DNA of A. orientalis, purified using Qiagen Genomic 
DNA Kit and stored at 4°C, to avoid subsequent difficulties concerning precipitation 
due to freezing. The amplification was not as difficult as for the NAAAR gene from 
TS-1-60, due to the similarities between the sequences of the 2 genes. The same 
- 35 - 
R.cstdE:s and. disrnssin 
conditions were used for the PCR reaction and successfully yielded the expected 
single band. The PCR product was digested with EcoRl/SphI restriction 
endonucleases and then ligated to EcoRI/SphI digested pTTQ18. The final construct 
was then used to transform E. coli Top 10. Positive transformants were identified by 
restriction analysis and used for expression in JM109. This plasmid was named 
pRS8-9 and sequenced to verify no changes were introduced from the original 
sequence. 
2.1.3. 	Amplification of other OSBS genes 
In addition to the cloning of two NAAAR genes mentioned above, two other OSBS 
genes, one from Bacillus subtilis and the other from E. coli, were cloned into 
pTTQ18, and respectively named pRS6-2, and pRS9-1. Although mapped using 
restriction enzymes, no further work was carried out upon these genes or their 
encoded enzymes due to time limitation and inconclusive data arising from growth 
studies. 
2.2. 	Creation of libraries by random mutagenesis 
Two different methods were used to create mutations within the cloned genes and 
create libraries of mutants which could be used for screening later with the in vivo 
selection. The first method, by error prone PCR, used the kit from Clontech 
(DiversifyTM PCR random mutagenesis), whereas the second method used the 
imitator strain Epicurian Coli ® XL1-Red. 
2.2.1. 	Library generation using error prone PCR 
The two plasmids pRS7-1 and pRS8-9 were subjected to error-prone PCR using the 
manufacturer's protocol. Each plasmid was used as a DNA template and was 
subjected to 9 parallel PCR reactions with the same conditions but with different 
reaction mixtures. The 2 parameters modified in the mixture were the concentrations 
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of MnSO4 and dGTP. As the concentration of these two reagents was increased, the 
intensity of the corresponding band decreased (Figure 24). This was due to the fact 
that amplification (processiveness of the polymerase) becomes more limited as 
mutations increase. Unfortunately, the error prone PCR failed on pRS8-9 despite 
several attempts using modified protocols, entire plasmid or fragment as DNA 
template. No fragment of the desired size was amplified, the electrophoresis gels 
showing either no band fragment or a smear. 
Figure 24: error prone PCR on NA.A.AR TS-1-60 gene 
The nine mutagenesis reactions carried out on TS-1-60 racemase gene were then 
mixed as followed: Reactions 1 to 3, 4 to 6 and 7 to 9 mixed together to give 3 
different samples with an average number of mutations per 1000 bp of 2.3, 4.3 and 7 
respectively. These three samples were then digested and cloned into expression 
vector pTTQ18. These three libraries were purified and named pRS7-1/13, pRS7-
1/46 and pRS7-1/79. The detail protocol of this method is described Materials 
section. 
2.2.2. 	Libraries generated using the mutator strain Epicurian Coli ® XL1-Red 
Two methods were used to produce libraries of mutated plasmids using E. coli XL1-
Red. The initial step was common to both methods: The two plasmids were used to 
transform the imitator strain using the manufacturer's protocol. 
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2.2.2.1. First method to create libraries of mutants 
The first method consisted of spreading the transformed cells on LB Agar Amp200. 
The plates were then incubated for 24-30 hours, and then the cells recovered by 
resuspending the colonies into 10 ml of LB. As E. coli XL1-Red has a doubling time 
of 90-120 mins, approximately 15 generations of cells were produced. This 
corresponded to one cycle of mutation. The plasmids were purified for screening, 
while 150 p1 of resuspended cells was spread on each of five freshly prepared LB 
Agar Amp 200  plates for another cycle of mutation. At the end of this cycle, the 
plasmids were isolated and used to transform E. coli XL1-Red, and subjected to 
another cycle of mutation. Plasmids were purified and used to retransform every two 
cycles fresh mutator strain to avoid the rapid accumulation of mutations in the host 
genomic DNA, which can lead to the loss of genotype specificity and viability. The 
plasmid was subjected to 5 cycles of mutation to produce the library of mutants after 
15, 30, 45, 60 and 75 cells generations (pRS7-1/1P to pRS7-1/5P libraries). 
2.2.2.2. Second method to create libraries of mutants 
The second method consisted of using the transformed cells to inoculate 20 ml of LB 
Amp 200  and the culture was grown for 24-30 hours. This corresponded to one cycle 
of mutation. The plasmids were purified for screening, while 20 p1 of the culture was 
used to inoculate LB Amp200, and subjected to a second cycle of growth. The 
plasmids were then purified and used to transform fresh E. coli XL1-Red, and 
subjected to another cycle of mutation. The plasmids were transformed every two 
cycles of growth. The plasmid was subjected to 5 cycles of mutation to produce the 
library of mutants after 15, 30, 45, 60 and 75 cells generations. (pRS7-1/1S to pRS7-
115S libraries). 
ktuts and discussion 
2.3. 	In vivo selection 
The central aim of the project was the development of an in vivo method to identify 
specific enzymes using a specific bacterial auxotrophic mutant. The selection for the 
enzyme which relieves the auxotrophy should be high throughput, enabling the 
screening of 10
8 
 10 independent colonies per plate. 
Principles of the in vivo selection to relieve the auxotrophy: 
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2.3.1. 	L-phenylalanine (L-phe) as the first auxotrophy to be examined 
Initially the phenylalanine system was studied, mainly because a phenylalanine 
auxotroph was already available from the E. coli Genetic Stock Center (Yale 
University, New Haven, USA). 
-39- 
Resu1 	nd C1iCLSk 
2.3.1.1. Feeding studies on the L-phe auxotroph strain CGS C7421 
See Appendix 11.1. for genotype of this strain. 
2.3.1.1.1. Initial growth tests of the auxotrophic strain on M9/glucose medium 
Initial feeding experiments were carried out to confirm the phenotype of the strain 
and to show that only the free L-amino acid could relieve the L-phenylalanine 
auxotrophy. The exact composition of the M9/glucose minimal medium is shown in 
the Materials section. In order for the strain to be useful and appropriate for the 
selection, no growth should be observed on an M9/glucose based minimal medium 
alone as well as when supplemented with D-phenylalanine or N-acetyl-D-
phenylalanine, but observed when supplemented with L-phenylalanine and with N-
acetyl-L-phenylalanine. In the latter case, this should indicate the ability of the strain 
to hydrolyse the acetyl group (existence of a natural acylase). 
Media supplement Expected growth for selection Actual growth 
None No No 
L-phenylalanine Yes Yes 
D-phenylalarnne No Yes 
N-Ac-L-phenylalanine Yes Yes 
N-Ac-D-phenylalanine No Yes 
Table 2: Feeding tests on the L-phe auxotroph 
Experiments shown in Table 2 showed the strain to be able to grow on M9/glucose 
minimal medium supplemented by either N-acetyl-D-Phe or N-acetyl-L-.Phe as well 
as D-Phe although no growth was observed on unsupplemented M9 alone. 
Following this observation, an extensive literature review[1 17-119] revealed that the 
complementation of certain L-amino acid auxotrophies in E. coli could be relieved by 
supplementation of the growth medium with the corresponding D-enantiomer of the 
amino acid. Genetic and biochemical studies have conclusively shown this to be 
16:SIL1tS and diSlOfl 
attributed to a broad specificity D-amino acid dehydrogenase encoded by the dadA 
gene and induced by many D-amino acids. The action of the dehydrogenase converts 
the D-amino acid to the corresponding keto acid, which can then be transaminated to 
the L-isomer by one or more endogenous transaminases. The D-amino acid 
dehydrogenase is principally required for growth on racemic alanine or L-alanine as a 
carbon source and is non-essential to the prototrophic cell. Based on this literature 
review, Figure 25 shows the expected routes by which E. coli can use a D-amino acid 
to overcome an L-amino acid auxotrophy. 
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Figure 25: Modes of amino acid utilisation by E. coli 
Accordingly, the dadA gene was required to be deleted in amino acid auxotrophic 
strains of E. coli to determine the effect on further development of the planned 
selection (as no mutants were already available with the appropriate genetic 
backgrounds). Deletions are the most appropriate for this type of experiment (where 
a powerful growth selection is applied) to avoid false positives through reversion of 
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the mutation. Additionally, the deletion method[ 120] (rapid and general) could be 
developed into a useful method in the lab. 
The principle of this method is fairly simple (Figure 26): A PCR product is generated 
using primers with extensions that are homologous to regions adjacent (Hi and H2) 
to the gene to be inactivated and also homologous to template plasmids carrying 
antibiotic resistance genes (P1 and P2) that are flanked by FRT (FLP recognition 
target) sites. The strain to be modified is then transformed with the PCR product in 
the presence of a helper plasmid, which stabilises the PCR product and facilitates 
integration and gene replacement at the target. The deletants are selected by acquired 
antibiotic resistance, and the deletion is verified by PCR. The antibiotic resistance 
can eventually be removed if desired using an FLP helper plasmid. 
Step 1 PCR amplify FRT-flanked resistance gene 
X~a  
Step 2. Transform strain expressing X Red reconibinase 
Gene A 	I 	Gene B 	 Gene 
Step 3. Select antibiotic-resistant transformants 
	
FRT 	 FRT 
Antbiohc esisumce 
Gene A 	 Gene C 
Step 4. Eliminate resistance cassette using a FLP expression plasmid 
FFtT 
Gene A 
A simple gene disruption strategy. Hi and H2 refer to the homology 
extensions or regions. Ri and P2 refer to priming sites. 
Figure 26: Gene disruption strategy 
2.3.1.1.2. Deletion of the dadAX genes from CGS C7421 using the? Red system. 
The deletion was first created in strain BW251 13 which is supplied with the 
disruption system. This strain is AaraBAD and hsdR which according to the authors 
makes the creation of deletions easier. 
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In E. coli, the dadX gene is involved in L-alanine catabolism. This gene encodes an 
alanine racemase and is situated in an operon together with the dadA gene, encoding 
D-alanine dehydrogenase. The dadA gene encodes one of the two subunits of D-
amino acid dehydrogenase. This enzyme is bound by strongly hydrophobic 
interactions to the inner membrane and directly linked to the respiratory chain. The 
dadA and dadX genes are transcribed together from a promoter proximal to dadA. As 
the dadA and dadX genes form one transcriptional unit[121], it seemed logical to 
delete both genes rather than only dadA to avoid possible complications with 
membranes function and amino acid transport. The cat gene (chioramphenicol 
resistance) was introduced to select the deletant strain. The first step of the 
inactivation of dadAX was the amplification of the cat gene (chioramphenicol acetyl 
trans ferase-chloramphenicol resistance) by PCR, with homologous priming 
sequences of the gene to inactivate. The PCR product was then used along with the 
RED helper plasmid to transform the original strain BW25 113. The antibiotic 
resistance replacing dadAX allowed the selection of transformants, in which the 
dadA-dadXoperon was disrupted. The new strain was named ET1. 
Experiments were then carried out to transfer the dadAX deletion to a phenylalanine 
auxotroph by P1 transduction. The strain ET  was first infected and lysed with phage 
P1, and the P1 lysate was then mixed with the strain to be modified. After 
transduction the new strain was screened on chloramphenicol plates to select the 
positive mutants. Although 5 mutants were successfully isolated and tested against 
the deletion, the shape of the colonies were irregular, and the colonies screened on 
M9 with different supplements were still able to grow on M9 which indicated either 
one or several genes enabling the biosynthesis of L-Phe from D-Phe and N-Ac-D-Phe. 
After several attempts the conclusion was that no transductant of the correct 
phenotype could be obtained. At this point a change in the choice of the auxotrophic 
selection was therefore made. Although there were other options to construct a L-phe 
auxotroph (e.g. direct deletion of pheA in ET1), another system using L-methionine 
auxotrophy was to be considered at this time. Emphasis was switched to the 
methionine system as the NAAAR is described to be the most active using N-acetyl 
methionine. 
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2.3.2. 	L-methionine as the second auxotrophy to be examined 
2.3.2.1. Use of CGSC6563 
See Appendix 11.1. for genotype of this strain. 
The advantage of using L-methionine auxotrophy is that a methionine auxotroph 
which also carries a dadA mutation was already available. But this approach also had 
some drawbacks. A strain containing point mutation of metB has the possibility to 
revert. This situation is not ideal for a high throughput selection due to the potential 
for false positives. The strain therefore needs to be frequently restreaked on M9 to 
rule out this possibility (Figure 27). 
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Figure 27: Modes of methionine utilisation by E. coli 
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2.3.2.1.1. 	Feeding studies on CGSC6563 
These feeding experiments were carried out to confirm that only the free L-amino 
acid could relieve the methionine auxotrophy. In order for the strain to be useful and 
appropriate for the selection, no growth should be observed on M9 alone as well as 
when supplemented with D-methionine or N-acetyl-D-methionine, but observed when 
supplemented with L-methionine and eventually with N-acetyl-L-methionine. In the 
latter case, this growth should indicate the ability of the strain to hydrolyse the acetyl 
group (existence of a natural acylase). 
After testing this strain on M9/glucose minimal medium to validate the selection, it 
appeared the strain was behaving as expected (Table 3). The auxotrophy of this strain 
was confirmed, and its ability to hydrolyse N-acetyl-L-methionine meant that there 
was no requirement to use a complementary acylase. Due to the dadA mutation, the 
strain was not able to use N-acetyl-D-methionine as a source of L-methionine. 
Media supplement Expected growth for selection Actual growth 
None No No 
L-methionine Yes Yes 
D-methiornne No No 
N-Ac-L-methionine Yes Yes 
N-Ac-D-methionine No No 
Table 3: Feeding assays on CGSC6563 
2.3.2.1.2. Validation of the selection using 2 enzymes with NAAAR activity 
In order to validate the selection it was necessary to show that although the strain 
was unable to grow on N-acetyl-D-methionine, if the NAAAR was expressed into the 
strain, the stain would acquire the ability to grow on N-acetyl-D-methionine. The 
strain CGSC6563 was therefore transformed with pTTQ18, pRS7-1 and pRS8-9, and 
two assays were carried out in parallel on the three systems on M9/glucose minimal 
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medium, by inducing the expression of NAAAR. The results, shown in Table 4, 
confirmed the selection was working. 
Media 
supplement 













None No No No No No No 
L-methionine Yes Yes Yes Yes Yes Yes 
D-methionine No No No No No No 
N-Ac-L-methionine Yes Yes Yes Yes Yes Yes 
N-Ac-D-methionine No No No Yes No Yes 
Table 4: Growth observed using CGSC6563 transformed with different plasmids (red highlight 
the specific effect of the NAAAR activity) 
When the plasmids carrying the NAAAR genes were induced, the strain was able to 
grow on N-acetyl-D-methionine, as the only source of L-methionine. As no growth of 
CGSC6563 was observed when only D-methionine was supplemented but growth 
observed when the only supplement to the M9/glucose minimal medium was N-
acetyl-D-methionine, the most likely explanation was that the N-acetyl-D-methionine 
was being converted into N-acetyl-L-methionine, consistent with the expression of 
functional NAAAR activity. 
However, the colonies growing on N-acetyl-D-methionine were significantly smaller 
than the colonies growing on L-methionine or N-acetyl-L-methionine. This 
observation could be explained if only a small amount of N-acetyl-D-methionine was 
racemised, and therefore the rate of racemisation was insufficient for normal growth. 
Therefore this threshold for growth provided a basis to calibrate the strain for 
efficient selection of mutations leading to more efficient racemisation. Thus, the next 
stage was to optimise the cell growth in the selection to be able to identify strongly 
growing colonies (important for finding mutants). Two calibrations were required to 
achieve this. 
kCSLLis InC1 d SCUSiUfl 
The first experiment was to study the tolerance and growth of the strain when 
subjected to different concentration of cobalt. Several groups reported the 
requirement of a divalent metal ion for OSBS or NAAAR catalysis. The enolate 
anions are generated in the first coordination sphere of the divalent metal so these 
can be stabilized by potentially large electrostatic interactions. Although the 
M9/glucose minimal medium contained Mg2 , NAAAR has better affinity with Co 
2+ 
 
for activity[70, 72, 73]. However it is also known that cobalt is toxic to E. coli above 
a certain concentration[122-124]. 
Therefore the cobalt tolerance of the auxotroph stain had to be tested. The 2 systems, 
CGSC6563/pRS7-1 and CGSC6563/pRS8-9, expressing the NAAAR were plated on 
M9/glucose containing N-acetyl-D-methionine as well as IPTG to induce the 
expression of NAAAR. As shown in Table 5, two parameters were taken in 
consideration to determine the optimal concentration of cobalt. Firstly the size of the 
colonies which could be interpreted as being related to the increase in the availability 
of L-methionine, and secondly the total number of colonies for the same reason. 
CoCl2 concentration (mM) 0 0.1 0.15 0.2 0.25 0.3 0.35 0.5 
Colonies size - * * ** ** *** *** **** 
Colony number  
Increasing number of asterisks represents an increase in size (or number) 
Table 5: Cobalt tolerance of CGSC6563 
The optimal concentration of cobalt was determined experimentally to be 0.3 mM. 
At this concentration the growth of the auxotroph benefited in two ways (size and 
number) from the concentration of cobalt as it was used by the NAAAR to catalyse 
the reaction of racemisation of the N-acetyl-D-methionine. However cobalt became 
toxic for the cells for a concentration above 0.3 mM reflected by the decrease of the 
number of colonies. This could be linked to the maximal uptake of cobalt into the 
binding site of the enzyme. 
Moderate concentration (e.g. 0.3 mM) seemed to have a positive effect on the 
growth, but had however no influence on the speed of the growth, which still was 4-5 
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days to obtain a large colony size. These conditions may enable the isolation of 
cobalt independent variants. 
Thus, the second calibration was based on the N-acetyl-D-methionine substrate 
concentration. As for the first calibration with cobalt tolerance, it was considered that 
it might be possible to increase the rate of cell growth by increasing the 
concentration of substrate and thereby further calibrating the selection. The usual 
substrate concentration used in M9/glucose minimal medium is 50 mg!l (0.262 mM) 
for N-acetyl-D-methionine. This concentration is not sufficient for normal cell 
growth as shown. This observation could be related to the high KM values, 
respectively 11.3 mM and 24 mM, for the NAAAR from TS-1-60 (pRS7-1) and A. 
orientalis (pRS8-9). These values were determined by in vitro assay with purified 
enzyme. 
Table 6 summarises the results of the effects of the substrate concentration upon cell 
growth using a cobalt concentration of 0.3 mM. Several measurements were taken. 
The first observation was on the colony growth: the growth was faster with N-acetyl-
D-methionine concentrations at least 5 times higher than initially studied. As the 
concentration of N-acetyl-D-methionine increased, the duration of the incubation 
necessary to obtain significant colonies size decreased from 5 days to 2 days. The 
second observation concerned the size of the colonies: the higher the concentration, 
the bigger the colonies. The third concerned the number of colonies which increased 
as did the concentration of N-acetyl-D-methionine. But the most interesting 
observation arose from comparing the results at 41.83 mM and 52.3 mM N-acetyl-D-
methionine: fewer colonies with pRS7-1 were observed at the higher concentration, 
but the number and the size of the colonies carrying pRS8-9 were still increasing. It 
was considered that this could reflect the reported substrate inhibition of these 
enzymes by N-acetyl-D-methionine (50 mM for pRS7-1, 200 mM for pRS8-9). 
EM 
N-Ac-D-methionine 
0.262 0.523 1.05 2.09 3.14 4.18 5.23 10.46 20.91 31.37 41.83 52.3 
concentration (mM) 
Growth (days) 5 5 4 4 3 3 3 2 2 2 2 2 
Very 
Colonies size * ** ** *** *** *** **** **** **** ***** ***** 
small 
pRS7-1 few * * ** ** ** *** *** *** **** **** ** 
Colonies  
number r— 
pRS8-9 few * * ** ** ** *** *** *** **** **** ***** 
Increasing number of asterisks represents an increase in size (or number) 
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The optimal conditions for colony growth were thus established by consideration of 
the results outlined above. As the colonies should ideally be small enough to 
differentiate better racemase activity through increased colony size, the optimal 
concentration of N-acetyl-D-methionine should be 15 times higher (3.14 mM) than 
the concentration of N-acetyl-L-methionine which enables similar growth (size and 
number) to supplementation with L-methionine. However, the optimal concentration 
of N-acetyl-D-methionine to screen libraries of mutants could then be slightly 
decreased from this "threshold" to perhaps 1-2 mM to identify mutations in NAAAR 
which generate improvements in racemase activity, depending on how stringently the 
selection is to be operated. 
2.3.2.1.3. Screening libraries of mutants 
The first libraries to be screened were the libraries created by error prone PCR 
(section 2.2.1). These 3 libraries were used to transform CGSC6563 to detect 
racemase variants with better activity and plated directly on M9/glucose minimal 
medium supplemented with 2 mM of N-acetyl-D-methionine, 0.3 mM of CoC12 and 
1mM IPTG. A sample of each transformation mixture was spread on LB agar 
Amp 200  as control for transformation efficiency. No colonies of significant size 
appeared on the plates suggesting that the libraries of mutants did not possess any 
particular mutations that significantly improved the racemase activity. 
However, the efficiency of cell transformation by plasmid DNA (Figure 28) was 
found to be extremely poor (107108  expected transformants by electroporation): the 
2 first samples yielded low numbers of transformants (9000, 7500) and the last one 
yielded 60,000 transformants. 
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Figure 28: Transformation of the 3 different libraries of TS-1-60 mutants created by error 
prone PCR 
The second libraries to be screened were those created using the XL1-Red mutator 
strain. The five libraries (pRS7-1/1P to pRS7-1/5P libraries) were used to transform 
CGSC6563 and plated directly on M9/glucose minimal medium supplemented with 2 
mM of N-acetyl-D-methionine, 0.3 mM of CoC12 and 1 mM IPTG. A sample of each 
transformation mixture was spread on LB agar Amp 200  (200g/ml) as control for 
transformation efficiency. As observed with the previous libraries screened, no 
colonies grew on the selective plates. 
The cells plated on LB agar indicated that these transformations with plasmid DNA 
from the 5 cycles of mutation also yielded low levels, only 102103  colonies/tg of 
DNA. Ideally, as mentioned earlier, the number of transformants should be ca 108 
colonies/ag of DNA. A possible explanation for the low transformation efficiency 
was the purity of the DNA. This hypothesis was refuted by using the libraries of 
mutants to transform different commercially available strains of XL1-Blue 
(chemically competent and electrocompetent cells). The same quantities of plasmid 
DNA (50 ng DNA from pRS7-1 libraries) yielded 
105106 
 transformants/jtg with 
these cells. Although lower than expected, this was significantly higher than the 
transformants obtained from CGSC6563 which yielded only 102103 
transformants/tg and suggested that for some reason this strain was poorly 
transformable with these plasmids. 
51 
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Although CGSC6563 appeared promising for the selection experiment, the concerns 
over the poor transformation efficiency were significant. The low level of 
transformation mitigated against the benefit of the very high throughput of the in vivo 
selective method. Clearly improvement of the competency of the CGSC 6563 strain 
was needed and hence chemically competent and electrocompetent cells were 
prepared from CGSC6563. Repetition of the preparation of the chemically competent 
and electrocompetent cells was carried out by harvesting the cells at a different 
0D500 (from 0.4 to 0.8), using fresh isolates and modified protocols. However the 
results were reproducible for all the transformations, yielding at most of only a few 
thousand transformants when CGSC6563 was used. Consequently the auxotrophic 
strain was deemed not to be suitable for very efficient transformation. One possible 
explanation was that it may be possible that other mutations in that strain affected the 
transformation and thus rendering it inadequate for the desired purpose, namely the 
screening of mutant libraries with the highest number of transformants. 
Therefore it was critical to the success of this approach to find a suitable auxotroph 
strain, which also could be transformed by recombinant mutated plasmid DNA at 
high efficiency. A new strategy was planned focussing on the deletion of 2 genes 
(one involved in the pathway of methionine biosynthesis and the second one as 
described earlier: dadAX gene) using a host strain, which was first tested for efficient 
transformation to create a more appropriate auxotroph for selection. This strategy 
had the additional benefit that it could employ deletion mutations that could not 
revert. 
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Figure 29: The pathway of methionine biosynthesis in E. coli 
In order to create a methionine auxotroph strain, it was crucial to determine 
rationally which gene had to be inactivated. In E. coli, methionine is generated from 
homoserine (Figure 29) in four steps involving the participation of six different 
enzymes. Therefore four possibilities existed to disrupt methionine biosynthesis. The 
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choice of the particular step to interrupt methionine biosynthesis had to be 
considered carefully as it could affect the general health and fitness of the strain. 
Homoserine is converted into O-succinyl L-homoserine by homoserine succinyl 
transferase (encoded by the metA gene). The reaction of O-succinyl L-homoserine 
and L-cysteine is catalysed by metB (cystathionine y-synthase) to yield succinate and 
cystathionine, which is then degraded into homocysteine by the action of metC. This 
reaction can also be catalysed by malY which is a bifunctional enzyme (repressor of 
maltose regulon / cystathionine -lyase). The final step is an S-methyl transfer which 
is catalysed in two alternative ways by two enzymes, metE (cobalamine-independent) 
and/or metH (cobalamine-dependent), to yield methionine. 
Interrupting the fourth step would therefore involve two deletions, which meant 
increased time as well as difficulty. Similarly, the interruption of the third step would 
also involve two deletions (time consuming, difficulties). Concerning the two first 
steps, none of the genes involved appeared to be essential for other functions in E. 
coli; therefore either of them could be deleted. However, it seemed more rational to 
interrupt the first step of the pathway, rather than the next one. 
Therefore, for the above reasons the gene chosen for deletion in the pathway of the 
methionine biosynthesis was the metA gene. 
2.3.2.2.1. Use of CGSC4474 (W3110) 
See Appendix 11.1. for genotype of this strain. 
The prototrophic reck strain W3110 (CGSC4474) has no additional supplementary 
requirement for growth on M9/glucose minimal medium. The choice of this strain 
offered several advantages namely (i) 2 mutations only, which means a more simple 
growth medium, (ii) less likely to complicate the selective approach and (iii) if 
deletion mutations were introduced in dadAX and metA, no reversion would be 
possible to generate false positives. In addition, the introduction of antibiotic markers 
at the deleted loci would assist in reducing contamination on selective plates and 
make it easier to follow any changes at the deleted loci (by PCR). The idea was to 
use the deletion system developed by Datsenko And Wanner[ 120] directly on W31 10 
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strain to inactivate the two genes involved in the biosynthesis of L-methionine (dadA 
and metA) and create a new auxotroph strain. However this strain is arabinose 
positive, and therefore is able to catabolise arabinose and use it as carbon and energy 
source. This was a concern as the gene deletion system uses arabinose in the 
induction of the RED system (pKD46), to enable gene deletions, so the function of 
arabinose as inducer could be compromised by its consumption as a carbon and 
energy source rather than a gratuitous inducer. This point is alluded to by the authors 
who reported this deletion system but the magnitude of the effect of using an ara 
host is not reported. 
Discussions with other groups using the method revealed problems when the strain 
BW25 113 was not used as the host for the deletion. The system is clearly more 
efficient in an arabinose negative strain such as BW25 113 than in arabinose positive 
strains. It was then decided to carry out inactivation of each gene in two stages: 
firstly create the deletion into BW25 113 and secondly transduce the deletion into 
CGSC4474 (Figure 30). Attempts to introduce the mutation in CGSC4474 were 
unsuccessful. Alternatively, an additional deletion in metA could be introduced to the 
dadAX mutant of BW25 113 (ET1) and used as the auxotroph strain if the 
transduction of the dadAXmutation was not successful. 
The replacement of dadA and metA respectively by chioramphenicol and kanamycin 
resistance, would also allow more control over possible contaminants. 
BW231 13/pKD46 
d.d4A 
0 	Phageinlectirm QTaansation PhagePi foern lys ate 
BW25tttIpKD46
CGSC4474 0  
CQSC4474/dndAL 
pKD461 Transfomsatiost + 
2 - Q (111111) 	PhagePi Transformation tysate 
EPI/ptW46 Ert/.nssAzt 	 I 
PCR prodnet dadA&:Cmt' 
2 Q PCR product aresAA::Kan' 
CGSC4474/dojANrsetAA 
Figure 30: Auxotroph strain construction stategy 
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2.3.2.2.2. 	Use of BW25 113 as the auxotrophic, selective host. 
See Appendix 11.1. for genotype of this strain. 
After several unsuccessful attempts to replace part of the metA gene, new primers 
were designed using longer homology extensions. However, this experiment proved 
to be unsuccessful. As an alternative, new primers were designed to delete part of the 
metB gene. After several unsucessful attempts to replace part of the metB gene with 
kanamycin resistance, the strategy was modified and a part of the metB gene was 
succesfully replaced with chloramphenicol resistance instead of kanamycin. 
Phenotypic expression (outgrowth) is less important for chloramphenicol resistance 
than kanamycin resistance. Kanamycin is an inhibitor of protein synthesis, which 
binds to the S12 protein of the 30S ribosomal subunit and thereby inhibits the 
initiation of synthesis of the polypeptide chain. However, when the kanamycin 
concentration is sufficiently low, initiation can still occur, causing extensive 
misincorporation of amino acids. This misincorporation happens because kanamycin 
alters codon-anticodon recognition, i.e. it induces misreading of the code. Thus 
spontaneous mutation frequencies to kanamycin resistance have been studied[125, 
126], and appear to arise at high frequencies under conditions of low selective 
antibiotic concentrations and specific growth conditions. In contrast chloramphenicol 
inhibits peptidyl transferase activity of the 70S ribosome. This antibiotic is very 
powerful and hence more efficient than kanamycin (not only inhibits growth but also 
is toxic for the cells). 
The dadA-dadX operon had previously been disrupted in the strain called ET1 
(section 2.3.1.1.2). The deletion was confirmed by PCR (Figure 31, column 1) and 
growth on M9/glucose minimal medium (supplemented with different methionine 
derivatives). The cat gene (chloramphenicol acetyl transferase- chloramphenicol 
resistance) was introduced to select for the new strain. However, in order to use the 
chloramphenicol resistance a second time to select the disruption of the metB gene, 
the removal of the cat gene replacing the first deletion was required. 
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The strain ET1 was therefore transformed with pCP20[127] (FLP helper plasmid) 
and transformants were selected at 30°C. The helper plasmid shows thermal 
induction of FLP synthesis. pCP20 expresses the FLP recombinase, which acts on 
the directly repeated FRT[128] (FLP recognition target) site flanking the resistance 
gene. The strain was then simply cured of pCP20 by growth at 43°C, as the plasmid 
has a temperature-sensitive replicon. The loss of the cat gene was checked by PCR 
on 6 different transformants using flanking oligos (Figure 31, columns 1'). The new 
strain called SET1 was purified 4 times at 43°C to be sure that the plasmid was 
completely cured. 
The inactivation of the metB gene using the same antibiotic marker and method was 
performed on two strains: SET1 and BW25113. The deletion of the metB gene was 
successful using a homologous priming sequence longer than described in the 
reported method (70 bp instead of 36-50 bp recommended) but failed on previous 
attempts using 50bp homologous priming sequences either with kanamycin or 
chloramphenicol resistance genes. The strain derived from SET1 was named SET2, 
while the strain derived from BW25 113 was called SET3. The correct disruption was 
checked by PCR (Figure 31, columns 21, 22 and 3). To assist selection and control of 
the new strain the chloramphenicol resistance was retained in the genome. 
The transduction of the two disrupted genes into CGSC4474 to create an auxotroph 
strain was considered. However, as a result of the two disruptions introduced in 
BW251 13, the new mutant SET2 seemed perfectly appropriate for as the auxotroph 
strain and therefore, it was decided to assess SET2 for auxotrophy and thus 
acceptability for in vivo selection. 
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First deletion: dadAX 
	
Second deletion: metB 
C 	1 1' (Cm1R  removed) 
C: control (wild type genes) 2609 bp 
1: ElI (BW251 13 with dadAX inactivated) 
1749 bp, 
1': SET! (Eli- CmIS)  649bp, 
C C 21 22 3 
C: control (wild type gene) 1161 bp 
21, 22: SET2 (SET! with metB inactivated) 
3: SET3 (BW251 13 with metB inactivated) 
Size disrupted gene (21,22,3): 1330 bp 
FHT 
42 \ 
Hi and H2 homology regions are dependent of the gene to be inactivated 
dadAX deletion 	 \metBeletion 




III FRI 	 FRI HI 
____EJIII4II1tJ 1 
111 FRI HI 
649bp 
Figure 31: PCR verification of the deletions 
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2.3.2.2.3. 	Feeding studies of SET2 
See Appendix 11.1. for genotype of this strain. 
In order to validate the selection, the growth of the newly created strain had to be 
tested on M9/glucose minimal medium for auxotrophy. As expected, the strain was 
unable to grow if not supplemented either with L-methionine or N-acetyl-L-





SET21 	SET22 	SET3 
M9 Yes No No No 
M9+L-methionine Yes Yes Yes Yes 
M9+ N-acetyl-L-methionine Yes Yes Yes Yes 
M9+D-methionine Yes No No Yes 
M9+ N-acetyl-D-methionine Yes No No Slight 
Table 7: Growth of the newly created strains from BW25113 observed on different media 
The auxotrophy of the SET2 strain was confirmed, and its ability to hydrolyse N-
acetyl-L-methionine meant no requirement to use a complementary acylase. 
Similarly, the strain SET3 (AmetB: : Cmli?) was not prototrophic as the biosynthesis of 
methionine was interrupted: no growth was observed any more on M9/glucose 
minimal medium. However, the expression of dadA, which was not inactivated in 
this strain, facilitated deamination of D-methionine as growth was still observed on 
D-methionine and N-acetyl-D-methionine. This strain however serves as an 
appropriate control to demonstrate efficient transport of the D-amino acid substrates 
(Figure 32). 
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M9/glucose minimal medium supplemented with L-methionine 	M9/glucose minimal medium supplemented with D-methionine 
M9glucuseniituiiial medium 	 (left plate) and V_acetyl_L_methlon[Ile (right plate) 	 (left plilc) end Ailed) l-l)-rnelhionille (right plate) 
Figure 32: Growth assays on strains SET21(top left), SET22 (bottom) and SET3 (top right) 
A new auxotroph strain SET2 requiring L-methionine as substrate was created using 
E. coli BW25 113 (exonuclease deficient). 2 genes were knocked out: dadAX (D-
amino acid dehydrogenase/alanine racemase) and metB (0-
succinylhomoserine(thiol)-lyase), preventing the mutant strain from growing if not 
supplemented with L-methionine. SET2 could potentially be a good candidate for in 
vivo selection. 
2.3.2.2.4. 	Validation of the selection using NAAARs 
As the SET21 strain was proven to be a methionine auxotroph, and unable to grow 
on N-acetyl-D-methionine or D-methionine, then if the NAAAR is expressed into the 
strain, we would expect N-acetyl-D-methionine to be racemised. The strain would 
then be able to grow when supplemented only with N-acetyl-D-methionine, as N-
acetyl-L-methionine would be generated. To test this proposal, the strain SET21was 
transformed with pTTQ18, pRS7-1 and pRS8-9, and two assays (with and without 
induction of the expression of NAAAR) were carried out in parallel on the three 
systems in M9/glucose minimal medium. The results, shown in Table 8, confirmed 
the phenotype to be as expected and appropriate for selection. When induced, the 
recombinant strain SET21 expressing NAAAR was able to grow on N-acetyl-D-
methionine, consistent with the production of L-methionine. As the only supplement 
incorporated to the M9/glucose minimal medium was N-acetyl-D-methionine, the 
kCSLIItSnU d1SLLs-1r 
only explanation was that the substrate was converted into N-acetyl-L-methionine, 
establishing the expression of the NAAAR activity. 
Media supplement 













None No No No No No No 
L-methionine Yes Yes Yes Yes Yes Yes 
D-methionine No No No No No No 
N-Ac-L-methionine Yes Yes Yes Yes Yes Yes 
N-Ac-D-methionine No No No Yes No Yes 
Table 8: Growth observed using SET21 transformed with different plasmids (red highlight the 
specific effect of the NAAAR activity) 
Thus, the next stage was to optimise the cell growth in the selection to be able to 
identify significant colonies (important for finding mutants). Two calibrations were 
required to do so. 
2.3.2.2.5. 	Cobalt tolerance of SET2 1 
As mentioned earlier, (section 2.3.2.1.2.) NAAAR requires a divalent metal ion for 
catalysis. Although the M9/glucose minimal medium contained Mg2 , NAAAR has 
higher activity in the presence of CO2 ions. However, as also noted above, cobalt is 
also toxic to E. coli at high concentrations. Therefore cobalt tolerance of the 
auxotroph stain had to be tested. The 2 NAAARs systems were plated on M9 
supplemented with N-acetyl-D-methionine and IPTG to induce the expression of 
An empirical determination of the optimum concentration of Co2 was used. The 
experiment, based on the growth of the strain using a range of Co 2+  concentrations 
from 0 to 1mM (0.05mM increments). To minimize the errors from measurements, 4 
replicates of plates were used (Figures 33 and 34). The error in measuring the size is 
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around 0.1mm. Increasing the concentration of CO 2 did not have any positive effect 
on the number of colonies. The number of colonies was found to decrease at a 
constant rate (Figure 33). At a concentration of cobalt greater than 0.4 mM, less than 
20% of the colonies survived. 
Cobalt tolerance of SET2I 
----*-No induction of the 
plasn-ids (control 100 
 













0,1 	0,2 	0.3 	OA 	0.50,60.7 	0.8 	0.8 	1 
Cobalt concentration (mM)  
Figure 33: Effect of cobalt on the number of colonies 
However, the increased concentration of cobalt had a slight positive effect on the size 
of the colonies (Figure 34). Thus when comparing the growth of cells bearing the 
cloned NAAAR genes or control plasmid (pTTQ1 8), at concentrations of cobalt 
lower than 0.3 mM, the inhibitory effect of cobalt on colony size was not as 
significant upon colonies expressing NAAAR as in the control. This observation 
might be explained by the fact cobalt was sequestered by the NAAAR enzymes. At 
concentrations of cobalt higher than 0.3 mM, the size of colonies became very small 
and the colonies were very difficult to distinguish. 
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Cobalt tolerance of SET2I on N-acetyl-o-methionine 
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Figure 34: Effects of cobalt concentration on the size of colonies 
The growth decreased rapidly after only minimal supplementation with Co 
2+ 
 ions. 
The expression of the 2 racemases seemed to affect the growth/ health of SET2 1 
(comparison of the growth when induced or not, Figure 33). This observation was 
supported by the growth of the control plasmid (pTTQ18), as its growth was 
identical to the assay with or without induction. To verify this hypothesis, growth 
controls were performed with the 3 systems on L-methionine (Figure 35) to compare 
rate of growth with the N-acetyl-D-methionine assays. 
As suggested, the expression of the two racemases affected the health and growth of 
SET2 1. When grown on M9 + L-methionine, decrease of growth of the three systems 
was observed as the concentration of cobalt increased. But when growth was 
performed on M9 + L-methionine + IIPTG, a difference of the growth was observed 
between the control system (pTTQ18, top left portion of the plate) and the 2 NAAAR 
systems (pRS7-1 and pRS8-9, respectively bottom portion and top left portion). This 
difference of the growth was possibly due to the fact that the genes were expressed in 
a high-copy vector ('-100 copies per cell). As the protein was produced, the carbon 
source was depleted more rapidly, and the growth suffered accordingly. At a 
concentration of 0.25 mIvI Co 
2+ 
 and above, the colony size was so small that 
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M9 + L-methioninc 	M9 + L-methionine+ !PTG 	 M9 + L-methionine 	M9 + L-methlonrne+ IPTO 
Figure 35: Cobalt tolerance of SET21 when NAAAR expressed. Top left: control using pTTQ18; 
bottom: using pRS7-1 (NAAAR from TS-1-60); top right: using pRS8-9 (NAAAR from A. 
orientalis)) 
Considering the fact that a concentration of 0.2 mM Co 
2+ 
 in the assay produced 
colonies which were 75% of the normal size, the concentration for cobalt should not 
exceed 0.2 mM in the assay. Using a range of cobalt concentration from 0 to 0.2 mM 
therefore seemed to be most appropriate as the aim of the screening is to isolate 
improved enzymes (e.g. greater reaction rate, less cobalt-dependant, higher level of 
resistance to substrate inhibition). 
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2.3.2.2.6. Effect of the substrate concentration on SET21 
Using SET2 1 transformants, similar results were found to the effects of substrate 
concentration when using transformants of CGSC6563 (Table 6). As discussed 
earlier, the optimal conditions were then established considering these results. As the 
colonies have to be small enough to differentiate better NAAAR activity, the optimal 
concentration of N-acetyl-D-methionine to screen libraries of mutants should be 15 
times higher (3.14 mM) than the concentration of N-acetyl-Lmethionine used to test 
the selection. This gives the same kind of growth (colony size and number) as when 
the medium is supplemented with L-methionine. For the screening of libraries, this 
optimal concentration could be slightly decreased to allow a better differentiation of 
improvement of activity, depending on how stringent the selection is intended to be. 
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2.4. 	Screening libraries of mutants 
The 13 libraries of randomly mutated pRS7-1 plasmid DNA (sections 2.2.1, 2.2.2.1 
and 2.2.2.2) were used to transform SET21 and plated directly on M9/glucose 
minimal medium supplemented with 2 mM of N-acetyl-D-methionine, 0.2 mM of 
CoC12 and 1 mM IPTG. A sample of each transformation mixture was spread on LB 
agar Amp 200  as control for transformation efficiency. Libraries were transformed 
with a relatively good efficiency (l05106  transformants/tg of DNA). 
After picking and replating the largest and fastest growing colonies, on identical 
media, only one mutant appeared to have a significantly improved growth rate. This 
mutant (designated 3P2) was isolated from the library called pRS7-1/3P, which was 
created from the third cycle of growth of the mutator strain grown on plates. The 
plasmid was isolated and, used to retransform fresh SET21 cells, and then plated 
onto M9/glucose minimal medium supplemented with 2 mM of N-acetyl-D 
methionine, 0.2 mM of CoC12 and 1 mM IPTG to validate that the growth was due to 
the plasmid expression and not from the host. In principle the strain should not have 
reverted, although some secondary mutation could in theory have occurred. The 
growth was confirmed as plasmid dependent. 
Mutant 3P2 was then plated on M9/glucose minimal medium supplemented with a 
range of concentrations of N-acetyl-D-methionine, ranging from 0.26 mM to 2.00 
mM, to determine the threshold for growth of the 3P2 colony in comparison to the 
wild type NAAAR. This experiment was designed to provide an indication of the 
improvement in the activity of the NAAAR. Surprisingly, at the lowest concentration 
of N-acetyl-D-methionine (0.26 mM), the strain SET21/3P2 grew at the same rate as 
if it was supplemented with L-methionine, whereas the strain bearing the unmutated 
plasmid (SET21/pRS7-1) required a concentration of N-acetyl-D-methionine of 2 
mM to show a similar rate of growth. This significantly reduced requirement for N-
acetyl-D-methionine in comparison to the unmutated pRS7-1 strongly suggested that 
the NAAAR activity in the cell had been significantly increased. The concentration 
of N-acetyl-D-methionine had in fact been reduced by a factor of 7.63. This factor 




was produced by random mutagenesis using XL1-Red mutator strain, the possibility 
arose that expression of the gene had been increased since not only the gene but the 
entire plasmid had been subjected to random mutations. Protein gels of whole cell 
cultures were then performed to determine whether the increased rate of growth of 
the SET21/3P2 mutant was attributable to the NAAAR enzyme being expressed at a 
higher level in the cell than the NAAAR of SET21/pRS7-1. The results (Figure 36) 
indicated no obvious increased level of production of NAAAR (The NAAAR band is 
expected to be ca 39 kDa, as indicated by the arrow). 
*IIL - 
Proteins produced before induction 
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Figure 36: Protein gel of pRS7-1 and its variant 3P2 
Plasmid DNA of pRS7-1 and 3P2 was prepared and complete, double stranded 
sequence analysis was carried out on the coding and regulatory regions of the 
NAAAR gene from pRS7-1 and 3P2. Alignment of the deduced amino acid 
sequences of the NAAAR genes from pRS7-1 and 3P2 showed that a single DNA 
change had been introduced (G878-A878) in the NAAAR gene of 3P2. This change 
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leads to a single amino acid difference between the wild type TS-1-60 NAAAR, 
which has glycine (GGG) at position 293, and the 3P2 variant in which the glycine 
has been replaced by glutamic acid (GAG) at position 293 (See Appendix 11.5.). 
2.5. 	Chiral HPLC assays 
An efficient assay was required to assess in vitro dynamic kinetic resolution and to 
analyse the racemisation versus the hydrolysis of N-Ac-D-Amino Acids. Chiral high-
performance liquid chromatography (HPLC) columns are used in both application 
development and preparative work. HPLC has proven to be useful for resolving 
racemates and the determination of absolute configuration of enantiomers and has 
become the method of choice for chiral separations[129]. Many chiral columns have 
been used to measure the enantiomeric composition of amino acids or N-acylamino 
acid derivatives individually. However no method has been developed to measure 
simultaneously the enantiomeric composition of amino acids and their N-acyl 
derivatives. Recently a Taiwanese group has investigated several HPLC chiral 
columns and reported[130] a suitable column to measure the enantiomeric 
composition of amino acids and N-acetyl amino acids simultaneously and directly 
from the enzymatic reaction solution (aqueous solution), more specifically using DL-
methionine and N-acetyl-DL-methionine. This column, CHJIROBIOTIC TTM, 
developed by D.W. Armstrong, is commercialised by ASTEC (Advanced Separation 
Technologies, Whippany, USA). The column is based on covalently bond of an 
amphoteric macrocyclic glycopeptide (teicoplanin) to silica gel as the chiral 
stationary phase ligand and can be used in both the normal-phase and reversed-phase 
modes[131, 132]. Teicoplanin is naturally produced by the Actinoplanes 
teicomycetus mildew and contains 20 asymmetric centers surrounding four cavities. 
The teicoplanin chiral stationary phase appears to have excellent enantio selectivity 
for native amino acids, peptides, a-hydroxycarboxylic acid, and a variety of neutral 
analytes, including cyclic amides and amines[133]. The separation mechanism is 
believed to involve hydrogen bonding, dipole stacking, steric and charge interaction, 
ic—yr complexation, and inclusion. 
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Results and disussion 
2.5.1. 	Standard calibration 
In order to measure the enantiomeric composition of amino acids and N-acetyl amino 
acids simultaneously, standard calibration chromatograms (Figure 37) had to be run 
to identify the optimal mobile phase composition. The concentration used was 10mM 
for all amino acids and N-acetyl amino acids. 
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Figure 37: HPLC profile of D-, L-methionine and N-acetyl-D-, L-methionine 
(1: L-Met, 2: D-Met, 3: N-acetyl-L-Met, 4: N-acetyl-D-Met) 
2.5.2. 	Simultaneous analysis of in vivo racemisation and hydrolysis by HPLC 
pRS7-1 was expressed in JM109 by induction with IPTG. The cells were recovered 
by centrifugation, and resuspended into an aqueous solution containing 5 mg/ml of 
N-acetyl-D-methionine (0.262 mM). An initial sample was taken and injected as 
reference (Figure 38). The mixture was then incubated at 37'C, and a sample was 
taken at intervals of 1, 2, 4 and 48 hours and injected into the column (Figure 39). 
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Figure 38: Initial profile of the enzymatic reaction containing 0.262m1'I N-acetyl-D-Met 
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Figure 39: HPLC profile of the in vivo racemisation and hydrolysis of 0.262mM N-acetyl D-Met 
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The clear progress of separation of the amino acids and their derivatives allowed the 
various reactions to be followed in real time, namely (i) the racemisation of N-acetyl-
D-methionine (4) into N-acetyl-L-methionine (3), (ii) the hydrolysis of N-acetyl-L-
methionine (3) forming L-methionine (1), and (iii) the hydrolysis of N-acetyl-D-
methionine (4) forming D-methionine (2). However, after 2 hours, the reaction 
slowed down as the cells died. 
Thus, the HPLC assay appeared to be promising for assessing the activity of 
NAAAR semi-quantitatively. This assay is therefore complementary to the in vivo 
selection, which is more qualitative. 
2.6. 	HPLC assay on the mutant NAAAR 
The data generated in vivo indicated that a single mutation in the TS-1-60 gene had 
given rise to an NAAAR variant which enhanced the growth of E. coli under 
conditions where NAAAR activity was the rate limiting factor for growth. To 
support this finding, and verify that the 3P2 variant did in fact possess a higher level 
of NAAAR activity than its progenitor, an assay for NAAAR activity was developed 
in vitro, and was carried out using extracts of SET21/pRS7-1 and SET21/3P2. Two 
different experiments were carried out. The first experiment attempted to validate the 
fact that cobalt was absolutely required for racemisation as the enzyme is a 
metalloenzyme, and to test the 3P2 variant for possible reduced cobalt dependence. 
The second experiment was carried out to more accurately quantify the level of 
racemisation of N-acetyl-D-methionine by 3P2 and pRS7-1 and to correlate the 
results with those observed with the in vivo selection concerning an improvement of 
the racemase activity of 3P2. 
2.6.1. 	Calibration of the HPLC profile 
In order to identify the different peaks on the HPLC profile, standards were run 
under the conditions to be used for the racemisation assays as shown in Figure 40. 
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The separation system (mobile phase composition) used was different to the one 
described above in section 2.5.2. 
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Figure 40: HPLC profile of a mixture of 10m1'1 u-methionine(4), 30mM L-methionine(2), 
20mM N-acetyl-D-methionine(3) and 40mM N-acetyl-L-methionine(1) 
It was important to be able to accurately quantify the different products in the 
mixture to follow the progress of the racemisation reaction. The areas of the different 
peaks reflected the quantity of the different methionine enantiomers and derivatives. 
The intensity of the peaks for the enantiomers were different but it appeared that a 
relationship existed between the concentrations and the areas of the peaks 
corresponding to N-acetyl-L-methionine and N-acetyl-D-methionine. Determination 
of the unknown amount of one enantiomer was therefore possible using the known 
concentration of the other enantiomer. Experimentally, using the specific conditions 
described in section 9.2.2., it was found that: 
Area N-acetyl-L-methionine  1.1 475*Area corresponding to equivalent absorption N-acetyl-D-methionine 
Therefore it was possible to determinate the conversion of N-acetyl-D-methionine 
into N-acetyl-L-methionine. 
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2.6.2. NAAAR requirement for cobalt 
NAAAR has been widely described as being a metalloenzyme. It requires a metal 
ion, like magnesium, manganese, or zinc but gives the highest activity using 
cobalt[70]. It was decided to assess the activity of the 3P2 variant with cobalt using 
the optimal concentration of 6 mM determined experimentally by different groups. 
As shown in Figures 41 to 44, the assays were carried out over a period of 24 hours. 
For clarity, the figures show the experiments only at the beginning and after 24 
hours, although samples were taken regularly. 
When no cobalt was added, racemisation did not occur with the wild type racemase, 
as no peak was observed at 5 minutes (the retention time corresponding to N-acetyl-
L-methionine) (Figure 41). This was an important observation as it was thought that 
the presence of metal ions within the cells might have been sufficient to enable some 
NAAAR activity. 
Assay pRS7I without cobalt 
- TO No Cobalt 
pRS71 T+24hour No Cobalt C 




Figure 41: HFLC profile of biotransformation using 10mM N-acetyl-D-Met and pRS7-1 
expressed in 50mg of wet weight of SET2-1 without addition of cobalt 
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However, as shown in Figure 42, when pRS7-1 was replaced by the 3P2 variant, the 
HPLC profile showed a slight degree of racemisation of 2.1% (presence of a small 
peak at 5 minutes). In addition a corresponding decrease in the concentration of N-
acetyl-D-methionine was also observed. The latter could possibly be explained by 
hydrolysis to D-methionine since there also appeared to be a new peak at 15 minutes 
which corresponded to D-methionine. Approximately 50% of the N-acetyl-D-
methionine had disappeared, which could not be explained (converted and used by 
some surviving cells- at this concentration of cobalt no cells could normally 
survived- cobalt tolerance of the strain- no growth at all for a concentration above 1 
MM). 




E0.14 --.-- ........................................ 
012 - - - 
0.1  -TO No Cobalt I 
0.08 - ----- ------.-. 	.- __________--- -3P2T+24hourNoCobalt 
o 0.06 
 
< 0.04  
002 ---- - - 
0 . 	1 
-0.02 10. 
Time (mm) 
Figure 42: HPLC profile of biotransformation using 10m11'1 N-acetyl-D-methionine and 3P2 
expressed in 50mg of wet weight of SET2-1 without addition of cobalt of 50mg of wet weight 
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Figure 43: HPLC profile of biotransformation using 10mM N-acetyl-n-methionine and wild 
type enzyme expressed in 50mg of wet weight of SET2-1 and assayed with 6mM cobalt 
When cobalt was used in the assays, both the 3P2 and the pRS7-1 wild type NAAAR 
enzymes showed activity. The wild type enzyme showed a lower level of activity, 
and racemisation after 24 hours was incomplete (Figure 43). Only 10.1% of N-
acetyl-D-methionine was racemised (14.1% conversion if the concentration of N-
acetyl-L-methionine was compared to the concentration of the residual N-acetyl-D-
methionine). 
Compared to the wild type enzyme, the variant enzyme showed significantly greater 
racemase activity, with almost complete racemisation (75.8% conversion if the 
concentration of N-acetyl-L-methionine was compared to the concentration of the 
residual N-acetyl-D-methionine, 16.6% conversion if the concentration of N-acetyl-L-
methionine was compared to the initial concentration of N-acetyl-D-methionine) 
occurring within 24 hours (Figure 44). 
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Figure 44: HPLC profile of biotransformation using 10m1'1 N-acetyl-D-methionine and the 
variant enzyme expressed in 50mg of wet weight of SET2-1 assayed with 6mM cobalt 
However, another peak appeared with similar retention time (15 mins) to that of D-
methionine. This was unexpected because if this was indeed D-methionine, a similar 
peak due to hydrolysis might be expected with SET21/pRS7-1 since the only 
difference between the two strains was the single amino acid mutation of NAAAR. 
In addition, the hydrolysis of N-acetyl-L-methionine might also be expected to occur, 
and a peak corresponding to L-methionine should be visualised on the HPLC profile. 
L-methionine would not be expected to be consumed rapidly by resting cells, in the 
presence of a highly toxic concentration of cobalt. As this peak at 15 minutes only 
appeared when the 3P2 variant activity was assayed, a possible explanation could be 
the introduction in 3P2 of a secondary hydrolytic activity towards N-acetyl-D-
methionine. 
A more detailed time course experiment was then carried out to compare the 
racemase activity of the wild type TS-1-60 enzyme and the 3P2 variant. The 
racemisation was followed over 24 hours to assess the respective NAAAR activities. 
As shown in Figures 45 to 51, racemisation of N-acetyl-D-methionine was seen to 
occur much more rapidly with the 3P2 variant than the wild type enzyme. The 
decrease in concentration of N-acetyl-D-methionine is symbolised by "0", while the 
increase in concentration of N-acetyl-L-methionine is symbolised by "O". 
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Figure 45 
Assay after 1.5 hours 
019 
014  
0 	 -PR S7l T+1.51OLw6n11 Cobalt 
009 	- 	 - -- 	 -3P2T+1.5lwur6nIStCobalt 
v ::: :L 
Time (win) 
Assay after 1 hour 




I 	 pRS71 T*llommr 6mM Cobalt 
3P2 T+lbamo 6mM Cobalt 
-e 	009 
o 
.-------_ 	. ............. 
004 ...... 
-9.01 f0 1 	 20 
Time (min) 
Figure 46 
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Assay after 3 hours 
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Figure 51 
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Figure 52: Mass balance of pRS71 racemisation assay 
These data are summarised in Figures 52 to 55. The mass balance in the assay using 
the wild-type enzyme (Figure 52) showed an overall decrease of N-acetyl-methionine 
over time (loss of almost 20%), whereas ideally it should remain constant and close 
to the initial mass (TO). This suggested either some N-acetyl-D-methionine or some 
N-acetyl-L-methionine (or both) is degraded during the process, and cannot be 
visualised. 
Figure 53: Mass balance of 3P2 racemisation assay 
The same observation was made with the mass balance of the assay using the variant 
enzyme (Figure 53), but the loss of material was doubled (40%), and the appearance 
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of a new peak (having the same retention time as D-methionine) suggested that in 
addition to the unexplained loss of the N-acetyl-D or/and L- methionine, some of the 
N-acetyl-D-methionine was hydrolysed as well. Since the only known difference 
between the two strains examined, is the single point mutation in the 3P2 variant, this 
suggested the variant enzyme might have evolved a new activity, a D-aminoacylase. 
If so, then the mutation G293E increased the rate of the racemisation, but also 
introduced an other catalytic activity. Following this observation, an extensive 
literature review[134-136] revealed several articles which report aspartic acid to be 
closely involved in the catalytic mechanism of D-aminoacylase. Glutamic acid is also 
mentioned where it probably acts as a general base to activate the nucleophile water. 
Abstracting the proton from the water molecule, and the tightly bound zinc ion 
polarizes the carbonyl-oxygen bond, thus facilitating the nucleophilic attack on the 
amide carbon atom to form the tetrahedral intermediate. Cleavage of the carbon-
nitrogen bond is assisted by the simultaneous protonation of the amide nitrogen. 
Similarly, in the case of the variant enzyme, the novel glutamic acid could play the 
same role. Interestingly, the concentration of the N-acetyl-L-methionine formed 
seemed to increase in the same proportion as that of D-methionine. This might reflect 
a competition between two reactions catalysed by the variant enzyme: racemisation 
and hydrolysis. However, even with the loss of some starting material, the 
concentration of N-acetyl-L-methionine formed by the mutant enzyme remained far 
more significant than that of the wild-type enzyme. 
Figure 54: Comparison of the rate of racemisation between the variant and the wild type enzyme 
(R=ratio of the products from each reaction over time deduced from HPLC, considering the 
residual N-acetyl-D-methionine as reference) 
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Additionally, the comparison of the rate of racemisation as shown in Figure 54 
consistently showed a 6-fold increase in the rate of racemisation by 3P2 over the 
wild type TS-1-60 NAAAR enzyme throughout the experiment. Interestingly, this 
result showed a remarkable similarity with the solid phase assay (plate assay). With 
the reference being the rate of colony growth on L-methionine, to obtain a similar 
growth rate with the wild type enzyme, a concentration of N-acetyl-D-methionine of 
2 mM was required; whereas the variant enzyme showed the same growth for a 
concentration 7.63 times lower (0.262 mM- section 2.5). The solid phase assay could 
therefore possibly offer more quantitative information than expected about the 
improvement of the variant. 
Figure 55: Comparison of the rate of racemisation between the variant and the wild type enzyme 
(R=ratio of the products from each reaction over time deduced from HPLC, considering the initial 
concentration of N-acetyl-D-methionine as reference) 
However, if the comparison of the rate of racemisation takes into consideration the 
initial concentration of N-acetyl-D-methionine (Figure 55), the rate is no longer 
constant but decreases throughout the experiment. This might reflect the depletion of 
the substrate more important for the variant experiment: the rate of racemisation of 
the variant slows down as the concentrations of N-acetyl-L- and D-methionine 
equilibrate. 
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These experiments were repeated to assess the racemase activity of pRS7-1 and 3P2 
variant using either N-acetyl-D-methionine or N-acetyl-L-methionine as starting 
material. The results are shown in Figures 56 and 57. 
Assay racemisation pRS7I after 24 hours 
15 	20 
- 	N-acetyl-L-met TO 
- pRS7I/N-acetyl-L-nut 
N-acetyl-D-met TO 
pRS71/N-acetyl-D-rrt I I 
Figure 56: HPLC profile of the in vivo reaction using pRS71 expressed in SET2-1 assayed with 
6mM cobalt with either N-acetyl-L- (1) or N-acetyl-D-met (2) as starting material 
The wild type enzyme showed as expected[70, 80] a substrate preference towards N-
acetyl-L-methionine. Conversion from N-acetyl-D-methionine to N-acetyl-L-
methionine was preferred. As previously no peaks corresponding to the D-, or L-
methionine were observed. 
Rosults and discussion 
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Figure 57: HPLC profile of the in vivo reaction using 3P2 expressed in SET2-1 assayed with 
6mIVI cobalt with either N-acetyl-L- (1) or N-acetyl-D-met (2) as starting material 
The 3P2 variant showed the same enantiopreference towards N-acetyl-L-methionine. 
However, whatever starting material was used, a peak corresponding to D-
methionine (3) appeared (15 minutes), suggesting again the mutation carried by the 
3P2 variant introduced a second catalytic activity. 
However, in another experiment, the additional peak observed was not D-methionine, 
but L-methionine. Therefore these results have to be interpretated with extreme 
caution until further purification and full kinetic characterisation of the NAAAR 
activity of the 3P2 variant. 
2.7. 	Hypothesis about the role of the mutation 
High resolution crystal structures of NAAAR enzymes from Amycolatopsis. species 
TS 1-60, used in this study, and Deinoccocus radiodurans are now available[79, 80] 
and the mechanism of NAAAR activity is now well documented. From these 
analyses, the framework K165-D185-E216-D241-K265 has been determined to 
catalyse 1,1-proton exchange of N-acylamino acids in this enzyme. The enzyme is 
constituted by four subunits enclosing the substrate (Figure 14): catalytic site (C), 
metal-binding site (M), side-chain-binding site (S) and a flexible lid region (L). The 
NAAAR activity is attributed to the location of two lysine residues (K165, K265) in 
sufficiently close proximity to facilitate proton abstraction or donation from either 
face of N-acylamino acid substrates. A modelling study of the G293E mutation of 
3P2 variant shows its location to be in close proximity to the substrate and the 
terminal amino group of each lysine residue (Figure 58). 
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Figure 58: Active site residues of TS-1-60 
Lysine residues at positions 165 and 265 which participate in N-acylamino acid 
racemisation are indicated in black. Glycine 293 which is mutated to glutamic acid in 3P2 is 
also indicated in black 
The software used for the modelling was Insight II from Acceirys 
(http://www.accelrys.com), and the initial crystal structures used were available on 
the NCBI website (http://www.ncbi.nlm.nih.gov). 
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The mutation (G293E) is located in the S region, which is a hightly conserved region 
between NAAAR sequences (See Appendix 11.5.), introducing a long acidic chain, 
which could act either: 
As a proton donor to the one of the lysine catalyst (K165 or K265) and then 
abstracting the cc-proton of the carboxylate. The negatively charged intermediate is 
stabilised by the bound CO2 ion, and then the second lysine catalyst donates an cc-
proton to yield the racemised product. 
As a proton donor to the intermediate formed by the abstraction of the U.-proton of 
the carboxylate. (Regenerated by one of the lysines). 
These two hypotheses are very unlikely as the pH is neutral or slightly basic (in vivo 
reaction), so the glutamic acid is as its deprotonated form. 
By abstracting the a-proton of the carboxylate 
As a proton relay between the 2 lysines. This hypothesis could explain the 
observed improvement of the NAAAR activity. 
As a general base during catalysis, abstracting a proton from a water molecule. 
The amide bond then undergoes a nucleophilic attack to form the tetrahedral 
intermediate. Cleavage of the carbon-nitrogen bond is assisted by the simultaneous 
protonation of the amide nitrogen. This hypothesis could explain the formation of the 
deacetylated amino acid. 
Although based only on a model at present, this active site location would be 
consistent with the mutation exerting an influence on substrate proton abstraction, as 
shown Figure 59. A high-resolution crystal structure of the 3P2 variant would 
confirm the position of E293 and greatly assist the interpretation of the effect of this 
mutation upon catalysis. 
Figure 59: Model of the active site of 3P2 variant indicating the estimated distances (in A) 
between substate and the different residues involved in the NAAAR activity 
2.8. 	Conclusion 
In conclusion, this study attempted to develop a new high throughput in vivo 
screening method to identify N-acylamino acid racemase activity in enzymes of the 
enolase superfamily. In addition the bacterial strain used in the screen was employed 
as a host in which to select random mutations which increase the NAAAR activity in 
specific enzymes. The principle objectives were achieved, and showed this to be an 
original approach to the high throughput concept, complemented with a more 
quantitative in vitro assay using HPLC. The choice to select the NAAAR from 
Amycolatopsis TS-l-60 was based upon the fact the enzyme already possessed a low 
level of NAAAR activity but also some properties, which were significant limiting 
for a useful biocatalyst, such as relatively low turnover, and substrate mediated 
inhibition at concentrations exceeding 50mM. The in vivo selective method was an 
excellent way to explore this very interesting N-acylamino acid racemase activity 
reported in the enolase superfamily. The known NAAAR was used to determine its 
effect in restoring growth to the E. coli mutant and therefore validation of this 
selection. 
Furthermore the screening of libraries of mutants derived from the wild type enzyme 
unveiled a mutant strain with an improved activity, which further demonstrated the 
value of the in vivo approach, as it is possible to screen easily a library of 106 108 
mutants per assay. Another interesting observation about the selection was made on 
the correlation between substrate inhibition of the two racemases and the 
concentration at which the colonies appeared to decrease in number. The selection 
may be suitable for gathering additional useful direct information about the 
characteristics of the enzymes such as substrate inhibition and kinetics (general 
improvement of the rate of catalysis) without having to purify the enzymes. 
Additionally, the mutation made in the wild type enzyme of TS-1-60 is a good basis 
for future studies (saturation mutagenesis, purification, kinetics, additional rounds of 
laboratory evolution) and eventual detailed investigations of the hypotheses made 
about the effect of the mutation upon enzyme function (substrate inhibition, general 
improvement of the activity). 
Additionally, the complernentarity of this method and methods of rational 
mutagenesis proved to be useful. The work of Gent, Babbitt, and Wang on NAAAR 
have helped to correlate the structure of this enzyme (and others of the enolase 
superfamily) to its function. This has provided a basis to locate the 3P2 mutation and 
to predict its effect upon the enzyme. Similarly, the method developed in this work 
permits the identification of mutations which might never be considered in 
structure/function and rational mutagenesis approaches. The combination of the two 
strategies is therefore synergistic and extremely powerful for future application. 
2.9. 	Future work 
The 3P2 variant identified in this work should be fully characterised in future work 
to support the preliminary in vitro racemisation data. To conduct detailed kinetic 
analysis the enzyme should be first isolated and purified to homogeneity. This can 
perhaps best be achieved using a well developed procedure such as poly-histidine 
tagging (Invitrogen). This work has been initiated by sub-cloning the genes encoding 
the wild type TS-1-60 NAAAR and the 3P2 variant into the vector pET16b to 
construct in-frame poly-histidine fusions. The resulting constructs will next be 
characterised. The 3P2 variant will then be purified to homogeneity by Ni-chelation 
chromatography for full kinetic characterisation of its NAAAR activity. In parallel it 
is now appropriate to conduct additional random mutation upon the 3P2 variant and 
saturation mutagenesis at the G293E position to examine the effect of alternate 
amino acid substitutions at this location. This may require re-calibration of the 
selection using lower levels of expression of the 3P2 variant. In addition it would be 
extremely interesting to introduce the G293E mutation to the corresponding position 
(also a glycine) in the NAAAR of A. orientalis and other close homologues of the 
TS-1-60 NAAAR. 
The variant unveiled by the selection may also have acquired a degree of acylase 
activity with high enantioseletivity towards N-acetyl-D-methionine. To further test 
this possibility, particularly with purified enzyme, the racernisation should be 
monitored in separate experiments which use either N-acetyl-D-rnethionine and N-
acetyl-L-methionine as starting material. This will provide conclusive evidence for 
any acylase activity and could reveal the variant to be very useful industrially, as the 
substrate (N-acetyl-L-methionine) might be racemised and then hydrolysed 
immediately, yielding 100% D-methionine from N-acetyl-L-methionine without the 
assistance of any other enzyme- the ultimate goal of an efficient dynamic kinetic 
resolution. This could be the first step towards a new way of rational design of 
biocatalysts, which to date has generally been based on improving the activity of 
existing enzymes or shifting the activity towards another existing activity in the same 
superfamily. The fact that it might be possible to introduce a novel activity in an 
enzyme which was not originally designed for such an activity appears to be very 
exciting, as the design may focus on how the reaction is catalysed (and the residues 
which are involved in a particular reaction), and may consider the superfamily aspect 
(general characteristics/aspects) rather than individual specificity. 
Furthermore, following the successful construction of this selection, the screening of 
potential novel racemases could proceed and the deletion method could be applied to 
additional aniino acids of academic and commercial interest, such as phenylalanine, 
leucine, and tyrosine auxotrophs, to enable the testing of this selection with alternate 
substrates. 
Genes from various sources could also be studied. The first source could be NAAAR 
homologues or libraries of fragments from bacterial strains including: Rhodoccocus, 
Streptomycetes and Aniycolatopsis. Introducing libraries containing chromosomal 
fragments of these organisms into selective strains would test the frequency of 
NAAAR occurrence. These homologues or fragments could be either in native forms 
or following mutagenesis using mutator or error-prone PCR. The homologue 
approach could make use of many hundreds of individual NAAAR homologues now 
identifiable in public genomic databases. This point illustrates how microbial 
genornics has provided a wealth of information and accessible genetic material for 
biocatalyst development. The last source could use genes encoding known enolase 
superfamily members: OSBS from Bacillus subtilis, enolase from E. co/i, 
cycloisomerase from Rhodococcus erythropolis, racemase from Pseudornonas 
putidas and potentially others. 
The approach could be extended to the selection for additional superfamily enzyme 
activities. Deletion mutations could also be planned in the E. co/i OSBS and enolase 
genes. These would be used to select for these activities also in randomly mutated 
enolase superfamily enzymes and other gene sources such as libraries. 
Mutations in the E. co/i menC gene, which encodes OSBS, have been used 
previously to define the native activity of the TS-1-60 NAAAR. Therefore a deletion 
in the gene may be more broadly applicable to identify this activity through mutation 
of related enzymes of the superfamily. Similarly the gene encoding the E. coli 
enolase could be deleted. Complementation of this essential function could also be 
explored to identify mutations in related enzymes that lead to acquisition of enolase 
activity. 
In this way, it is hoped that some insight into the potential interconversion of these 
closely related enzyme activities can be gained and the potential to evolve novel 
activities also explored. Ideally some of these experiments will result in valuable 
novel biocatalysts. The methods described in this work, for example the gene 
deletion system, may also be developed into very general methods potentially useful 
for biocatalyst generation through selection. Finally this work illustrates that 
principles that date from very early work in strain development can still be applied in 
novel and powerful applications by taking advantage of recent advances in 
methodology and informatics. 
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3. Experimental: Stock Recipes (Maniatis) 
Chemicals and reagents for buffers, assay mixtures and cultures medium were used 
as supplied from commercial sources, and were standard laboratory grade. 
3.1. 	LB medium 
25 gIL of LB Broth (Fisher Chemicals) or prepared as followed per litre: 
Sodium chloride 	 log 
Triptone 	 log 
Yeast extract 	 5 g 
3.2. 	LB agar medium 
LB medium 	 300 ml 
Agar 	 4.5 g 
3.3. 	R-top agar 
Tryptone log 
NaCl 8g 
Yeast extract 1 g 
Agar 8g 
Water to a final volume of 1 litre 
After autoclaving: 
CaC12 1M 2 ml 
20% glucose 5 ml 
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3.4. 	Medium for R plates 
Tryptone lOg 
NaCl 8g 
Yeast extract 1 g 
Agar 12g 
Water to a final volume of 1 litre 
After autoclaving: 
CaCl2 1M 2 ml 
20% glucose 5 ml 
3.5. 	lOx M9 salts 
Na2HPO4.7H20 128g 
KH2PO4 30 g 
NaCl 5g 
NH4C1 lOg 
Water to a final volume of 1 litre 
3.6. 	50x TAE 
Tris base 242g 
Glacial acetic acid 57.1 ml 
EDTA 0.5M (pH 8.0) 100 ml 
Water to a final volume of 1 litre 





4. Experimental: cloning 
4.1. 	General techniques 
E. coli strains were obtained from E. coli Genetic Stock Center (Yale University, 
New Haven, USA). E. coli XL1-Red and XL1-Blue competent cells were purchased 
from Stratagene (La Jolla, USA). E. coli ToplO were purchased from Invitrogen 
(Paisley, UK). 
Expression vector pTTQ18 was provided by Dr Michael Stark (University of 
Dundee, UK). pET16b was purchased from Novagen (Nottingham, UK). 
Oligonucleotides were purchased fom Interactiva (Ulm, Germany) and 
ThermoElectron (Ulm, Germany). 
DiversifyTM PCR random mutagenesis was purchased from BD Clontech UK 
(Basingstoke, UK). 
Restriction enzymes and T4 ligase were purchased from New England Biolabs 
(Hitchin, UK). PuReTaqTM Ready-to-goTM PCR beads were purchased from 
Amersham Biosciences (Little Chalfont,UK). 
Purification kit for plasmids, genomic DNA, PCR and gel extraction were purchased 
from Qiagen (Hilden, Germany). E-Gels were from Invitrogen. 
Readygels (Precasted 10-20% Tris-HC1 acrylamide gels) were purchased from Bio-
Rad and run either on a BioRad Powerpac 200 or Powerpac 1000. EZB1ueTM  gel 
staining solution was purchased from Sigma. 
PCR experiments were carried out on a Stratagene RoboCycler Gradient 96 or on an 
Eppendorf Mastercycler® personal (Eppendorf AG, Hamburg, Germany). 
Electroporation were performed using a Bio-Rad Gene Pulser II Electroporation 
System (Hemel Hemperstead, UK). Centrifugation were performed either with a 
Eppendorf 5415C or 5415R microcentrifuge or Heraeus Biofuge pico for small scale 
or with a Sorvall® RC 5C Plus or RC 26 Plus centrifuge (Kendro Laboratory 
Products Limited (Bishop's Stortford, UK) for larger scale. 
OD and DNA concentration were analysed using an Eppendorf BioPhotometer. 
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CHIROBIOTIC TTM  chiral column (Catalogue number: 12024 - 5m 250x4.6mm) 
was purchased from Astec (Advanced Separative Technologies Ltd, Congleton, UK). 
4.2. 	Construction of plasmids 
4.2.1. With NAAARs from TS-1-60 and Amycolatopsis orientalis 
4.2.1.1. Gene amplification from TS-1-60 by PCR 
The gene (1105 bp) was amplified from the chromosomal DNA using PCR. The 
chromosomal DNA was purified using QIAGEN Genomic DNA extraction kit 
yielding a concentration of DNA of 450 j.ig/ml. Two nucleotides were designed 
according to the termini of the coding region, and containing unique restriction sites 
for subcloning into the expression vector pTTQ 18 and utilised in the reaction. 
The N-terminus EcoRI primer contained a unique EcoRI restriction site indicated in 
bold: 
5 '-GACGAATTCGAAACTCAGCGGTGTGGAACTGCGCCGGG-3' 
The C-terminus S 2hI primer contained a unique Sphl restriction site indicated in 
bold: 
5 '-GACGCATGCCTACGAACCGATCCACACCTTTGCCGTGGTC-3' 
The PCR reaction was performed using a pureTaq Ready-to-go PCR bead with Taq 
DNA polymerase. One bead was mixed with 0.6 p1 of each primer (from a 1 pmol/p1 
primer solution), 1 p1 of chromosomal DNA template and 22.8 p1 of water. 
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The PCR reaction was performed using the following optimised cycle conditions: 















l min 30s 
3 mins 
The PCR product mixed with loading buffer was identified using TAE agarose gel 
electrophoresis by UV visualisation of ethidium bromide stain. The corresponding 
band (1116 bp) was purified using a QlAquick gel extraction kit, and eluted in 30 jt1 
of EB buffer (elution buffer). 
4.2.1.2. Gene amplification from A. orientalis by PCR 
The gene (1105 bp) was amplified from the chromosomal DNA using PCR. The 
chromosomal DNA was purified using QIAGEN Genomic DNA extraction kit 
yielding a concentration of DNA of 470 jig/ml. Two nucleotides were designed 
according to the termini of the coding region, and containing unique restriction sites 
for subcloning into the expression vector pTTQ1 8 and utilised in the reaction. 
The N-terminus EcoRI primer contained a unique EcoRI restriction site indicated in 
bold: 
5 '-GACGAATTCGAAACTCAGCGGTGTGGAACTGCGCCGGG-3' 
The C-terminus Sphl primer contained a unique Sphl restriction site indicated in 
bold: 
5 '-GACGCATGCCTACGAACCGATCCACGCTTTCTCCGTGGTG-3' 
The PCR reaction was performed using a pureTaq Ready-to-go PCR bead. One bead 
was mixed with 0.6 jil of each primer (from a 1 pmol/pi primer solution), 1 p1 of 
chromosomal DNA template and 22.8 p1 of water. 
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The PCR reaction was performed using the following optimised cycle conditions: 















l min 3Os 
3 mins 
The PCR product mixed with loading buffer was identified using TAE agarose gel 
electrophoresis by UV visualisation of ethidium bromide stain. The corresponding 
band (1116 bp) was purified using a QlAquick gel extraction kit, and eluted in 30 jil 
of EB buffer. 
4.2.1.3. 	Construction of the plasmids pRS7-1 and pRS8-9 
The amplified DNA fragments and the vector pTTQ1 8 were doubled digested with 
EcoRI and SphI. The reaction mixture were prepared as followed: 
17 tl of PCR product or pTTQ18 vector DNA 
2 tl of EcoRI NEBuffer 
0.5 p1 EcoRl 
0.5 p1 SphJ 
The correct fragment (4514 bp) issued from the doubled digestion of the vector was 
identified using TAE agarose gel electrophoresis by IJY visualisation of ethidium 
bromide stain. The DNA was purified using a QlAquick gel extraction kit, and eluted 
in 30 jil of EB buffer (elution buffer). 
The digested PCR products were purified using QlAquick PCR purification kit, and 
eluted in 30 p1 of EB buffer. 
The ligation of the PCR product and the vector (ratio concentration 
vector/insert==1/5) was performed using T4 DNA ligase following the supplier's 
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protocol. The reaction was incubated at room temperature for 30mins-lhour. The 
ligation was then purified with QlAquick PCR purification kit. The construct was 
used to transform E. coli ToplO electrocompetent cells. The electrocompetent cells 
were thawed on ice and mixed with 10 to 25 ng of construct, and then transferred to a 
prechilled 1 mm gap electroporation cuvette, and subjected to a single pulse of 1.8 
W, set at a capacitance of 25 F and a resistance of 200 Q. The cells were 
immediately resuspended in 850 tl of SOC after transformation and incubated at 
37°C under agitation for 1.5 hours. 
Colonies were screened on LB Agar Amp200. Plasmid DNA was purified with a 
QlAprep spin miniprep kit, and then doubled digested with EcoRI and Sphl. The 
fragments (4514 and 1116 bp) issued from the doubled digestion were identified 
using TAB agarose gel electrophoresis by UV visualisation of ethidium bromide 
stain. 
Additional digestions were performed on the plasmid to verify the presence of 
various restriction sites. 
4.2.1.4. 	Expression of NAAAR gene in pRS7-1 
Two 500 ml glass conical flasks containing 50 ml of LB Amp200 were inoculated 
with 50 il of overnight culture. IPTG was added to one culture to a final 
concentration of 1mM, while the second culture served as a control. Growth under 
agitation at 37°C was followed by measuring OD600. A lml sample was spun down 
for each measure, the pellet resuspended into 100 p1 of SDS-reducing loading buffer 
and heated for 1 min at 100°C, and spun down to remove all debris. Samples were 
loaded in an acrylamide gel (10-20% Tris-HC1), and run at a constant voltage of 200 
V. The gel was stained using staining reagent (EZBIueTM from Sigma) and agitated 




4.2.2. 1. From E. coli 
The menC gene encoding the OSBS from E. coli (963 bp) was amplified by PCR 
from a single colony. Two oligonucleotides, corresponding to the termini of the 
coding region, were designed to contain unique restriction sites for subcloning into 
pTTQ18 and utilised in the reaction. 
The N-terminus EcoRI primer contained a unique EcoRI restriction site indicated in 
bold: 
5 '-GACGAATTCGCGTAGCGCGCAGGTATAC-3' 
The C-terminus S 2hl primer contained a unique Sphl restriction site indicated in 
bold: 
5 '-GACGCATGCTCATAACAACCGCTCCAGTGC-3' 
The PCR reaction was performed using a pureTaq Ready-to-go PCR bead. One bead 
was mixed with 0.6 Vtl of each primer (from a 1 pmol/j.il primer solution), 23.8 ti of 
water and a single colony taken from a fresh plate. 
The PCR reaction was performed using the following optimised cycle conditions: 

















The PCR product mixed with loading buffer was identified using TAB agarose gel 
electrophoresis by UV visualisation of ethidium bromide stain. The corresponding 
band was purified using a Qiagen gel extraction kit, and eluted in 30 tl of EB buffer. 
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The PCR product and the vector pTTQ 18 were doubled digested with EcoRI and 
The reaction mixture were prepared as followed: 
17 j.il of PCR product or pTTQ 18 vector DNA 
2 p1 of EcoRI NEBuffer 
0.5 j.il EcoRI 
0.5 p1 SphI 
The correct fragment (4514 bp) issued from the doubled digestion of the vector was 
identified using TAB agarose gel electrophoresis by UV visualisation of ethidium 
bromide stain. The DNA was purified using a QlAquick gel extraction kit, and eluted 
in 30 p1 of BB buffer. 
The digested PCR product was purified using QlAquick PCR purification kit, and 
eluted in 30 tl of EB buffer. 
The ligation of the PCR product and the vector (ratio concentration 
vector/insert=1/5) was performed using T4 DNA ligase following the supplier's 
protocol. The reaction was incubated at room temperature for 30 mins-1 hour. The 
ligation was then purified with QlAquick PCR purification kit. The construct was 
used to transform E. coli ToplO electrocompetent cells. The electrocompetent cells 
were thawed on ice and mixed with 10 to 25 ng of construct, and then transferred to a 
prechilled 1mm gap electroporation cuvette, and subjected to a single pulse of 1.8 
W, set at a capacitance of 25 .iF and a resistance of 200 Q. The cells were 
immediately resuspended in 850 p1 of SOC after transformation and incubated at 
37°C under agitation for 1.5 hours. 
Colonies were screened on LB Agar Amp200. Plasmid DNA was purified with a 
QiAprep spin miniprep kit, and then doubled digested with EcoRI and $p.  The 
fragments (4514 and 971 bp) issued from the doubled digestion were identified using 
TAE agarose gel electrophoresis by UV visualisation of ethidium bromide stain. 
Additional digestions were performed on the plasmid to map it and verify the 
presence of various restriction sites. 
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4.2.2.2. From Bacillus subtilis 168 
The menC gene encoding the OSBS from Bacillus subtilis (1113 bp) was amplified 
by PCR from the chromosomal DNA. The chromosomal DNA was purified using 
QIAGEN Genomic DNA extraction kit yielding a concentration of DNA of 350 
jig/ml. Two oligonucleotides, corresponding to the termini of the coding region, 
were designed to contain unique restriction sites for subcloning into pTTQ18 and 
utilised in the reaction. 
The N-terminus Sacl primer contained a unique Sacl restriction site indicated in 
bold: 
5 '-GACGAGCTCTATCGAAATAGAAAAAATCACGC-3' 
The C-terminus $pj primer contained a unique Sphl restriction site indicated in 
bold: 
5 '-GTCGCATGCTTAACCATGCTGTGTGAAAACATC-3' 
The PCR reaction was performed using a pureTaq Ready-to-go PCR bead. One bead 
was mixed with 0.6 p1 of each primer (from a 1 pmol/p1 primer solution), 1 p1 of 
chromosomal DNA template and 22.8 tl of water. 
The PCR reaction was performed using the following optimised cycle conditions: 






1) 96°C 	 5 mins 
2)95°C 40s 
50°C 	 40s 
72°C 1 min 30s 
Repeat from 2) for 30 cycles 
72°C 	 5 mins 
The PCR product mixed with loading buffer was identified using TAE agarose gel 
electrophoresis by UV visualisation of ethidium bromide stain. The corresponding 
band was purified using a Qiagen gel extraction kit, and eluted in 30 p1 of EB buffer. 
tiIIE 
Fxper rn,rta 
The PCR product and the vector pTTQ 18 were doubled digested with Sacl and 
The reaction mixture were prepared as followed: 
17 !.il of PCR product or pTTQ 18 vector DNA 
2 tl of NEBuffer 1 
0.5 j.il Sad 
0.5 p1 SphI 
The correct fragment (4524 bp) issued from the doubled digestion of the vector was 
identified using TAE agarose gel electrophoresis by LTV visualisation of ethidium 
bromide stain. The DNA was purified using a QlAquick gel extraction kit, and eluted 
in 30 tl of EB buffer. 
The digested PCR product was purified using QlAquick PCR purification kit, and 
eluted in 30 p1 of EB buffer. 
The ligation of the PCR product and the vector (ratio concentration 
vector/insert=1/5) was performed using T4 DNA ligase following the supplier's 
protocol. The reaction was incubated at room temperature for 30 mins-1 hour. The 
ligation was then purified with QlAquick PCR purification kit. The construct was 
used to transform E. coli ToplO electrocompetent cells. The electrocompetent cells 
were thawed on ice and mixed with 10 to 25 ng of construct, and then transferred to a 
prechilled 1mm gap electroporation cuvette, and subjected to a single pulse of 1.8 
W, set at a capacitance of 25 p.F and a resistance of 200 Q. The cells were 
immediately resuspended in 850 jtl of Soc after transformation and incubated at 
37c under agitation for 1.5 hours. 
Colonies were screened on LB Agar Amp200. Plasmid DNA was purified with a 
QlAprep spin miniprep kit, and then doubled digested with Sacl and Sphl. The 
fragments (4524 and 1120 bp) issued from the doubled digestion were identified 
using TAB agarose gel electrophoresis by LTV visualisation of ethidium bromide 
stain. 
Additional digestions were performed on the plasmid to map it and verify the 
presence of various restriction sites. 
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5. Experimental: directed evolution 
5.1. 	Using error-prone PCR 
The random mutagenesis was performed following the manufacturer's protocol 
(Clontech) using the same primers used to clone the gene into pTTQ18. Nine 
reactions were prepared, and the thermal cycling was performed using the following 
parameters: 















1 min 30s 
3 mins 
The PCR products mixed with loading buffer were identified using TAE agarose gel 
electrophoresis by UV visualisation of ethidium bromide stain. 
The corresponding nine bands were cut from the gel and mixed as followed: 
Reactions 1 to 3, 4 to 6 and 7 to 9 mixed together to give 3 different samples. The 
three samples were purified using a QlAquick gel extraction kit, and eluted in 30 tl 
of buffer. 
These three samples the vector were then doubled digested with EcoRI and Sphl. 
Fragment from each sample were ligated into expression vector pTTQ1 8. The 
ligation was performed using T4 DNA ligase following the supplier's protocol. The 
reaction was incubated at room temperature for 30 mins. The ligation was then 
purified with QlAquick PCR purification kit. 
These three libraries were named pRS7-1/13, pRS7-1/46 and pRS7-1/79. 
-102- 
Exprimnta 
5.2. 	Using mutator strain 
Two methods were used to produce libraries of mutated plasmids using E. coil XL1-
Red. These methods differed from each other in the growth conditions: cultured in 
suspension in liquid medium or cultured on plates. 
5.2.1. First method to create libraries of mutants: growth on solid medium 
The plasmid was used to transform the mutator strain using the manufacturer's 
protocol. Then the method consisted in spreading on the transformed cells on LB 
Agar Amp200. 
The plates were incubated at 37°C for 24-30 hours, and then the cells recovered by 
resuspending the colonies into 10 ml of LB. As E. coil XL1-Red has a doubling time 
of 90-120 mins, approximately 15 generations of cells were produced (first cycle of 
mutation). The plasmids were purified (library pRS7-1/1P), while 150 p1 of 
resuspended cells was spread on each of five freshly prepared LB Agar Amp 200 
plates. The plates were incubated at 37°C for 24-30 hours, and then the cells 
recovered by resuspending the colonies into 10 ml of LB (second cycle of mutation, 
30 generations of cells). At the end of this cycle, the plasmids were isolated (library 
pRS7-1/2P) and used to transform fresh E. coil XL1-Red. The cells were plated on 
five freshly prepared LB Agar Amp200 plates, and incubated at 37°C for 24-30 hours. 
The cells were recovered by resuspending the colonies into 10 ml of LB (third cycle 
of mutation, 45 generations of cells). The plasmids were purified (library pRS7-
1/3P), while 150 pd of resuspended cells was spread on each of five freshly prepared 
LB Agar Amp200 plates. The plates were incubated at 37°C for 24-30 hours, and then 
the cells recovered by resuspending the colonies into 10 ml of LB (fourth cycle of 
mutation, 60 generations of cells). The plasmids were isolated (library pRS7-1/4P) 
and used to transform fresh E. coil XL1-Red. The cells were plated on five freshly 
prepared LB Agar Amp200 plates, and incubated at 37°C for 24-30 hours. The cells 
were recovered by resuspending the colonies into 10 ml of LB (fifth cycle of 
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mutation, 75 generations of cells). The plasmids were purified and constituted the 
library pRS7- 1 /5P. 
5.2.2. 	Second method to create libraries of mutants: growth in solution 
The two plasmids were used to transform the mutator strain using the manufacturer's 
protocol. Then this method consisted in growing the transformed the cells in 
suspension in LB Amp200 under agitation (250 rpm) at 37°C. 
The transformed cells were used to inoculate 20 ml of LB Amp 200  and the culture 
was grown for 24-30 hours (first cycle of mutation). The plasmids were purified 
(library pRS7-1/1S), while 20 pJ of the culture was used to inoculate LB Amp200, and 
subjected to a second cycle of growth under agitation for 24-30 hours. The plasmids 
were then purified (pRS7-112S) and used to transform fresh E. co/i XL1-Red. The 
transformed cells were used to inoculate 20 ml of LB Amp 200  and the culture was 
grown for 24-30 hours (third cycle of mutation). The plasmids were purified (library 
pRS7-1/3S), while 20 il of the culture was used to inoculate LB Amp200, and 
subjected to a fourth cycle of growth under agitation for 24-30 hours. The plasmids 
were then purified (pRS7-1/45) and used to transform fresh E. coli XL1-Red. The 
transformed cells were used to inoculate 20 ml of LB Amp 200  and the culture was 
grown for 24-30 hours (fifth cycle of mutation). The plasmids were purified and the 
library called pRS7-1/5S). 
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6. Experimental: development of an in vivo selective method 
6.1. 	Feeding assays on the strains: Growth on M9/glucose minimal medium 
plates 
To 270 ml of an autoclaved mixture of water and 1.5% agar, the following volume of 




lOx M9 salts 
Antibiotic if required: 







300 p1 of the stock solution 
300 tl of 1M stock solution 
According to the concentration required 
3 ml of a 5 mg/ml stock solution 
(Concentration of supplement substrate was adapted according the concentration 
needed) 
When plates with different concentrations of substrate were required, 30 ml of the 
hot M9 agar medium was poured into sterile tubes, and the appropriate concentration 
of substrate added individually to each tube and then poured into a petri dish. 
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6.2. 	Creation of a methionine auxotroph strain 
This method used is desribed by Datsenko & Wanner[120]. 
6.2.1. 	Deletion of dadAX gene 
6.2.1.1. 	Creation of the PCR fragment to disrupt the dadAX loci 
The dadAX loci (dadA 1660..2958 dadX 2968..4038) were first disrupted in E. coli 
BW251 13. The following primers were used for amplification of the cat gene 
(chloramphenicol resistance-1015 bp) from pKD3: 
N-terminus dadA primer contained the priming site of the cat gene indicated in bold 




C-terminus dadX primer contained the priming site of the cat gene indicated in bold 




The PCR reaction was performed using a pureTaq Ready-to-go PCR bead with Taq 
DNA polymerase. One bead was mixed with 0.6 tl of each primer (from a 1 pmol/j.il 
primer solution), 1 il of plasmid DNA template (pKD3) and 22.8 p1 of water. 
-106- 
L'Ixperinwnwl  
The PCR reaction was performed using the following optimised cycle conditions: 















1 min 30s 
5 mins 
The PCR product (1115 bp) was gel-purified using a QlAquick gel extraction kit, 
and eluted in 30 pA of EB buffer. 
6.2.1.2. dadAX gene disruption 
Transformants carrying the Red helper plasmid (pKD46) were grown in a 5 ml SOB 
culture with 5 j.il Amp10° and 10 p1 0.5M L-arabinose at 30°C to an 01)600 0.6 and 
made electrocompetent by concentrating 100-fold and washing three times with ice 
cold sterile water. The electrocompetent cells were thawed on ice and mixed with 10 
to 50 ng of PCR product, and then transferred to a prechilled 1 mm gap 
electroporation cuvette, and subjected to a single pulse of 1.8 kV, set at a capacitance 
of 25 pF and a resistance of 200 Q. The shocked cells were immediately added to 1 
ml of SOC and incubated 1 hour at 37°C under agitation. One half was then spread 
onto LB agar Cm130 to select Cm1R  transformants. If none grew within 24 hours, the 
remainder was spread after standing at room temperature. After primary selection, 
mutants were maintained on LB agar without antibiotic. They were colony purified 
once nonselectively at 37°C and then tested for ampicillin sensitivity to test for the 
loss of the helper plasmid. If it was not lost, then a few were colony purified once at 
43°C and similarly tested. 
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6.2.1.3. PCR verification 
The following primers flanking the site of the dadAX operon were used to verify 
simultaneous loss of the native gene fragment and gain of the new mutant-specific 
fragment: 
N-terminus checking primer for dadAX disruption: 
5 '-CCACTAATCCGCTTCTGAACG-3' 
C-terminus checking primer for dadAX disruption: 
5 '-CTTGTTGTAAGCCGGATCGGAG-3' 
6.2.2. 	Transduction of dadAX deletion created into BW251 13 to the phenylalanine 
auxotroph strain CGSC7421 using phage P1 
6.2.2.1. Preparation of lysates 
5 ml of LB broth containing 5 mM CaC12 (250 i1 of O.1M CaC12 for 5 ml of LB 
broth) were inoculated with 5 t1 of an overnight culture of ET1. The culture was 
aerated until the cells were growing exponentially and had reached a density of 2.108 
cells/mi. Plvjr were preadsorbed by adding 107 phage to 1 ml of this culture and 
incubating for 20 minutes in a 37°C water bath. 2.5 ml R-top agar (kept at 45°C) 
were then added and immediately plated onto a freshly made R plate. The plate was 
incubated at 37°C, face up, for 8 hours. At the end of this time the soft agar layer was 
scraped into a small centrifuge tube. The surface of the plate was washed with 1 ml 
of broth and the wash was added to the centrifuge tube. 5 drops of chloroform were 
added and the mixture was vortexed vigorously for 30 seconds. After standing 10 
minutes at room temperature the cells debris were centrifuged down and the 
supernatant, which contained the P1 lysate was collected. 
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6.2.2.2. Transduction with P1 lysates 
5 ml of fresh overnight culture of CGSC7421 were centrifuged and the pellet was 
resuspended in 5 ml of MC buffer. The solution was aerated at 37°C for 15 minutes. 
100 tl of the suspended cells were then added to each of 5 eppendorff tubes. 100 il 
of the P1 lysate were added to the first tube. 100 jil of a 10' dilution of the lysate 
were added to the second, 100 p1 of a 10.2  dilution of the lysate were added to the 
third, 100 jtl of a 10-3 dilution of the lysate were added to the fourth. Nothing was 
added to the fifth, which served as a control. A sixth tube was prepared with 100 p1 
of the P1 lysate, but no cells, as another control. The P1 were preadsorbed by 
incubation at 37°C in a water bath for 20 minutes. 200 p1 of 1M sodium citrate (to 
prevent killing of the recipient strain; sodium citrate prevents readsorption of the P1 
phage by removing Ca2 ions). The entire contents of each of the six tubes were 
plated on LB plates containing the appropriate antibiotic (the deleted gene carrying 
an antibiotic resistance gene as a marker for correct deletion). The plates were 
incubated at 37°C for 48 hours, and then examined to determine whether P1 
transduction of the deletion occurred. 
6.2.2.3. PCR verification of the transduction of the disruption 
The following primers flanking the site of the dadAX operon were used to verify 
simultaneous loss of the native gene fragment and gain of the new mutant-specific 
fragment into CGSC7421 using the previous PCR conditions: 
N-terminus checking primer for dadAX disruption: 
5 '-CCACTAATCCGCTTCTGAACG-3' 
C-terminus checking primer for dadAX disruption: 
5 '-CTTGTTGTAAGCCGGATCGGAG-3' 
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6.2.2.4. Elimination of chioramphenicol gene 
Cm1R mutant (ET1) was grown in a 5 ml LB culture with 5 tl Cm130 at 37°C to an 
OD600 0.6 and made electrocompetent by concentrating 100-fold and washing three 
times with ice cold sterile water. The electrocompetent cells were thawed on ice and 
mixed with 10 to 50 ng of pCP20 (FLP helper plasmid), and then transferred to a 
prechilled 1 mm gap electroporation cuvette, and subjected to a single pulse of 1.8 
W, set at a capacitance of 25 F and a resistance of 200 Q. The shocked cells were 
immediately added to 1 ml of SOC and incubated 1 hour at 30°C under agitation. 200 
p1 was then spread onto LB agar Amp200. Amp   transformants were selected at 30°C, 
after wich a few were colony purified once nonselectively at 43°C and then tested for 
loss of all antibiotic resistances. The majority lost the FRT-flanked chloramphenicol 
resistance gene and the FLP helper plasmid simultaneously. 
The same primers flanking the site of the dadAX operon used to verify simultaneous 
loss of the native gene fragment and gain of the new mutant-specific were used once 
again to confirm elimination of the chioramphenicol resistance using the previous 
PCR conditions. 
6.2.3. 	Deletion of metA gene 
6.2.3.1. Creation of the PCR fragment to disrupt the metA gene 
Attempts to delete metA (972bp) in E. colt BW25 113 using the method described by 
Datsenko & Wanner[ 120]. The following primers were used for amplification of the 
kan gene (kanamycin resistance-1304 bp) from pKD 13: 
N-terminus metA primer contained the priming site of the kan gene indicated in bold 






C-terminus metA primer contained the priming site of the kan gene indicated in bold 




The PCR reaction was performed using a pureTaq Ready-to-go PCR bead with Taq 
DNA polymerase. One bead was mixed with 0.6 tl of each primer (from a 1 pmo1/tl 
primer solution), 1 tl of plasmid DNA template (pKDl3) and 22.8 tl of water. 
The PCR reaction was performed using the following optimised cycle conditions: 















l min 30s 
5 mills 
The PCR product (1404 bp) was gel-purified using a QlAquick gel extraction kit, 
and eluted in 30 l of EB buffer. 
6.2.3.2. metA gene disruption 
Transformants carrying the Red helper plasmid (pKD46) were grown in a 5 ml SOB 
culture with 5 pi Amp'°° and 10 .tl 0.5M L-arabinose at 30°C to an OD600 0.6 and 
made electrocompetent by concentrating 100-fold and washing three times with ice 
cold sterile water. The electrocompetent cells were thawed on ice and mixed with 10 
to 50 ng of PCR product, and then transferred to a prechilled 1 mm gap 
electroporation cuvette, and subjected to a single pulse of 1.8 kV, set at a capacitance 
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of 25 p.F and a resistance of 200 0. The shocked cells were immediately added to 1 
ml of Soc and incubated 1 hour at 37°C under agitation. One half was then spread 
onto LB agar Kan 30  to select KanR  transformants. If none grew within 24 hours, the 
remainder was spread after standing at room temperature. 
6.2.4. 	Deletion of metB gene 
6.2.4.1. Creation of the PCR fragment to disrupt the metB gene 
Attempts to deleted metB (1161 bp) in E. coli BW251 13 by the method described by 
Datsenko & Wanner[120]. The following primers were used for amplification of the 
kan gene (13 04 bp) from pKD 13: 
N-terminus metB primer contained the priming site of the kan gene indicated in bold 




C-terminus metB primer contained the priming site of the kan gene indicated in bold 




The following primers were used for amplification of the cat gene (1015 bp) from 
N-terminus metB primer contained the priming site of the cat gene indicated in bold 






C-terminus metB primer contained the priming site of the cat gene indicated in bold 




N-terminus metB extended primer contained the priming site of the cat gene 




C-terminus metB extended primer contained the priming site of the cat gene 




The PCR reaction was performed using a pureTaq Ready-to-go PCR bead with Taq 
DNA polymerase. One bead was mixed with 0.6 jt1 of each primer (from a 1 pmollpi 
primer solution), 1 tl of plasmid DNA template (pKD3 or pKD13) and 22.8 tl of 
water. 
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The PCR reaction was performed using the following optimised cycle conditions: 















l min 30s 
5 mins 
The PCR products (1404 bp for kan gene, 1115 bp for cat gene and 1155 bp for cat 
gene with extended homology of metB gene) were gel-purified using a QlAquick gel 
extraction kit, and eluted in 30 jtl of EB buffer. 
6.2.4.2. metB gene disruption 
Transformants carrying the Red helper plasmid (pKD46) were grown in a 5 ml SOB 
culture with 5 p1 Amp 100  and 10 p.1 0.5M L-arabinose at 30°C to an 01)600 0.6 and 
made electrocompetent by concentrating 100-fold and washing three times with ice 
cold sterile water. The electrocompetent cells were thawed on ice and mixed with 10 
to 50 ng of PCR product, and then transferred to a prechilled 1 mm gap 
electroporation cuvette, and subjected to a single pulse of 1.8 kV, set at a capacitance 
of 25 p.F and a resistance of 200 0. The shocked cells were immediately added to 1 
ml of SOC and incubated 1 hour at 37°C under agitation. One half was then spread 
onto LB agar Kan 30  or Cm130 to select KanR  or  Cm1R  transformants. If none grew 
within 24 hours, the remainder was spread after standing at room temperature. After 
primary selection, mutants were maintained on LB agar without antibiotic. They 
were colony purified once nonselectively at 37°C and then tested for ampicillin 
sensitivity to test for the loss of the helper plasmid. If it was not lost, then a few were 
colony purified once at 43°C and similarly tested. 
MetB was disrupted in E. coli BW25 113 using the extended primers for Cm1R.  
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6.2.4.3. PCR verification 
The following primers flanking the site of the metB gene were used to verify 
simultaneous loss of the native gene fragment and gain of the new mutant-specific 
fragment: 
N-terminus checking primer for metB disruption: 
5 '-ATGACGCGTAAACAGGCCACC-3' 
C-terminus checking primer for metB disruption: 
5 '-TTACCCCTTGTTTGCAGCCCG-3' 
7. Experimental: validation of the in vivo DKR 
7.1. 	Preparation of electrocompetent cells 
A 5 ml LB (or LB Cm130 when SET21 was used) was inoculated with a single colony 
of CGSC6563 (or SET21) from a fresh plate, and grown overnight under shaking at 
37°C. 
5 ml LB (or LB Cm130 when SET21 was used) were then inoculated with 5 jl of the 
overnight culture and cultured under agitation at 37°C until the cells density reached 
an OD600 0.6. 
The cells were then transferred into a pre-chilled eppendorff tube, and spun down at 
13000 rpm for 4 mm, and supernatant removed. The cells were then washed twice 
with 1 ml of ice-cold sterile water and spun down for 10 min at 13000 rpm before 
removing the supernatant. The cells were finally resuspended into 50 Vtl of ice-cold 
sterile water and kept on ice. 
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7.2. 	Transformation into SET21 by electroporation 
The electrocompetent cells were thawed on ice and mixed with 10 to 25 ng of 
plasmid DNA, and then transferred to a prechilled 1 mm gap electroporation cuvette, 
and subjected to a single pulse of 1.8 kV, set at a capacitance of 25 p.F and a 
resistance of 200 Q. The cells were immediately resuspended in 850 p1 of SOC after 
transformation and incubated at 37°C under agitation for 45 mins to 1 hour. 
200 p1 were then plated on LB Agar Amp200. 
8. Experimental: screening of libraries 
8.1. 	Preparation of electrocompetent cells using CGSC6563 or SET21 
See section 7.1 
8.2. 	Transformation of libraries by electroporation 
The electrocompetent cells were thawed on ice and mixed with 10 to 25 ng of 
plasmid DNA, and then transferred to a prechilled 1 mm gap electroporation cuvette, 
and subjected to a single pulse of 1.8 kV, set at a capacitance of 25 j.tF and a 
resistance of 200 Q. The cells were immediately resuspended in 850 p1 of SOC after 
transformation and incubated at 37°C under agitation for 45 mins to 1 hour. 
The cells were then washed twice with imI of sterile 0.5% saline, and resuspended 
into 1 ml of sterile 0.5% saline. The suspension was spread on five M9 Amp 200  plates 
supplemented with 2 mM N-acetyl-D-methionine, and 0.3 MM  CoC12, and incubated 
at 37°C. 
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9. Experimental: in vitro assays of NAAAR 
9.1. 	Preparation of cells 
Two 50 ml LB Amp 200  were inoculated with 50 p1 of an overnight culture of 5 ml of 
cells and grown under agitation at 37°C. When 01)600 0.6, 50 j.il 1M IPTG was 
added to one of the culture, and the cultures left under agitation overnight at 37°C. 
The cells were then spun down and washed once with sterile water. The water was 
carefully removed and the cells were then weighed. 
9.2. 	HPLC assays the enzymatic reactions 
The column used in these assays was the CHIROBIOTIC TTM  chiral column. 
9.2.1. 	Initial test to assess the dynamic kinetic resolution 
The reaction solution (per ml) was prepared as followed: 
Phosphate buffer (0.1M / pH 7.0): 100 p1(10 mM) 
N-acetyl-D-methionine: 5 mg (0.262 mM) 
Sterile water: 900 jfl 
Cells (wcw): 50 mg of cells 
The reaction mixture was incubated at 37°C under agitation. 50 tl samples were 
taken regularly from both reaction mixtures, and spun down. The supernatant was 
carefully pipetted into a HPLC tube and directly analysed. 
The conditions used for the first HPLC assay were as followed: 
Mobile phase: 0.1% TEAAlmethanol/H20: 10/25/65 (v/v/v) 
Flow rate: 0.6 ml/min 
Injection volume: 5 jil 
Wavelength detection: 210 nm 
Duration: 20 mm 
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9.2.2. 	Enzymatic assays with cobalt 
The reaction solution (per ml) was prepared as followed: 
Tris-HC1 (0.5M / pH 7,5): 100 il (50 mM) 
N-acetyl-D-methionine (0.1M): 50 p1(5 mM) 
Cobalt chloride (0.1M): 60 pA (6 mM) 
Sterile water: 890 pd 
50 mg wet weight of cells 
The two reaction mixtures were then incubated at 37°C under agitation. 50 pA 
samples were taken regularly from both reaction mixtures, and spun down. The 
supernatant was carefully pipetted into a HPLC tube and directly analysed. 
The optimised conditions used for the HPLC assay were as followed: 
Mobile phase: 0.1% TEAAlmethanol/H20: 10/20/70 (v/v/v) 
Flow rate: 0.3 ml/min 
Injection volume: 5 t1 
Wavelength detection: 210 nm 
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11.1. 	Genotypes of E. coli strains used 
Phe auxotroph strain CGSC7421 (CAG12128) : X,pheA18::TnlO, rph-1 
Met auxotroph strain CGSC6563: araD139, A(argF-lac)169, 2, flb-5301, 
AdadA247, trpB202, fruA25, relAl, rpsL150(strR), metB185, deoCi 
Strain CGSC4474 (W31 10): X, IN(rrnD-rrnE), rph-1 
Strain BW25 113: A(araD-araB)567, AlacZ4 78 7(: :rrnB-4), lacIp-4000(lac1), X, 
rpoS396(Am), rph-1, A(rhaD-rhaB)568, rrnB-4, hsdR5l4 
Strain ET1: BW25113, AdadAX1959....ca??;  strain SET1: ET1 catS 
Strain SET2: SET1, AmetB920:..cat? 
Strain SET3: BW25 113, AmetB920:..cat/? 
11.2. 	NAAARs gene sequences 
Source: NCBI (http://www.ncbi.nlm.nih.gov) 
11.2.1. Gene cloned from Amycolatopsis sp. TS-1-60 (from IFO 15079) 
The sequence in bold corresponds to the priming site used for the PCR reaction. The 
DNA sequence encoding the acylamino acid racemase starts from base 62 to 1168. 
1 GAATTCCCCG GGTGACCGGC TTCGACCGAG CCGGCTTTTA CGTGATCTCC AAGGAGGAGC 
61 AGTGAAACTC AGCGGTGTGG AACTGCGCCG GGTGCAGATG CCGCTCGTCG CCCCGTTCCG 
121 GACTTCGTTC GGCACCCAGT CGGTCCGCGA GCTCTTGCTG CTGCGCGCGG TCACGCCGGC 
181 CGGCGAGGGC TGGGGCGAAT GCGTGACGAT GGCCGGTCCG CTGTACTCGT CGGAGTACAA 
241 CGACGGCGCG GAACACGTGC TGCGGCACTA CTTGATCCCG GCGCTGCTGG CCGCGGAAGA 
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301 CATCACCGCG GCGAAGGTGA CGCCGCTGCT GGCCAAGTTC AAGGGCCACC GGATGGCCAA 
361 GGGCGCGCTG GAGATGGCCG TGCTCGACGC CGAACTCCGC GCGCACGAGA GGTCGTTCGC 
421 CGCCGAACTC GGATCGGTGC GCGATTCTGT GCCGTGCGGC GTTTCGGTCG GGATCATGGA 
481 CACCATCCCG CAACTGCTCG ACGTCGTGGG CGGATACCTC GACGAGGGTT ACGTGCGGAT 
541 CAAGCTGAJG ATCGAACCCG GCTGGGACGT CGAGCCGGTG CGCGCGGTCC GCGAGCGCTT 
601 CGGCGACGAC GTGCTGCTGC AGGTCGACGC CAACACCGCC TACACCCTCG GCGACGCGCC 
661 GCAGCTGGCC CGGCTCGACC CGTTCGGCCT GCTGCTGATC GAGCAGCCGC TGGAAGAGGA 
721 GGACGTGCTC GGCCACGCCG AACTGGCCCG CCGGATCCAG ACACCGATCT GCCTCGACGA 
781 GTCGATCGTG TCGGCGCGCG CGGCGGCGGA CGCCATCAAG CTGGGCGCGG TCCAPJTCGT 
841 GAACATCAAA CCGGGCCGCG TCGGCGGGTA CCTGGAAGCG CGGCGGGTGC ACGACGTGTG 
901 CGCGGCGCAC GGGATCCCGG TGTGGTGCGG CGGGATGATC GAGACCGGCC TCGGCCGGGC 
961 GGCGAACGTC GCGCTGGCCT CGCTGCCGAA CTTCACCCTG CCCGGCGACA CCTCGGCGTC 
1021 GGACCGGTTC TACAAACCG ACATCACCGA GCCGTTCGTG CTCTCCGGCG GCCACCTCCC 
1081 GGTGCCGACC GGACCGGGCC TCGGCGTGGC GCCGATTCCG GAGCTGCTGG ACGAGGTGAC 
1141 CACGGCAAAG GTGTGGATCG GTTCGTAGCC CGCTACGAAT TCCGGAGGTA GATTTGGTCG 
1201 GATCGGACCA GCCGGTCCGC ACGAGGCCCG ATCTACCTTC GGGGGGTGCT GACACCGGTG 
1261 CCGAGCAAAC CGCACACGAG TCTGGGACGC GTCCTCGAAG CTCTCGGGGA CGTGCTCCTC 
1321 GAGCCGGTCG CCGTCGGCGC GACACGCGGC GGCAGCTCGG CGGGGTGGTG ATTCACGACC 
1381 CGCACGACGA CGCGGAATTC 
Native protein sequence (translated from the sequence above): 
V K L S G V E L R R V Q M P L V A P F R T S F G T Q S V R E L L L L 
R AV T PAGE G W GE CV T NAG PLY S SE Y ND GA E H V L R 
H Y L I P A L L A A E D I T A A K V T P L L A K F K G H R M A K G A 
L EM A V L D A EL R A HER SF AA EL G S V RD S V P C G VS V 
G I M D T I PQLLDVVGGYLDEGYVRIKLKIEpGWDV 
EPVRAVRERFGDDVLLQVDANTAyTLGDApQLAR 
L D P F G L L L I E Q P L E E E D V L G H A E L A R R I Q T P I C L 
DES I V S A R A A A D A I K L G A V Q I V N I K P G R V G G Y L E 
A R R V H D V C A A H G I P V W C G G M I E T G L G R A A N V A L A 
SLPNFTLPGDT5A5DRFyKTDITEpFVLSGGHLp 
VPTGPGLGVAp I P E L L D E V T T A K V W I GS 
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11.2.2. Gene cloned from Amycolatopsis orientalis (from NRRL 2452) 
The sequence in bold corresponds to the priming site used for the PCR reaction. The 
DNA sequence encoding the acylamino acid racemase starts from base 191 to 1297. 
1 	GGATCCGCGG ACGGGCCGAC CGTGCTCGTC GCGGTCCCGC CCGACATCGA ACGGTTGCGC 
61 CGCACCGACC CCGGTCGCGG CGACGCGTGG CGCGTCGGCT GCGCGA1GTC CTCGGCGGAC 
121 TGATGGCGGA CAACGCCAAG GTCGCCGGTT TCGATCGTGC CGGCTGGTAC GTGATCTCCA 
181 AGGAGCAGTC GTGAACTCA GCGGTGTGGA ACTGCGCCGG GTCCGGATGC CGCTCGTGGC 
241 CCCGTTCCGG ACGTCGTTCG GGACCCAGTC CGAGCGGGAA TTGCTGCTGG TCCGCGCGGT 
301 GACCCCGGCG GGCGAGGGCT GGGGCGAATC TGTCGCGATG GAGGCGCCGC TCTACTCGTC 
361 GGAGTACAAC GACGCCGCCG AGCACGTGCT GCGGAACCAT CTGATCCCCG CACTGCTGGC 
421 GGCCGAGGAC GTGACCGCGC ACAAGGTGAC GCCGTTGCTG GCGAAGTTCA AGGGCCACCG 
481 GATGGCGAAG GGCGCGCTGG AGATGGCGGT CCTCGACGCC GAACTCCGCG CGCATGACCG 
541 GTCCTTCGCG GCCGAGCTGG GGTCCACTCG CGACTCCGTG GCCTGCGGGG TCTCGGTCGG 
601 GATCATGGAC TCGATCCCGC ACCTGCTCGA CGTCGTCGGC GGCTACCTCG ACGAGGGCTA 
661 CGTCCGGATC AGCTGAAGA TCGAGCCCGG CTGGGACGTC GAGCCGGTCC GGCAGGTGCG 
721 TGAGCGCTTC GGTGACGACG TGCTGCTGCA GGTCGACGCG 1ACACCGCGT ACACGCTGGG 
781 CGACGCGCCC CTGCTGTCCC GGCTCGACCC GTTCGACCTG CTGCTGATCG AGCAGCCGCT 
841 CGAAGAAGAG GACGTGCTCG GCCACGCCGA GCTGGCCAAG CGGATCCGGA CGCCGATCTG 
901 CCTCGACGAG TCGATCGTCT CGGCCAAGGC CGCCGCGGAC GCGATCAAGC TCGGCGCCTG 
961 CCAGATCGTC ACATCAPJC CGGGCCGGGT CGGCGGATAC CTCGAAGCCC GCCGGGTGCA 
1021 CGACGTCTGC GCGGCACACG GGATCGCGGT GTGGTGCGGC GGGATGATCG AGACCGGGCT 
1081 CGGCCGGGCG GCCAACGTCG CACTGGCCTC GCTGCCCGGC TTCACGCTGC CGGGGGACAC 
1141 CTCGGCGTCC GGCCGGTTCT ATCGCACCGA CATCACCGAG CCGTTCGTGC TGGACGCCGG 
1201 GCATCTGCCG GTGCCGACCG GGCCGGGCCT CGGGGTGACT CCGATTCCGG ATCTTCTGGA 
1261 CGAGGTCACC ACGGAGAAAG CGTGGATCGG TTCGTAGCTT TCTACGAATT C 
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11.3. 	Sequences of the clones of NAAARs 
11.3.1. NAAAR gene sequence and in-frame translation from pRS7-1 (wild type 
gene from TS-1-60) 
MN 	S 	K 	L 	S 	G V 	EL R 	P. 	V 	Q 	M 	P 	L 
1 ATGAATTCGA AACTCAGCGG TGTGGAACTG CGCCGGGTGC AGATGCCGCT 
.V 	A 	P FR 	T S 	F 	G 	T Q 	S 	V RE 	L 	L 
51 CGTCGCCCCG TTCCGGACTT CGTTCGGCAC CCAGTCGGTC CGCGAGCTCT 
..L 	L 	R A 	VT PAGE 	G 	W 	G E 	CV 
101 TGCTGCTGCG CGCGGTCACG CCGGCCGGCG AGGGCTGGGG CGAATGCGTG 
TM 	AG 	PLY S 	SE Y 	ND 	G 	A 	E 	H 
151 ACGATGGCCG GTCCGCTGTA CTCGTCGGAG TACAACGACG GCGCGGAACA 
.V 	L 	R H 	Y 	L  PAL LA A ED 	I 	T 
201 CGTGCTGCGG CACTACTTGA TCCCGGCGCT GCTGGCCGCG GAAGACATCA 
..A 	A 	K VT 	P L 	LA 	K 	F 	KG HR 	M 
251 CCGCGGCGAA GGTGACGCCG CTGCTGGCCA AGTTCAAGGG CCACCGGATG 
A 	K 	GA 	L 	EM A 	V 	L D 	A 	EL 	R 	A 	H 
301 GCCAAGGGCG CGCTGGAGAT GGCCGTGCTC GACGCCGAAC TCCGCGCGCA 
.E 	R 	S F 	A 	A 	E 	L 	G 	S V 	RD S 	VP 	C 
351 CGAGAGGTCG TTCGCCGCCG AACTCGGATC GGTGCGCGAT TCTGTGCCGT 
..G 	VS V 	G 	I MD 	TI 	P 	Q 	L L 	DV 
401 GCGGCGTTTC GGTCGGGATC ATGGACACCA TCCCGCAACT GCTCGACGTC 
V 	G 	G 	Y 	L 	D 	E G 	Y 	V RI 	K 	L K 	I 	E 
451 GTGGGCGGAT ACCTCGACGA GGGTTACGTG CGGATCAAGC TGPAGATCGA 
.P 	G 	W DV 	E 	P 	V 	R 	A V 	RE P. 	F 	G 	D• 
501 ACCCGGCTGG GACGTCGAGC CGGTGCGCGC GGTCCGCGAG CGCTTCGGCG 
..D 	V 	L L 	Q 	V DAN 	T 	A 	Y 	T L 	G  
551 ACGACGTGCT GCTGCAGGTC GACGCGAACA CCGCCTACAC CCTCGGCGAC 
A 	P 	Q 	L AR 	L D 	P 	F G 	L 	L 	L I 	EQ. 
601 GCGCCGCAGC TGGCCCGGCT CGACCCGTTC GGCCTGCTGC TGATCGAGCA 
.P 	L 	E E 	ED 	V 	L 	G 	H A 	EL AR 	P. 	1 
651 GCCGCTGGAA GAGGAGGACG TGCTCGGCCA CGCCGAACTG GCCCGCCGGA 
..Q 	T 	P IC 	L DES 	I VS 	A P. 	A 	A 
701 TCCAGACACC GATCTGCCTC GACGAGTCGA TCGTGTCGGC GCGCGCGGCG 
AD 	Al K 	L 	G A 	V 	Q IV 	NI K 	P 	G-- 
751 GCGGACGCCA TCAAGCTGGG CGCGGTCCAA ATCGTGAACA TCAAACCGGG 
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.R 	V 	G G 	Y 	L 
- 
E 	AR 	R 	V 	H 	D V 	CA 	A 
801 CCGCGTCGGC GGGTACCTGG AAGCGCGGCG GGTGCACGAC GTGTGCGCGG 
..H 	G 	I P 	V 	W C 	G 	GM 	I 	E 	T G 	L 	G 
851 CGCACGGGAT CCCGGTGTGG TGCGGCGGGA TGATCGAGAC CGGCCTCGGC 
R 	A 	A N 	V 	AL A 	S 	L 	P 	N 	FT L 	P 	G-
901 CGGGCGGCGA ACGTCGCGCT GGCCTCGCTG CCGAACTTCA CCCTGCCCGG 
.D 	T 	S A 	SD 	R 	F 	Y 	K 	T 	DI T 	E 	P 	F 
951 CGACACCTCG GCGTCGGACC GGTTCTACAA AACCGACATC ACCGAGCCGT 
..V 	L 	S G 	G 	H L 	P 	V 	P 	T 	G 	P G 	L 	G 
1001 TCGTGCTCTC CGGCGGCCAC CTCCCGGTGC CGACCGGACC GGGCCTCGGC 
V 	API P 	EL L 	D 	E 	VT 	TA 	K 	V 	W 
1051 GTGGCGCCGA TTCCGGAGCT GCTGGACGAG GTGACCACGG CAAAGGTGTG 
.1 	G 	S * 
1101 GATCGGTTCG TAG 
11.3.2. Gene sequence from pRS8-9 (wild type gene A. orientalis) 
1 	ATGA1TTCGA AACTCAGCGG TGTGGAACTG CGCCGGGTCC GGATGCCGCT CGTGGCCCCG 
61 TTCCGGACGT CGTTCGGAAC GCAGTCGGAA CGGGAACTGC TGCTCGTCCG CGCGGTGACC 
121 CCGGCGGGCG AGGGCTGGGG CGAATGTGTT GCGATGGAGG CGCCGCTCTA CTCGTCGGAG 
181 TACAACGACG CCGCCGAACA CGTGCTGCGC ACCCACCTGA TCCCCGCCCT GCTGGCCGCG 
241 GAGGACGTGA CCGCGTACAA GGTGACGCCG TTGCTGGCGA AGTTCAAAGG GCACCGGATG 
301 GCGAAGGGGG CGCTGGAGAT GGCGGTCCTC GACGCAGA2C TCCGCGCGCA CGAGCGGTCC 
361 TTTGCCGCCG AGCTCGGGTC CACACGCGAT TCCGTGGCCT GCGGGGTCTC GGTCGGGATC 
421 ATGGACTCGA TCCCGCAGCT GCTCGACGTC GTCGGCGGCT ACCTCGACGA AGGCTATGTC 
481 CGGATCAAAC TGAAGATCGA GCCCGGCTGG GACGTCGAGC CGGTCCGGCA GGTGCGTGAG 
541 CGCTTCGGTG ACGACGTGCT GCTCCAGGTC GACGCGAACA CCGCGTACAC CCTGGGCGAC 
601 GCGCCCCTGC TGTCCAGGCT CGACGCCTTC GATCTGCTGC TGATCGAGCA GCCGCTCGAA 
661 GAGGAGGACG TGCTCGGCCA CGCCGAACTG GCGAAGCGGA TCCGGACGCC GATCTGCCTC 
721 GACGAGTCGA TCGTGTCCGC CA1GGCCGCC GCGGACGCGA TCAAGCTGGG CGCGTGCCAG 
781 ATCGTCAACA TCAA1CCGGG CCGCGTCGGC GGCTACCTCG AAGCACGCCG GGTGCACGAC 
841 GTCTGCGCGG CGCACGGGGT GGCGGTGTGG TGCGGCGGGA TGATCGAGAC CGGCCTCGGC 
901 CGCGCGGCCA ACGTCGCGCT GGCCTCGCTG CCCGGTTTCA CGCTGCCGGG GGACACCTCG 
961 GCCTCCGGCC GGTTCTACCG CACGGACATC ACCGAGCCGT TCGTGCTGGA CGCCGGGCAC 
1021 CTGCCGGTGC CGACGGGACC GGGACTGGGC GTGACTCCGA TTCCGGAACT CCTGGACGAG 
1081 GTCACCACGG AGAAAGCGTG GATCGGTTCG TAG 
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11.3.3. Gene and corresponding NAAAR protein sequence from the variant 3P2. 
The base highlighted in red corresponds to the base mutation in the variant 3P2, 
whilst the amino acid in bold corresponds to the mutation G293E (glycine->glutamic 
acid) made in the protein sequence of this variant. 
MN 	S K 	L 	S 	G V 	EL R 	V Q 	M 	P 	L 
1 ATGAATTCGA AACTCAGCGG TGTGGAACTG CGCCGGGTGC AGATGCCGCT 
.V 	A 	P FR 	T 	S 	F 	G 	T Q 	S 	V R 	EL 	L 
51 CGTCGCCCCG TTCCGGACTT CGTTCGGCAC CCAGTCGGTC CGCGAGCTCT 
..L 	L 	R A 	VT PAGE 	G 	W 	G E 	CV 
101 TGCTGCTGCG CGCGGTCACG CCGGCCGGCG AGGGCTGGGG CGAATGCGTG 
TM 	AG PLY S 	SE Y 	ND 	G 	A 	E 	H 
151 ACGATGGCCG GTCCGCTGTA CTCGTCGGAG TACAACGACG GCGCGGAACA 
.V 	L 	R H 	Y 	L 	PAL LA 	A ED 	I 	T 
201 CGTGCTGCGG CACTACTTGA 
- 
TCCCGGCGCT GCTGGCCGCG GAAGACATCA 
..A 	A 	K VT 	P L 	LA 	K 	F 	KG HR 	M 
251 CCGCGGCGAA GGTGACGCCG CTGCTGGCCA AGTTCAAGGG CCACCGGATG 
A 	K 	GA 	L 	EM A 	V 	L D 	A 	EL 	H 	A 	H 
301 GCCAAGGGCG CGCTGGAGAT GGCCGTGCTC GACGCCGAAC TCCGCGCGCA 
.E 	R 	S F 	A 	A 	E 	L 	G 	S V 	RD S 	VP 	C 
351 CGAGAGGTCG TTCGCCGCCG AACTCGGATC GGTGCGCGAT TCTGTGCCGT 
..G 	VS V 	G 	I MD 	TI P 	Q 	L L 	DV 
401 GCGGCGTTTC GGTCGGGATC ATGGACACCA TCCCGCAACT GCTCGACGTC 
V 	G 	G 	Y 	L 	D 	E G 	Y 	V RI 	K 	L 	K 	I 	E 
451 GTGGGCGGAT ACCTCGACGA GGGTTACGTG CGGATCAAGC TGAAGATCGA 
.P 	G 	W DV 	E 	P 	V 	R 	A V 	RE R 	G D 
501 ACCCGGCTGG GACGTCGAGC CGGTGCGCGC GGTCCGCGAG CGCTTCGGCG 
..D 	V 	L L 	Q 	V DAN 	T A 	Y 	T L 	G  
551 ACGACGTGCT GCTGCAGGTC GACGCGAACA CCGCCTACAC CCTCGGCGAC 
A P Q L AR L D P F G L L L I E  
601 	GCGCCGCAGC TGGCCCGGCT CGACCCGTTC GGCCTGCTGC TGATCGAGCA 
.P L E E ED V L G H A EL AR RI 
651 	GCCGCTGGAA GAGGAGGACG TGCTCGGCCA CGCCGAACTG GCCCGCCGGA 
..Q T P IC L DES I V S A HA A 
701 	TCCAGACACC GATCTGCCTC GACGAGTCGA TCGTGTCGGC GCGCGCGGCG 
AD Al K L G A V Q IV NI K P G-
751 	GCGGACGCCA TCAAGCTGGG CGCGGTCCAA ATCGTGAACA TCAAACCGGG 
-134- 
Appendices 
.R 	V 	G G 	Y 	L E 	AR 	R 	V 	H 	D V 	CA 	A• 
801 CCGCGTCGGC GGGTACCTGG AAGCGCGGCG GGTGCACGAC GTGTGCGCGG 
..H 	G 	I P 	V 	W C 	GEM 	I 	E 	T G 	L 	G 
851 CGCACGGGAT CCCGGTGTGG TGCGGCGAGA TGATCGAGAC CGGCCTCGGC 
R 	A 	A 	N 	VA 	L A 	S 	L 	P 	N 	FT L 	P 	G 
901 CGGGCGGCGA ACGTCGCGCT GGCCTCGCTG CCGAACTTCA CCCTGCCCGG 
.D 	T 	S A 	S 	DR 	F 	Y 	K 	T 	DI T 	E 	P 	F 
951 CGACACCTCG GCGTCGGACC GGTTCTACAA AACCGACATC ACCGAGCCGT 
..V 	L 	S G 	G 	H L 	P 	V 	P 	T 	G 	P G 	L 	G 
1001 TCGTGCTCTC CGGCGGCCAC CTCCCGGTGC CGACCGGACC GGGCCTCGGC 
V 	API 	P 	EL L 	D 	E 	VT 	TA 	K 	V 	W 
1051 GTGGCGCCGA TTCCGGAGCT GCTGGACGAG GTGACCACGG CAAAGGTGTG 
.1 	G 	S * 
1101 GATCGGTTCG TAG 
- 135- 
Apc•1Ci1ccs 
11.4. 	Targeted genes for deletion to create methionine auxotroph 
11.4.1. dadA -dadX genes (dadAX) 
The dadAX genes were knockout, deletion replaced by Cm1' and then Cm1R  removed 
from genome of new E. coli strain ET1 to yield SET 1. The sequences highlighted in 
red are the homologous regions of the primers used to replace the fragment in 
between by chioramphenicol resistance. The sequences in bold are the priming 
sequences used to check the deletion. 
dadA 1660..2958 
dadX 2968..4038 
1441 TTATCAGAGT GCCACTAATC CGCTTCTGAA CGGAATTTTA TGCTGGATAA AAAGGGCGTT 
1501 CAGCAGGAGA TACTAAAGAC GCCATATTGC CGCAGAGTCA GGGAGATGTG ACCAGCTTCA 
1561 CCATAAAAAA GCCGCATGTT GAATATATT TTCAACTGAG TTATCAAGAT GTGATTAGAT 
1621 TATTATTCTT TTACTGTATC TACCGTTATC GGAGTGGCTA TGCGAGTTGT CATACTGGGA 
1681 AGTGGTGTGG TAGGCGTTGC CAGCGCCTGG TACTTAAATC AGGCAGGACA TGAGGTCACC 
1741 GTCATTGATC GGGAGCCGGG GGCCGCCCTG GAAACCAGTG CCGCGAATGC CGGGCAAATC 
1801 TCCCCCGGAT ATGCTGCACC GTGGGCGGCA CCAGGTGTGC CTTTAAAAGC GATTAAATGG 
1861 ATGTTCCAGC GCCATGCGCC GCTGGCGGTT CGTCTCGACG GTACGCAGTT CCAGTTGAAA 
1921 TGGATGTGGC AAATGTTACG TAACTGCGAC ACCAGCCACT ACATGGAAAA CAAAGGGCGG 
1981 ATGGTGCGTC TGGCGGAATA CAGCCGTGAT TGCCTGAAG CATTGCGCGC CGAAACCAAT 
2041 ATTCAGTATG AGGGCGTCA GGGTGGGACG CTGCACTGT TCCGTACCGA ACAACAGTAT 
2101 GAAAATGCGA CCCGCGATAT CGCCGTGCTG GA2GATGCCG GCGTACCGTA TCAGCTGCTG 
2161 GAATCCAGCC GCCTGGCGGA AGTGGAGCCC GCGCTGGCAG AAGTGGCGCA CAAACTGACG 
2221 GGCGGCCTGC AGTTACCCAA TGATGAACC GGAGACTGTC AGCTATTTAC CCAGAATCTG 
2281 GCGCGGATGG CGGAGCAGGC GGGGGTTAAA TTCCGCTTTA ATACGCCCGT TGACCAACTG 
2341 CTTTGCGACG GCGAGCAAAT CTACGGCGTG A1GTGTGGCG ATGAGTGAT TAAGGCCGAT 
2401 GCGTATGTGA TGGCGTTTGG TTCTTACTCG ACGGCGATGC TCAAAGGCAT TGTTGATATT 
2461 CCGGTGTATC CGCTGAAAGG CTACTCGCTG ACCATTCCAA TTGCGCAGGA AGATGGTGCG 
2521 CCGGTATCCA CCATTCTTGA TGAAACCTAC AWITCGCCA TTACCCGTTT CGATAACCGC 
2581 ATTCGTGTTG GCGGAATGGC GGAGATTGTT GGTTTTAATA CCGAGCTGTT GCAACCGCGT 
2641 CGTGAAACGC TGGAGATGGT GGTTCGCGAT CTCTATCCAC GCGGCGGTCA TGTCGAGCAG 
2701 GCGACTTTCT GGACTGGTCT GCGCCCGATG ACGCCAGACG GCACGCCGGT TGTCGGGCGT 
2761 ACACGCTTTA APA?TCTGTG GCTGAZTACC GGTCACGGCA CGCTCGGCTG GACGATGGCT 
-136- 
2821 TGCGGTTCCG GTCAGTTGTT AAGCGATCTG CTCTCTGGTC GCACGCCAGC GATCCCATAT 
2881 GAGGATCTAA GCGTAGCGCG CTACAGCCGT GGATTTACGC CATCACGTCC GGGCCATTTA 
2941 CATGGCGCAC ACAGCTAAGG AAACGAGATG ACCCGTCCGA TACAGGCCAG CCTCGATCTG 
3001 CAGGCATTAA AACAGAATCT GTCCATTGTC CGCCAGGCCG CGACGCACGC GCGCGTCTGG 
3061 TCGGTGGTAA AAGCGAACGC TTACGGGCAT GGTATTGAGC GTATCTGGAG CGCGATCGGG 
3121 GCCACCGATG GCTTTGCATT GCTTAACCTG GAAGAGGCAA TAACGTTACG TGAGCGCGGC 
3181 TGGAAGGAC CGATCCTGAT GCTGGA1GGA TTTTTCCATG CTCAGGATCT GGAGATTTAT 
3241 GACCAGCACC GCCTGACCAC CTGCGTACAC AGCAACTGGC AGCTCAAAGC ACTGCAAAAT 
3301 GCGCGGCTAA AAGCACCGTT GGATATTTAT CTTAAGTGA ACAGTGGGAT GAATCGGTTG 
3361 GGCTTCCAGC CCGATCGCGT GCTTACCGTC TGGCAGCAGT TGCGGGCAAT GGCGAATGTT 
3421 GGCGAAATGA CCCTGATGTC GCATTTTGCC GAAGCGGAAC ATCCTGATGG AATTTCCGGC 
3481 CGGATGGCGC GTATTGAGCA GGCGGCGGAG GGGCTGGAGT GTCGGCGTTC GTTGTCCAAT 
3541 TCGGCGGCGA CTCTGTGGCA CCCGGAAGCG CATTTTGACT GGGTTCGGCC TGGCATTATT 
3601 TTGTATGGCC GTTCGCCGTC CGGTCAGTGG CGTGATATCG CCAATACCGG ATTACGTCCG 
3661 GTGATGACGC TAAGCAGTGA GATTATTGGT GTCCAGACGC TAAAAGCGGG CGAGCGTGTG 
3721 GGCTACGGCG GTCGCTATAC TGCGCGCGAT GAACAGCGAA TCGGCATTGT CGCCGCAGGG 
3781 TACGCCGACG GTTATCCGCG CCACGCCTTA ACCGGTACCC CTGTTTTAGT GGACGGCGTG 
3841 CGCACCATGA CGGTGGGGAC CGTCTCGATG GATATGCTAG CGGTCGATTT AACGCCTTGC 
3901 CCGCAGGCGG GTATTGGTAC GCCGGTTGAG CTGTGGGGCA AGGAGATCAA AATTGATGAT 
3961 GTCGCCGCCG CTGCCGGAAC GGTGGGCTAT GAGTTGATGT GCGCGCTGGC CGTACGCGTC 
4021 CCGGTTGTGA CGGTGTAACT TGTTGTAAGC CGGATCGGAG GCAACGTCTT CTGGGTGCAA 
- 137- 
l)PdceS 
11.4.2. metB gene 
The sequences highlighted in red are the homologous regions of the primers used to 
replace the fragment in between by chloramphenicol resistance. The sequences in 
bold are the priming sequences used to check the deletion. 
1 	ATGACGCGTA AACAGGCCAC CATCGCAGTG CGTAGCGGGT TWTGACGA CGAJCAGTAT 
61 	GGTTGCGTTG TCCCACCGAT CCATCTTTCC AGCACCTATA ACTTTACCGG ATTTAATGAA 
121 CCGCGCGCGC ATGATTACTC GCGTCGCGGC AACCCAACGC GCGATGTGGT TCAGCGTGCG 
181 CTGGCAGAC TGGAAGGTGG TGCTGGTGCA GTACTTACTA ATACCGGCAT GTCCGCGATT 
241 CACCTGGTAA CGACCGTCTT TTTGAAACCT GGCGATCTGC TGGTTGCGCC GCACGACTGC 
301 TACGGCGGTA GCTATCGCCT GTTCGACAGT CTGGCGAAAC GCGGTTGCTA TCGCGTGTTG 
361 TTTGTTGATC AAGGCGATGA ACAGGCATTA CGGGCAGCGC TGGCAGAAAP ACCCAAACTG 
421 GTACTGGTAG AAAGCCCAAG TAATCCATTG TTACGCGTCG TGGATATTGC GAAAATCTGC 
481 CATCTGGCAA GGGAAGTCGG GGCGGTGAGC GTGGTGGATA ACACCTTCTT AGCCCGGCA 
541 TTACAAAATC CGCTGGCATT AGGTGCCGAT CTGGTGTTGC ATTCATGCAC GAAATATCTG 
601 A1CGGTCACT CAGACGTAGT GGCCGGCGTG GTGATTGCTA AAGACCCGGA CGTTGTCACT 
661 GAACTGGCCT GGTGGGCAAA CAJTATTGGC GTGACGGGCG GCGCGTTTGA CAGCTATCTG 
721 CTGCTACGTG GGTTGCGAAC GCTGGTGCCG CGTATGGAGC TGGCGCAGCG CAACGCGCAG 
781 GCGATTGTGA ATACCTGCA ACCCAGCCG TTGGTGAAAA AACTGTATCA CCCGTCGTTG 
841 CCGGAAAATC AGGGGCATGA 1ATTGCCGCG CGCCAGCAAA A7GGCTTTGG CGCAATGTTG 
901 AGTTTTGAAC TGGATGGCGA TGAGCAGACG CTGCGTCGTT TCCTGGGCGG GCTGTCGTTG 
961 TTTACGCTGG CGGAATCATT AGGGGGAGTG GAAAGTTTA1 TCTCTCACGC CGCAACCATG 
1021 ACACATGCAG GCATGGCACC AGAAGCGCGT GCTGCCGCCG GGATCTCCGA GACGCTGCTG 
1081 CGTATCTCCA CCGGTATTGA AGATGGCGAA GATTTAATTG CCGACCTGGA AAATGGCTTC 
1141 CGGGCTGCAA ACAAGGGGTA A 
- 138- 
Amycolatopsis species TS-1-60 
Amycolatopsis orientalis 
Deinococcus radiodurans 
NAAAR from pRS7-1 
NAAAR from variant pRS7-1/3p2 
Amycolatopsis species TS-1--60 
Amycolatopsis orientalis 
Deinococcus radiodurans 
NAAAR from pRS7-1 
NAAAR from variant pRS7-1/3P2 
1 	 20 	 40 	 60 





61 	 80 	 100 	 120 
(54) LYSSEYNDGAEHLRHYLIPALLAEDITAKVTPLLAJ(FKGHRJIKGALEVLDAELR 




Amycolatopsis species TS-1-60 
Amycolatopsis orientalis 
Deinococcus radiodurans 
NAAAR from pRS7-1 
NAAAR from variant pRS7-1/3P2 
Amycolatopsis species TS-1-6O 
Amycolatopsis orientalis 
Deinococcus radiodurans 
NAAAR from pRS7-1 
NAAAR from variant pRS7-1/3P2 






181 	 v 200 	 220v 	 240 
(174) RAVRERFGDDVLLQVDANTAYTLGDAPQLARLDPFGLLLIEQPLEEEDVLGHAELARRIQ 
(174) RQVRERFGDDVLLQVDANTAYTLGDAPLLSRLDPFDLLLIEQPLEEEDVLG.TJELRIR 




241 V 	 260 	 280 	 300 
(234) TPICLDESIVSARAAADAIKLGAVQIVNIKPGRVGGYLEARRVHDVCAPJ.IGIPVWCGGMI 
(234) TPICLDESIVSAKAAADAIKLGACQIVNIKPGRVGGYLEARRVHDVCAAHGIAVWCGGMI 




301 	 320 	 340 	 360 
(294) ETGLGRANVALASLPNFTLPGDTSASDRFyKTDIT -EPFVLSGGHLPVPTGPGLGVAPI 
(294) ETGLGRAANVALASLPGFTLPGDTSASGRFYRTDIT-EPFVLDAGHLPVPTGPGLGIITPI 
(300) ESGIGRAHNIHLSTLSNFRLPGDTSSASRYWERDLIQEPLEAVDGLMPVPQGPGTGVTLD 
(296) ETGLGRAANVALASLPNFTLPGDTSASDRFYKTDIT -EPFVLSGGHLPVPTGPGLGVAPI 
(296) ETGLGRAANVALASLPNFTLPGD'rSASDRP'YKTDIT -EPFVLSGGHLPVPTGPGLGVAPI 
Amycolatopsis species TS-1-60 
Amycolatopsis orientalis 
Deinococcus radiodurans 
NAAAR from pRS7-1 
NAAAR from variant pRS7-.1/3P2 
Amycolatopsis species TS-1-60 
Amycolatopsis orientalis 
Deiriococcus radiodurans 
NAAAR from pR57-1 
NAAAR from variant pRS7-1/3P2 
Amycolatopsis species TS-1-60 
Amycolatopsis orientalis subsp. lurida 
Deinococcus radiodurans 
NAAAR from pRS7-1 
NAAAR from variant pRS7-1/3P2 






Comparison of the amino acid sequences of N-acylamino acid racemase from A. sp. TS-1-60, A. orientalis and D. radiodurans, and 
the ones expressed from pRS7-1, and its variant from pRS7-1/3P2. Sequence alignment by Vector NTI suite 6.0. 
The following colour representations were used to characterise the different amino acids: Identical residue; Conservative residue; 
Block of similar residue; Weakly similar residue; Non-similar residue. 
The acid/base catalysis sites are indicated by "•"; the metal ion binding residues are indicated by "7". The position of the variant 
pRS7-1/3P2 mutation was highlighted in red and indicated by".". 
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D-Amino Acid Tolerant Hosts 	Sci. 
D-Amino Acid Tolerant Hosts for D-Hydantoinase Whole Cell 
Biocatalysts 
By Robert]. Turner, Jo/in Aikens, Sylvain Royer, Louis DeFilippi, Abigail Yap, Denise Holzle, Neil Somers, 
and Ian G. Fotheringham* 
Whole cell biocatalysts which enable the concerted use of D-hydantoinase, D-carbamoylase, and racemase enzymes are valu-
able for the production of D-amino acids. However, Escherichia coli host strains used for this purpose efficiently degrade 
D-amino acids. This work demonstrates that D-amino acid degradation occurs largely through the concerted action of D-amino 
acid dehydrogenase, encoded by the dadA gene, and D-serine dehydratase, encoded by the dsdA gene. Deletion mutants of 
E. coli which lack these activities were constructed and compared against wild type strains in D-amino acid degradation. An 
E. coli dadA mutant reduced the degradation of D-methionine by one third, D-phenylalanine by two-thirds, and D-2-amino-
butyric acid nearly completely. Even though the dadA mutant had no effect on D-serine degradation, a dadA dsdA double 
mutant of E. coli additionally reduced degradation of D-serine, as well as D-phenylalanine, almost entirely. These strains are 
appropriate hosts for whole cell biosynthesis of D-amino acids using general approaches such as the hydantoinase system. 
1 Introduction 
The hydantoinase/carbamoylase process is well estab-
lished as an efficient means to produce D-amino acids by the 
dynamic kinetic resolution of D/L 5-monosubstituted hydan-
toins [1,2]. D-amino acids are now in increasing demand as 
valuable intermediates in the development of new pharma-
ceuticals including peptidornimetic drugs and recent ad-
vances in directed evolution and genomic approaches seem 
likely to expand the utility of the hydantoinase process in 
the manufacture of both D- and L-amino acids [3]. The effi-
ciency and enantioselectivity of the process requires the con-
certed use of a hydantoinase biocatalyst with it carbamoylase 
and, depending on the substrate, a racemase biocatalyst. It is 
therefore important to the overall process economics to pro-
duce these biocatalysts efficiently. Direct application of Es-
cheric/iia coli whole cell biocatalysts which produce each of 
the required enzymes from cloned genes has been shown to 
be extremely suitable for this purpose [4]. However, E. coli 
has been previously shown to be capable of D-amino acid 
degradation through the action of endogenous oxidoreduc-
tase enzymes which can efficiently catabolise D-amino acids 
to their corresponding keto acids [5-8]. In particular the D-
amino acid dehydrogenase (D-AAO) encoded by the E. coli 
dadA gene, encodes a dehydrogenase with broad substrate 
specificity for D-amino acids. This ability to degrade D-anii-
no acids, compromises the usefulness and breadth of applica-
tion of an otherwise efficient and scalable industrial route to 
produce D-amino acids. We report here, the construction 
and application of E. coli mutants deleted in the dadAX op-
eron and also in the dsdA gene, encoding D-serine dehydra-
tase and demonstrate that the use of such mutants as host 
[*1 	1. Fotheringham, author to whom correspondence should be addressed, 
e-mail: cmbral@mae.com),  R. S. Turner, S. Aikcns, S. Royer, L. DeFilippi, 
A. Yap, D. HoIzIe, N. Somers, deCODE Genetics, 2501 Davey Road, 
Woodridge IL 60517, USA. 
cells can significant reduce the catabolism of D-amino acids 
in metabolically active whole cells of E. coli. 
2 Materials and Methods 
Strains 
Strains designated CGSC were obtained from the Coli 
Genetic Stock Center (Yale University, CT). The following 
strains were used in this work. E. coli CGSC7177 (metA28, 
X), CGSC6563 [rnetB185, araD139, A(argF-lac)169, ?C, f/b-
5301, AdadA 247, trpB202, fruA25, re/Al, rpsLl50(str R),  
deoCl], BW25I13 [A(araD-araB)567, AlacZ 4787 (::ppvB-4) 
(A/ac Jp-4000(/acl"), ?, rpoS396(Am), rph-1, A(r/iaD-rhaB)-
568, rrnB-4, hsdR514)] [9], ET2 (BW25113, AdadAX::cat'), 
ET3 (ET2, AdadAX:: cat's), ET4 (ET3, AdsdA::kan')Plas-
mids. 
Reagents 
General reagents used in this work such as media, sub-
strates, and antibiotics were obtained from Sigma-Aldrich 
(St. Louis, MO). Enzymes for restriction and ligation of 
DNA were obtained from NEB (Beverly, MA) and used ac-
cording to standard protocols [10]. 
Oligonucleotides 
Oligonucleotides used to amplify the chloramphenicol re-
sistance marker from plasmid KD3 [9], used in the deletion 
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Oligonucleotides used to confirm the deletion of dadAX 
in BW25113 were as follows: 
5'-CCACTAATCCGC]ITCTGAACG-3' and 
5'-CTCCGATCCGGCTTACAACAAG-3' 
Oligonucleotides used to amplify the kanamycin resis-
tance marker from plasmid KD13 [9], used in the deletion of 




5'-GCAGCATCGCTCACCCAG G GAAAGGATTG CG-
ATGCTGCGTFGAAACrn17AATGGGAArFAGCCAT 
GGTCC-3' 
Oligonucleotides used to confirm the deletion of dsdA in 




Deletion of the dadAX and dsdA genes was carried out 
according to the protocol of Wanner ci al. [9] in which anti-
biotic resistance markers from the vectors pKD3 (chloram-
phenicol resistance) and pKDI3 (kanamycin resistance) 
were amplified by PCR primers which provide flanking se-
quences homologous to the target genes. Fragments of DNA 
capable of expressing antibiotic resistance markers were 
thus used to replace fragments of target genes by homolo-
gous recombination and could be subsequently removed by 
the use of a temperature sensitive helper plasmid pCP20. 
Microbial Culturing and DNA Manipulation 
General molecular biology procedures were carried out 
using standard protocols and enzymes used according to 
manufacturers' recommendations [10]. Strains were cultured 
on LB medium for routine cloning and preparation of cells 
for assay. Antibiotics, ampicillin (100 fLg/mL), kanamycin 
(50 ftglmL), and chloramphenicol (25 sg/mL) were supple-
mented as appropriate. Amplification of DNA by PCR was 
carried out using the HF PCR kit from Clontech (Palo Alto, 
CA). Preparation and manipulation of DNA fragments was 
carried out using QIAGEN (Valencia, CA) midi and mini 
molecular biology kits. Transformation of E. coli strains was 
carried out by electroporation using a BioRad GenePulser 
II with Pulse Controller. 
3 Amino Acid Degradation Assay 
Assays to study the degradation of the amino acids 
D-methionine, D-2-arninobutyric acid, D-phenylalanine, or 
D-serine by E. coli cells were carried out using freshly cul-
tured whole cells of BW25113, ET3, or ET4. Shake flasks 
containing 200 mL of LB were inoculated from 5 mL over-
night LB cultures of BW25113, ET3, or ET4 and grown to 
an 0.13.600 of 0.8. Cells were then harvested by centrifuga-
tion at 5,000 G for 20 minutes, washed in saline and used 
for assay of amino acid degradation at a concentration of 
100 mg/mL wet cell weight. In addition to the whole cells, 
the assay mixture contained 50 mM amino acid substrate in 
50 mM phosphate buffer at pH 8.0. Assays were carried out 
at 30°C for 10 hrs or 24 hrs, as indicated, with gentle agita-
tion. Analysis of amino acid degradation was determined 
from the absorbance of residual amino acids following deny-
atization by the AccQ-Tag method and HPLC (Waters Cor-
poration, MA). 
3.1 Results 
An initial qualitative study was undertaken to examine 
the effect of a deletion mutation in dadA upon D-methio-
nine degradation by resting cells of E. coli K12. For this 
purpose two strains obtained from the CGSC were com-
pared. The HPLC profiles of the incubation of D-nie-
thionine with cells of CSSC7177 (wild type dadA) or 
CGSC6563 (AdadA247) are shown in Fig. 1. Significant loss 
of D-methionine and appearance of its corresponding keto 
acid, 4-rnethylthio-2-oxobutyric acid, was apparent in the 
presence of CSSC7177 cells with no significant conversion 
evident in the presence of cells of strain CGSC6563. The ap-
pearance of 4-methylthio-2-oxobutyric acid strongly sug-
gested a significant role for the dadA gene product in this 
result. However, these strains were not isogenic and con-
tained additional mutations, including one in the methionine 
biosynthetic pathway, which could also account for this ob-
servation. Therefore, we next constructed strains of E. coli 
which differed only in the deletion of the dadAX region. 
The E. coli K12 strain BW25113 was chosen as the host 
for gene deletion studies due to its ara genotype which ren-
dered the strain particularly appropriate to the particular 
gene deletion protocol used. Using this approach, the da-
dAX operon of BW251 13 was replaced almost entirely by 
the chloramphenicol (cml) resistance marker derived from 
pKD3. The resulting strain, ET2, (BW25113 AdadAX::cm/') 
was then cured of the cml resistance marker using the 
plasmid pCP20 to yield the cml' strain ET3 (BW25113 
AdadAX). Confirmation that gene fragments had recom-
bined at the corresponding genomic targets was obtained 
from PCR fragments generated by primers which flanked 
the dadAX regions of homologous recombination in the 
ET2, ET3, and ET4. These showed that the 2.6 kb fragment 
of the wild type dadAX operon of BW25113 had been 
replaced in ET2 by a 1.7 kb fragment corresponding to the 
deletion mutation containing the cml resistance gene. Fol-
lowing removal of the cml marker from ET3, the 1.7 kb frag-
ment was replaced by the expected 0.7 kb PCR fragment. 
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Figure 1. HPLC profile of the degradation of D-niethionine by resting cells of E. co/i following 24 In incuba-
tion at 30CC. A) D-niethionine in the absence of cells. B) D-methionine incubated with 100 mg/noL wcw 
CGSC7I77 (wild type dadA). C) D-rnethioninc incubated with 100 niglmL wcw CGSC6563 (zdadAX). 
D) u-Keto acid standard. In each assay, D-rncthioninc was present at 50 mM in 50 mM phosphate buffer 
pFI 8.0. 
Similarly, the 1.6 kb fragment of the 
wild type dsdA operon of ET3 was 
shown to have been replaced in ET4 
by a 1.9 kb fragment corresponding 
to the deletion mutation containing 
the kanamycin resistance gene. 
Strains BW25113 and ET3 were 
then cultured for D-amino acid deg-
radation analysis. Degradation of 
D-amino acid substrates following 
10 hr incubating of either strain with 
D-methionine, 	D-phcnylalaninc, 
D-2-aminobutyric acid, or D-serine 
is shown in Tab. 1. The results indi-
cate that the elimination of D-amino 
acid dehydrogenase by deletion of 
the dadAX operon results in moder-
ately reduced degradation of 
D-methioninc by whole cells of 
E. coli. The effect of the dadAX 
deletion is however considerably 
greater upon D-phenylalanine and 
D-2-aminobutyric acid where degra-
dation of D-phenylalanine is reduced 
to 11.6% from 37.4% and degrada-
tion of D-2-aminobutyric acid is 
completely eliminated. In ET3, the 
complete degradation of D-serine re-
mains unaffected by mutation of 
dadAX. 
The dsdA gene of strain ET3 was 
then replaced by the kanarnycin 
(kan) resistance marker of pKD13 
using a similar approach to the dele-
tion of dadAX operon. The resulting 
strain, ET4 (BW25113 AdadAX, 
AdsdA::kanr) was then cultured in 
LB medium as before with BW25113 
and ET3 and harvested for amino 
acid degradation assays. The results 
of incubation of ET4 with D-rnethio-
nine, D-phenylalanine, D-2-amino-
butyric acid, and D-serine are shown 
in Tab. 2 in comparison to the earlier 
data generated using BW25113 and 
ET3. The results show that deletion 
of both the dadAX operon and the 
dsdA gene effectively abolishes the 
degradation of D-phenylalanine and 
D-2-aminobutyric acid in ET4 and in 
addition, mutation of dsdA reduces 
degradation of D-serine fromlOO % 
to 7 % in 10 hrs, indicating that 
D-serine dehydratase is the major 
D-serine catabolic activity in E. coli 
K12. 
0 	6 	10 	12 	14 
	
16 	15 
Retention Time aunt 
Eng. Life Sri. 2004, 4, No. 6 	httpi/www.els-journal.de 	© 2004 WILEY-VCH Verlag GrnhH & Co. KGaA, Weinheim 	 3 
Eng. 
Life 
Sci. Full Paper 
Table 1. Effect of dadA mutation upon degradation of D-amino acids by E.co/i. 
Values represent percentage loss of D-amino acid from initial concentrations 
present in the assay. Assay mixture contained cells at 100 mg/mE wcw, 50 m 
amino acid substrate in 50mM phosphate buffer at pH 8.0. Assays were carried 
out at 30°C for it) hrs. 
Strain D.Met D-Piic D-Abu D-Ser 
11W25113 -13.8 -37.4 -34.4 -If))).)) 
ET3 -8.7 -11.6 2.5 -100.0 
Table 2. Effect of dadit and cisdA mutation upon degradation of D-amino acids 
by Ecu/i. Values represent percentage loss of D-amino acid from initial 
concentrations present in the assay. Assay mixture contained cells at 1081mg/niL 
wcw, 50 mM am no acid substrate in 50 mM phosphate buffer at pH 8.)). Assays 
were carried out at 30°C for 10 hrs. 
Straiii D-Met D-Phe D-Abu D-Ser 
11W25113 -13.8 -37.4 -34.4 -100.0 
ET3 -8.7 -11.6 2.5 -if))).)) 
.ET4 -9.0 2.3 -1.6 -7.0 
3.2 Discussion 
Deletion mutations in the dadA and dsdA genes encoding 
D-amino acid dehydrogenase and D-serine dehydratase, re-
spectively, were constructed to investigate their effect upon 
catabolism of D-amino acids by resting whole cells of E. coli. 
The studies showed that degradation of commercially impor-
tant D-amino acids such as D-methioninc, D-phenylalanine, 
D-2-aminobutyric acid, and D-serine by F. coli can be signif-
icantly reduced or eliminated through these mutations. The 
dadX gene, encoding alanine raccmase, was also deleted as 
part of the dadAX operon, but is not likely to be implicated 
in D-amino acid catabolism. Under the assay conditions 
used, enzymatic degradation of particular D-amino acids by 
E. coli cells with wild type dadA and dsdA genes, occurs at 
significantly different rates. While D-methionine is slowly 
oxidized to 4-methylthio-2-oxobutyric acid, D-phenylala-
nine, D-2-aminobutyric acid are more rapidly degraded and 
D-serine is completely eliminated after 10 hrs. This is an im-
portant consideration if E. coli is to be considered as an ap-
propriate host organism for the manufacture of a variety of 
D-amino acids using a broadly applicable bioprocess such as 
the hydantoinase method. The demonstration that deletion 
mutants of E. coli such as the ET3 and ET4 strains described 
in this work do not significantly degrade a range of D-amino 
acids, significantly increases the potential to use K coli host 
strains such as these in applied bioprocesses. 
Acknowledgments 
The authors would like to acknowledge Degussa AG and 
deCODE Genetics Inc. for the provision of financial support 
and excellent research facilities for this work. Also the scien-
tific support and contributions from Dr. Oliver May and Dr. 
Stefan Verseck of Degussa are gratefully acknowledged. 
Received: August 17, 2004 [CET 21651 
References 
lii C. Sylda)k, ci a)., Microbial and enzymatic production of L-amino acids 
from D L-5-monosubstituted hydantoins, in l3iocatalvtic Production of 
,dnnno Acids and Derivatives (Eds: J. D. Rozzcl I. F. Wagner), I lansc r, 
New York 1992, p. 131-176. 
121 C. Syldatk ct at., Microbial and enzymatic production of D-amino acids 
from DL-5-monosubstitutect hydantoins, in Biocatalytic Production of 
Amino Acu/,c and Derivatives (Eds: 3. D. Rozzell, F. Wagner), Hauser, 
New York 1992, p.  75-127. 
131 0. May, P. T. Nguyen, F. Arnold, Inverting Enantioselectivity by 
Directed Evolution of Hydantoinase for Improved Production of L-
Methiomne, Nat. Biciiechnol. 2000, 18, 317-320. 
141 0. May et a)., Development of Dynamic Kinetic Resolution Processes 
for Biocatalytic Production of Natural and Nonnatural L-Amino Acids, 
Org. Process Rev. Dcv. 2002, 6, 452-457. 
J. Kuhn, R. L. Somerville, Uptake and utilization of aromatic D-amino 
acids in Escherichia coli K12, BBA 1974, 332 (2), 298-312. 
S. Wild, T. Klopotowski. D-Aniino acid dehydrogenase of Escheric/iia 
coli K12: Positive selection of mutants defective in enzyme activity and 
localiization of the structural gene, Mal. Grit. Genet. 1981. /81, 373-378. 
3. Wild, B. Obrepaiska, Regulation of expression of the dadA gene 
encoding D-amino acid dehydrogenase in Escherichia coli: Analysis of 
dadA-lac fusions and direction of dadA transcription, Mo/. Gm. Genet. 
1982, 186, 405-410. 
5. Wild et al. D-Aniino acid dehydrogenase: The enzyme of the first step 
of D-histidmne and D-methionine racenhization in Salmonella typhimur-
iuns, Mo/er. Grit. Genet. 1974. /28, 131-146. 
K. A. Datsenko, B. L. Wanner, One-step inactivation of chromosomal 
genes in Esrheric/iics coli K-12 using PCR products, PNAS 2000, 97(12), 
6640-6645. 
T. Manialis, E. F. Fritsch, J. Sambrook, Molecular C/oning:A Laboratory 
Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor NY 1982. 
© 2004 WILEY-VCT-I Verlag GmhI-T & Co. KGaA, Weinheim 	http://www.els-journal.de 	Eng. Life Sci. 2004, 4, No. 6 
